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There are multiple instances where standard methods in evolutionary approaches to 
studying human behaviour cannot easily test causality and/or examine the effects of 
psychological mechanisms on reproductive success. For example, research into life 
history theory, where manipulation of exposures is not typically possible, has previously 
been limited to standard analytical approaches that remain vulnerable to potential 
confounding bias. Additionally, although there has been a longstanding cliff-edge 
hypothesis for the maintenance of schizophrenia, investigation has been limited due to the 
constraints of family studies and the inability to manipulate the exposure or test long 
terms outcomes such as fitness.  
Mendelian randomization combines genetic and phenotypic information to investigate 
psychological and key evolutionary traits with fitness outcomes using a causal framework 
that does not rely on manipulating the exposure. I applied Mendelian randomization and 
other related methods to these two areas of evolutionary human behaviour research. 
According to life history this theory, earlier age at menarche and age at first sexual 
intercourse can be viewed as directing effort towards reproductive goals as part of a fast 
life history strategy and therefore show causal effects on reproductive and behavioural 
outcomes. The schizophrenia paradox refers to the evolutionary conundrum for how 
schizophrenia, a heritable disorder, is maintained in the population despite being 
associated with lower reproductive success for those diagnosed. 
I find some evidence that earlier age at menarche is causally related to traits that 
characterize a fast life history strategy, such as earlier age at first and last birth and lower 
educational attainment. Additionally, it appears that increased genetic liability for 
schizophrenia does not confer a fitness advantage and therefore the disorder is likely 
maintained through other explanations than cliff-edge effects. This thesis is novel in its 
application of epidemiological methods to test evolutionary theories of human behaviour 
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1.1 Thesis motivation and aim 
There are multiple instances where standard methods in evolutionary approaches to 
studying human behaviour cannot easily test causality and/or examine the effects of 
psychological mechanisms on reproductive success. The ability to make stronger causal 
inference by using genetic variants as instrumental variables has resulted in the rapid 
uptake of this method, Mendelian randomization (MR), within epidemiology. For my 
doctoral work, I aimed to apply MR and other related methods to two areas of research – 
life history theory (concentrating on age at menarche and age at first sexual intercourse) 
and the schizophrenia paradox. 
To my knowledge, my work here is the first to apply MR to these evolutionary questions. 
I was therefore highly motivated by the promise that this method holds to revolutionise 
evolutionary approaches and ultimately contribute to a better understanding of the causes 
and consequences of apparently maladaptive behaviour. I came to this PhD with an 
interest in evolutionary theory and approaches to behaviour, but with limited background 
in genetics or experience of statistical analysis and epidemiological methods for handling 
large, complex datasets. Due to this, I was grateful for the opportunity to conduct mini 
projects in the first year of this PhD programme and start the steep learning trajectory in 
order to gain these skills. I have since become very interested in the field of genetic 
epidemiology and hope to continue research in this area. 
1.2 Evolutionary approaches to behaviour 
Proposed in the mid-19th century, evolutionary theory describes the process of how traits 




refers to individual differences in survival and reproduction due to differences in 
observable traits, termed phenotype (Darwin, 1859). Although natural selection acts on 
the phenotype, the genetic basis of these traits is passed on intergenerationally. The 
genetic basis of traits is termed the genotype, which increases or decreases in frequency 
over generations depending on the differential reproduction of individuals. Selection 
therefore gives rise to adaptive traits when a certain phenotype leads to a reproductive 
advantage and the genotype is therefore passed onto more offspring. Requirements for 
selection include variation between individuals, that this variation is heritable (a 
proportion is explained by genotype) and that it causes differential reproductive success 
(Darwin, 1859). Reproductive success is measured by how many of an individual’s 
offspring also reproduce, although it is often proxied by the number of children that an 
individual has (Daly & Wilson, 1999). Fitness is a term also used to describe the number 
of children that an individual has. 
Evolutionary theory can explain the existence of traits, both physical and behavioural, 
and has been successful in providing a framework for many areas of study, including 
mate choice, cooperation and individual differences (see Tooby & Cosmides, 1990, or 
Daly & Wilson, 1999). I focus on human traits in this thesis. There are two main 
evolutionary approaches to studying human behaviour: evolutionary psychology (EP) and 
human behavioural ecology (HBE). There is debate between these two approaches about 
how to define and measure adaptions, mainly due to each approach adopting a different 
level of explanation (Daly & Wilson, 1999). These levels of explanations were proposed 
by Tinbergen (1963) and provide distinct but complementary investigations of behaviour. 
According to Tinbergen (1963), for an integrative understanding of behaviour, 
investigations should include both ‘proximate’ and ‘ultimate’ (sometimes referred to as 
functional) levels of explanation. Proximate explanations incorporate how an individual’s 
behaviour occurs, such as the psychological mechanisms that causes a behaviour within a 
specific immediate context (see section 1.2.2.1 for example). Ultimate explanations focus 
on why a trait has evolved, such as why a behaviour is adaptive and increases 
reproductive success (see section 1.2.1.1 for example). In order to have a complete 
understanding of behaviour, there should also be knowledge of ontogeny (proximate 
explanations over time) and phylogeny (ultimate explanations over time) of a behaviour 
rather than only investigation of individuals today (Tinbergen, 1963). See Figure 1:1 for 
an illustrative summary.  
I now discuss the EP and HBE approaches in turn, highlighting some limitations in their 




of explanation and discussing whether the methods typically used in each approach allow 
for causal conclusions. I will then discuss the potential that MR may hold to overcome 
these limitations and provide a new form of evidence. 
 
Figure 1:1 Summary of introductory structure and thesis approach. 
 
1.2.1 Evolutionary psychology 
The EP approach aims to investigate psychological mechanisms underlying human 
behaviour and their evolution (Ketelaar & Ellis, 2000). This approach assumes that the 
human brain is formed of specialized mechanisms to solve specific problems, particularly 
ones encountered in stable environments over the ancestral period (Tooby & Cosmides, 
1990). These specialized mechanisms are thought of as evidence of ‘good’ design that we 
can examine today, where ‘good’ design would indicate selection for the trait through 
benefits to an individual’s reproductive success and this successful design is therefore 
termed ‘good’ (Tooby & Cosmides, 1990). From this, EP focuses on whether 
psychological mechanisms demonstrate features expected of ‘good’ design to solve a past 
problem, arguing that such evidence is adequate for determining whether a trait is 
adaptive. By considering this evidence as adequate, the approach does not actually 
measure reproductive success and regards current fitness-associations as irrelevant to 
present design, with any environmental changes considered too recent for evolution 




focuses on proximate explanations for behaviour although it assumes ultimate 
explanations led to the evolution of any given mechanism (Tinbergen, 1963).  
1.2.1.1 Methodology 
To investigate psychological mechanisms, EP relies on experiments and observational 
studies (particularly with self-report questionnaire data). For example, one area that has 
been widely investigated in EP is attractiveness, with many experimental studies on 
attractiveness evaluating whether mechanisms are in place to recognise facial cues as a 
signal of mate quality that could lead to increased reproductive success. One such study 
manipulated the exposure of male facial stimuli to be more masculine or feminine and 
assessed whether preferences change over the menstrual cycle to reflect a psychological 
mechanism designed to promote adaptive choices (Penton-Voak & Perrett, 2000). Again, 
whether these preferences actually result in increased reproductive success is not tested in 
EP investigations. 
This narrow focus on mechanistic design characteristics as proxies for fitness is a 
limitation of the EP approach (Penton-Voak, 2011). Effects on reproductive success are 
required for selection to act and for a behaviour to be termed adaptive and the EP 
approach only assumes this. If attractiveness judgements are proposed as part of a suite of 
adaptive mechanistic behaviours that serve the ultimate goal of successful reproduction, 
possibly via health benefits, then it is important to actually empirically test the likelihood 
of a successful outcome (Penton-Voak, 2011). EP investigations do not therefore provide 
a direct test of selection.  
A further limitation of EP methodology is the lack of ecological validity in experiments, 
where experiments do not approximate the real-world that is being examined and 
therefore the extent that findings can be generalized to a real-life setting is limited. For 
example, facial stimuli in attractiveness experiments are often manipulated composites of 
faces and may therefore not be generalizable to the mating decisions of real faces outside 
of experimental settings. On the other hand, this experimental methodology is also a 
strength of the EP approach as we can be more confident that a change in the outcome is 
due to the condition or exposure and assume exchangeability, meaning that the risk of an 
outcome in one group is the same as the risk in another group had they obtained the same 
value of the exposure (Hernán, 2004). Theoretically, we can never be completely certain 
about our causal conclusions as the counterfactual is, in reality, never observed (Hernán, 
2004; Pingault et al., 2018); the counterfactual is the ‘other’ value of the exposure, that 




allows for exchangeability by creating groups that are balanced for potential confounding 
factors (a common cause of the exposure and outcome that produces spurious 
associations) (Hernán, 2004). Due to this, randomized controlled experiments, as 
sometimes used in EP, are placed at the top of the evidence hierarchy for causal inference 
methodology (Davies, Holmes, & Davey Smith, 2018). Overall, it is therefore important 
to consider the ability of methods to provide causal evidence. Experiments, which are 
often used in EP, allow for causal inference but are limited in what exposures can be 
manipulated in an experimental setting and important evolutionary outcomes such as 
fitness cannot be measured. Therefore, although the experimental method tests causation, 
links between experimental evidence and evolution in this context are always indirect. 
Another type of methodology used in EP is observational studies as there are 
circumstances where it is not possible to manipulate exposures for experimental designs 
(Rohrer, 2018). For example, standard analytical approaches applied to observational data 
have been used to examine life history theory in humans where it is not possible to 
manipulate developmental environments or reproductive behaviours (discussed further 
below) (Nettle, Frankenhuis, & Rickard, 2012; Richardson, Harrison, Hemani, & Davey 
Smith, 2018). These standard analytical approaches applied to observational data are 
likely to be affected by confounding bias, undermining causal inference (Webb, Bain, & 
Page, 2017). For this reason, these methods are placed lower down the hierarchy of causal 
inference ability (Webb et al., 2017). In traditional observational methods, attempts are 
made to adjust for confounders to try and achieve exchangeability (Webb et al., 2017). 
However, this requires adjustment of all confounders, which may or may not be measured 
(Webb et al., 2017). Furthermore, if a confounder is measured it is still possible that 
measurement error is present, leading to residual confounding (and even bias 
amplification) even if the variable is adjusted for in models, thus biasing causal estimates 
(Webb et al., 2017). In some instances, it is also possible that the outcome is in fact 
influencing the exposure, termed reverse causation (Webb et al., 2017). Reverse causation 
is difficult to address with cross-sectional data in which the temporal relationship 
between the exposure and outcome is less clear than in longitudinal studies (Webb et al., 
2017). Overall, this means that EP hypotheses that cannot be tested in an experimental 
setting, and therefore use observational data instead, can be limited in the ability for 
causal conclusions. 
1.2.1.2 Genetics 
Some evolutionary psychologists argue that fitness-relevant traits will not show heritable 




fitness genetic variant over time (Tooby & Cosmides, 1990). Therefore, any heritable 
variation indicates no selection acting and a lack of adaptive significance (Tooby & 
Cosmides, 1990). From this, EP regards genetic influences as redundant when studying 
behaviour and focus has been on similarities across humans rather than observed 
variation (Nettle, 2006; Tooby & Cosmides, 1990). If heritable individual variation is 
discussed, such as frequency dependent selection where optimum phenotypes depend on 
the proportion of that phenotype in a population, then this is given very low significance 
(Nettle, 2006). Conversely, others argue that more weight should be given to 
interindividual variation at the genotypic level in humans as this variation is frequently 
observed (see Nettle, 2006). Behaviour geneticists have shown that many important 
fitness traits are highly heritable, demonstrating that the population contains genetic 
variation. For example mental health disorders (Schizophrenia Working Group of the 
Psychiatric Genomics Consortium, 2014) and personality (Nettle, 2006) are heritable 
traits that do show fitness-associations (Nettle, 2006; Nettle & Clegg, 2006). 
This heritable variation can arise through multiple means, such as genetic mutations and 
cost-benefit trade-offs. For example, EP hypothesizes that facial symmetry is used as a 
cue for mate quality. Genetic mutations can cause heritable variation in symmetry and 
therefore have effects on attractiveness and subsequent fitness (Nettle, 2006). For 
personality traits investigated in EP, it is likely that heritable variation persists from trade-
offs of the costs and benefits of behaviours in certain contexts where at any point in space 
and time there is an optimum value of the trait for fitness (Nettle, 2006). These costs and 
benefits therefore have effects on reproductive success, meaning fitness-relevant traits 
can show heritable variation as optimal values differ contextually (Nettle, 2006). If there 
is no cost then selection would act to narrow heritable variation (Nettle, 2006). In this 
thesis, I leverage this heritable variation of evolutionary relevant traits to investigate 
causal effects of age at menarche, age at first sexual intercourse, schizophrenia liability 
and educational attainment on fitness (and other behavioural) outcomes.  
1.2.2 Human behavioural ecology 
Behavioural ecology combines the study of animal behaviour with evolutionary theory to 
study the fitness consequences of a behaviour (Daly & Wilson, 1999; Winterhalder & 
Smith, 2000). When applied to the study of human behaviour, the field is termed HBE 
and was introduced in the mid-1970s (Daly & Wilson, 1999; Winterhalder & Smith, 
2000). In this approach, complex decisions are broken down into a set of rules or 
conditions and individuals are construed as fitness-maximisers (Daly & Wilson, 1999; 




reproductive success of individuals, this approach mainly provides ultimate level 
explanations for human behaviour (Tooby & Cosmides, 1990).  
1.2.2.1 Methodology 
HBE originated through applying models from behavioural ecology in the biological 
sciences to humans via the study of hunter-gatherer optimal foraging models for 
resources. These studies remain at the heart of the approach’s methodology (Daly & 
Wilson, 1999; Winterhalder & Smith, 2000). Contemporary hunter-gatherer societies 
offer natural ‘experimental’ settings for research to investigate how humans have evolved 
(Mulder, 2006). As an example, Mulder (1990, 2006) investigated the fitness-maximizing 
decision making of marital choices among the Kipsigis people of Kenya when 
considering prospective husbands’ resources (land ownership) and their number of 
existing wives. It was found that although women prefer bachelors over polygynists, they 
appear to incorporate a potential husbands’ resources to provide for multiple wives which 
impacts reproductive success (Mulder, 1990, 2006). Again, for an integrative 
understanding of behaviour, investigations should include both proximate and ultimate 
levels of explanation. As these studies only examine differential reproduction today, they 
therefore provide ultimate level explanations (Mulder, 2006). The proximate mechanisms 
underlying how humans reach such an adaptive strategy is often disregarded in HBE 
(Mulder, 2006).  
Through studying individuals in society via natural experiments, the HBE approach uses 
ecologically valid methods. However, by doing so, experimental control is sacrificed and 
confidence in identifying a true causal effect may be diminished compared to a 
randomized experiment. As discussed above, without randomization and manipulation of 
exposures it is difficult to conclude that confounding factors are not causing spurious 
results.  
The focus on ultimate explanations, rather than also incorporating possible mechanisms 
for an integrative understanding of behaviour (discussed in section 1.2), and the lack of 
ability for causal inference are limitations of the HBE approach that I have attempted to 
address in this thesis (Mulder, 1990, 2006). 
1.2.2.2 Genetics 
Evolutionary theory centres around genetic processes yet rarely is genetic data used to 
inform the research (Hadfield, Nutall, Osorio, & Owens, 2007). This applies to the HBE 




underlying mechanisms, genetic influences are ignored (Hadfield et al., 2007; Rubin, 
2016). The HBE approach does not consider this a limitation in determining the 
evolutionary dynamics of a population (Hadfield et al., 2007; Rubin, 2016). This focus on 
the fitness of phenotypes is termed the phenotypic gambit under the assumption that 
phenotypic patterns can be used as predictors of genetic patterns (Hadfield et al., 2007; 
Rubin, 2016). Although the phenotypic gambit does simplify investigations, as 
behaviours are regulated by numerous genes as well as environmental factors and their 
interactions, this deterministic view can lead to false predictions of evolutionary 
hypotheses for human behaviour (Hadfield et al., 2007; Rubin, 2016). Recently, there has 
been increasing recognition that many traits relevant to HBE show polygenic inheritance 
that can be exploited in quantitative genetic methodology to overcome the phenotypic 
gambit and allow for causal conclusions of evidence (Hadfield et al., 2007; Rittschof & 
Robinson, 2014). 
1.3 Mendelian randomization 
Epidemiology is the study of the aetiology, distribution, and control of disease. 
Instrumental variable analysis is a method developed in economics and used within 
epidemiology. An instrument is a variable that robustly predicts the exposure of interest 
and shows no independent association with the outcome that does not act via the exposure 
(Lousdal, 2018). Recently, with the availability of genetic data, genetic variants are 
increasingly used as instruments in epidemiology to estimate causal effects of a 
phenotype of interest on an outcome, termed Mendelian randomization (Davies, Holmes, 
et al., 2018; Kaprio, 2000). The underlying principle of MR is that alleles should be 
randomly distributed within a population and if an allele is also associated with a trait of 
interest then we can look for outcomes that covary with the presence or absence of that 
allele (Conley, 2009). Therefore, by using genetic variants as instruments, MR can mimic 
a randomized experiment and allow for stronger causal inference than standard analytical 
methods by exploiting genetic information to attain reasonable approximation of the 
counterfactual scenario and estimate causal effects (Pingault et al., 2018) (Davey Smith & 
Ebrahim, 2003). It can be therefore be helpful to think of MR as ‘nature’s randomized 
controlled experiment’ in which participants are allocated to different exposure levels due 
to their genetic liability, randomized at conception.  
Genetic variants in MR can be used to instrument or proxy environmental, molecular or 
physiological traits that are affected by the genetic variant (Hemani, Zheng, et al., 2018). 




(Davey Smith & Ebrahim, 2003). Early applications therefore focused on health traits, 
such as C-reactive protein, however the method has more recently been used to 
investigate some psychological traits and/or reproductive behaviours as both exposures 
and outcomes (Day, Helgason, et al., 2016; Gage, Davey Smith, Ware, Flint, & Munafò, 
2016; Gage et al., 2017; Taylor et al., 2016; Wootton, Lawn, et al., 2018). Incorporating 
genetic factors into methodology through MR can also overcome some of the limitations 
discussed above for evolutionary approaches to human behaviour; as MR allows 
investigation of both psychological phenomena (proximate explanations) and fitness 
outcomes (ultimate explanations) it therefore potentially provides a direct test of 
evolutionary hypothesis by empirically testing the likelihood of increasing reproductive 
success for any given mechanism or trait. In this way, MR can help to integrate EP and 
HBE approaches and their levels of explanation for more satisfactory evolutionary 
accounts of behaviour and provide a new form of evidence (Tinbergen, 1963). Attempts 
to reconcile these approaches have been done previously (see Smith, 2000, for review) 
and there has been a growth of interest in providing ultimate explanations alongside 
proximate mechanisms in recent years (Nettle, 2006). I therefore propose that MR should 
be employed within evolutionary approaches to studying human behaviour with its 
potential to revolutionise the field. Additionally, MR overcomes issues of confounding 
and reverse causation in non-experimental designs to provide stronger causal inference 
than standard analytical approaches using observational data. A more detailed discussion 
of MR methods is provided in Chapter 2.  
1.3.1 Applying Mendelian randomization 
In this thesis, I used MR to investigate two areas of evolutionary theory relevant to 
human behaviour – life history theory and the schizophrenia paradox. 
1.3.1.1 Life history theory 
Life history theory addresses how organisms differ in allocation of limited resources to 
growth and reproductive efforts, characterizing species into those on ‘fast’ or ‘slow’ life 
history strategies (Ellis, 2004; Ellis & Bjorklund, 2012). A ‘fast’ life history strategy is 
characterised by more effort directed towards reproduction such as earlier puberty and 
sexual activity, whereas a ‘slow’ life history strategy can be described by later maturity 
and proportionally greater investment in a smaller number of children (Ellis, 2004; Ellis 
& Bjorklund, 2012). For example, rabbits undergo rapid sexual development, short 
interbirth intervals and various other traits demonstrating short-term goals that 
characterize a fast life history strategy (Figueredo et al., 2005). Conversely, elephants 




on a slow life history strategy (Figueredo et al., 2005). The shorter life expectancy of 
rabbits than elephants increases the adaptive benefits of taking a fast life history strategy 
(Figueredo et al., 2005). Furthermore, within-species variation in life history strategy has 
been proposed. For example, in developmental environments characterized by harsh 
conditions and high extrinsic mortality, adopting a fast life history strategy may increase 
reproductive success in comparison to a slower strategy with delayed reproduction 
(Belsky, Steinberg, & Draper, 1991; Ellis, 2004; Ellis & Bjorklund, 2012; Figueredo et 
al., 2005).  
For humans, life history theory has been applied to characterize individuals into those on 
relatively faster or slower strategies (Figueredo et al., 2005), with substantial variation 
between humans in the timing of significant reproductive life events such as age at 
menarche (the start of a woman’s sexual maturity and reproductive potential) and first 
sexual intercourse (Belsky et al., 1991; James, Ellis, Schlomer, & Garber, 2012). Life 
history theory explains this variation as an adaptive response to an individual’s 
developmental environment and adverse childhood experiences have been shown to 
associate with earlier age at menarche (Magnus et al., 2018). Adverse childhood 
environments are also associated with earlier age at first sexual intercourse 
(Lenciauskiene & Zaborskis, 2008; Richardson et al., 2018; Waldron et al., 2015). Life 
history strategies consist of a suite of adaptations and whilst adopting a fast life history 
strategy evolved due to reproductive advantages in certain conditions, it may also have 
costs to an individual in modern environments. Such costs include those associated with 
teenage pregnancy and risky behaviours like violence, criminality, and substance abuse 
(Ellis & Bjorklund, 2012; Hawes, Wellings, & Stephenson, 2010; Simpson, Griskevicius, 
Kuo, Sung, & Collins, 2012). Therefore, as well as previous research into the causes of 
earlier age at menarche and sexual intercourse (Lenciauskiene & Zaborskis, 2008; 
Magnus et al., 2018; Richardson et al., 2018; Waldron et al., 2015), it is also important to 
examine how traits within life history strategies affect each other, especially as starting 
menarche is necessary for reproduction and age at first sexual intercourse may be 
modifiable via policy and environmental changes. Previous research has framed later 
traits such as age at first birth within a life history perspective (Nettle, 2011). I address 
this in the present study by examining the effects of two reproductive traits (age at 
menarche and age at first sexual intercourse) on other reproductive and behavioural 
outcomes including age at first birth, age at last birth and educational attainment. By 
looking at these traits that occur later in life, and assuming age at menarche can 
somewhat proxy early life adversity and a fast life history strategy, I take a life course 




Standard analytical approaches applied to observational data have been used to examine 
life history strategies in humans as it is not possible to manipulate developmental 
environments in experimental settings (Nettle et al., 2012; Richardson et al., 2018). 
However, as discussed above, inferring causality in studies using such approaches is 
difficult and likely to be affected by confounding bias (Davey Smith & Ebrahim, 2003). 
For example, structural equation modelling has been proposed to investigate life history 
theory. One study investigated lifetime allocation of resources to reproduction, proxied by 
number of offspring that survived to 18 years, mean inter-birth interval and age at last 
birth (Helle, 2018). Although the author stresses the benefits that an SEM framework 
provides in handling measurement error of exposure variables, the potential for 
confounding is always a concern as these methods allow for the control of measured but 
not for unmeasured confounders (Helle, 2018; Warrington, Freathy, Neale, & Evans, 
2018). Even though it is difficult to manipulate reproductive timings, particularly age at 
menarche but also age at first sexual intercourse (Helle, 2018), we can apply MR to 
investigate causal relationships between these traits and outcomes of interest. Although 
MR has been used to previously investigate age at menarche with many later life health 
outcomes (e.g., Sequeira, Lewis, Bonilla, Davey Smith, & Joinson, 2017), the study here 
will provide stronger causal inference for age at menarche and evolutionarily relevant 
outcomes. 
1.3.1.2 The schizophrenia paradox 
Schizophrenia is a severe and debilitating mental disorder that is substantially heritable 
(Van Dongen & Boomsma, 2013). The prevalence of schizophrenia remains stable over 
populations and time, and yet is associated with lower reproductive success for those 
diagnosed (Bundy, Stahl, & MacCabe, 2011; Essen‐Möller, 1959; Jablensky et al., 1992; 
Nettle & Clegg, 2006; Van Dongen & Boomsma, 2013). This creates an evolutionary 
puzzle: how is schizophrenia maintained in the population despite apparent negative 
selection? Multiple theories have been proposed to explain this paradox (Essen‐Möller, 
1959; Huxley, Mayr, Osmond, & Hoffer, 1964; Power et al., 2013; Shaner, Miller, & 
Mintz, 2004). One is mutation-selection balance, which suggests that selection against 
detrimental genetic variants is counteracted by the continuous occurrence of new 
mutations (Mullins et al., 2017; Rees, Moskvina, Owen, O’Donovan, & Kirov, 2011). 
Another is that effects over many common genetic variants are individually too weak to 
be under negative selection (Loh et al., 2015; Mullins et al., 2017; Van Dongen & 




Another popular theory is that stabilizing selection operates. Stabilizing selection is 
where the optimum fitness level for a trait is approximately at the mean of the trait and 
fitness declines along a normal distribution on either side of this optimum (Essen‐Möller, 
1959; Huxley et al., 1964; Lewis, 1958; Nesse, 2004). Within this, ‘cliff-edge’ effects on 
fitness hypothesize that fitness increases with increased expression of the trait until a 
threshold, where increased expression then results in a steep decline in fitness for some 
individuals (Nesse, 2004; Van Dongen & Boomsma, 2013). It has been suggested that 
schizophrenia-related traits may demonstrate ‘cliff-edge’ effects on fitness (Nesse, 2004; 
Nettle, 2001; Shaner et al., 2004; Van Dongen & Boomsma, 2013). Some have suggested 
that this peak occurs at levels of symptoms that could result in a diagnosis of 
schizophrenia, with a reproductive advantage among healthy individuals with an 
increased liability for the disorder (such as genetic liability and in the absence of the 
disorder itself) compensating for the lower reproductive success of those with the 
disorder itself (Keller & Miller, 2006; Nesse, 2004; Nettle & Clegg, 2006; Van Dongen & 
Boomsma, 2013). It is suggested that this reproductive advantage is maintained by sexual 
selection and mediated via creativity and/or risky behaviour (Del Giudice, Angeleri, 
Brizio, & Elena, 2010; Nettle, 2006; Nettle & Clegg, 2006; Shaner et al., 2004; Wang et 
al., 2016). Behaviourally, it is possible that higher genetic liability for schizophrenia may 
be associated with attractive traits (e.g., creativity) and therefore also with a greater 
number of children (Del Giudice et al., 2010; Nettle & Clegg, 2006). For example, 
schizotypy, a personality measure of schizophrenia-proneness, has been shown to be 
associated with creativity, short term mating interest and mating success (Crow, 2008; 
Del Giudice et al., 2010; Nettle & Clegg, 2006). Additionally, genetic liability for 
schizophrenia is associated with increased risk of unprotected sex (Wang et al., 2016).  
Relatives of people with schizophrenia are assumed to have an intermediate level of 
genetic liability for the highly heritable disorder (Del Giudice, 2010). Studies into 
whether cliff-edge fitness maintains the prevalence of schizophrenia have therefore 
largely focused on family studies. However, despite extensive research, there is no clear 
evidence of increased fecundity in relatives of individuals with schizophrenia (Bundy et 
al., 2011; Del Giudice, 2010; Power et al., 2013). Del Giudice argued that family studies 
underestimate the reproductive benefits of schizophrenia-proneness in the general 
population (Del Giudice, 2010). He highlights that relatives not only share genetic 
liability for schizophrenia but also their environments, which may hinder fitness and 
result in apparent negative selection (Del Giudice, 2010). These family studies also 
suggest that optimum fitness could occur before the appearance of symptoms that might 




within a non-case sample. It is therefore important to investigate a potential reproductive 
advantage of schizophrenia-proneness in the wider population, rather than relying on 
family studies alone. Moreover, it is important to investigate causal relationships between 
schizophrenia risk and reproductive success, rather than relying on observational 
methods. 
The recent developments in genetic epidemiology, discussed throughout this thesis, mean 
that it is now possible to investigate the fitness effects of genetic liability for 
schizophrenia in the wider population. Genetic variants associated with schizophrenia 
have been used to show that genetic liability for schizophrenia (using a score comprising 
of these individual genetic variants) is positively associated with creativity and risk-
taking (Power et al., 2015; Richardson et al., 2018; Schizophrenia Working Group of the 
Psychiatric Genomics Consortium, 2014). Evidence for associations between genetic 
liability for schizophrenia and age at first birth is mixed. Higher genetic liability for 
schizophrenia was found for those with a young age at first birth (e.g., below 20 years) 
compared to those with an intermediate age at first birth (Mehta et al., 2016; Ni, Gratten, 
Wray, Lee, & Science, 2017). Another study found no clear evidence for linear or 
quadratic associations between a genetic liability for schizophrenia and age at first birth 
(Mullins et al., 2017). Two previous studies also used schizophrenia-associated genetic 
variants to investigate whether genetic liability for schizophrenia is associated with 
number of children but results were again inconclusive, perhaps due to limited power 
(Beauchamp, 2016; Mullins et al., 2017). The studies showed estimates in the direction of 
a reproductive advantage but confidence intervals were typically wide and consistent with 
no effect (Beauchamp, 2016; Mullins et al., 2017). Nevertheless, these studies 
demonstrate how genetic liability for schizophrenia can be measured in the wider 
population. 
In this thesis (Chapter 5), I applied a range of methods with roots in genetic epidemiology 
to test part of the cliff-edge hypothesis. I examined whether increasing genetic liability 
for schizophrenia increases reproductive success in multiple population-based samples 
which are not selected on schizophrenia status and therefore include very few cases. This 
linear increase is predicted for part of cliff-edge fitness where a reproductive advantage 
among healthy individuals with higher genetic liability for the disorder compensates for 




1.4 Chapter summary 
This thesis is novel in its application of epidemiological methods to test evolutionary 
hypotheses of human behaviour. These methods, such as MR, combine genetic and 
phenotypic information to investigate psychological and key evolutionary traits with 
fitness outcomes using a causal framework. I applied such methods to understand the 
causal relationships in evolutionary theories of life history and the maintenance of 
schizophrenia in the population. Research into life history theory, where manipulation of 
exposures is not typically possible, has previously been limited to standard analytical 
approaches that include possible confounding bias. Although there has been a 
longstanding cliff-edge hypothesis for the maintenance of schizophrenia, investigation 
has been limited due to the constraints of family studies and the inability to manipulate 
the exposure or test long terms outcomes such as fitness. The genetic methodologies 
applied begin with a MR study testing the life history theory. According to this theory, 
earlier age at menarche and age at first sexual intercourse can be viewed as directing 
effort towards reproductive goals as part of a fast life history strategy and therefore show 
causal effects on reproductive and behavioural outcomes (Chapter 4). In Chapter 5 I use 
MR, Linkage disequilibrium (LD) score regression and polygenic risk score (PRS) 
analysis to investigate the schizophrenia paradox (Chapter 5). I discuss these methods in 





 Genetic epidemiological methods 
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Wootton, R. E., Richmond, R. C., Stuijfzand, B. G., Lawn, R. B., Sallis, H. M., Taylor, 
G. M. J., Jones, H. J., Zammit, S., Davey Smith, G., & Munafò, M. R. (2018). Causal 
effects of lifetime smoking on risk for depression and schizophrenia: Evidence from a 
Mendelian randomisation study. Psychological Medicine. E-pub ahead of print. 
2.1 Chapter overview 
As discussed in Chapter 1, this thesis addresses evolutionary questions using MR 
methods. In this chapter, I first provide a brief overview of MR. I then describe the 
assumptions, instruments and various ‘methods’ of MR in detail. Although I use the term 
‘methods’ as is usual in the field, these are simply variants of MR. Here, I have attempted 
to amalgamate the theoretical concept of MR with some practical details for carrying out 
analysis. For a full theoretical review see Davey Smith and Ebrahim (2003), for more of a 
practical guide see Davies et al. (2018) and for a full glossary of MR see Lawlor et al. 
(2019). Lastly, I briefly discuss other genetic epidemiology methods used in my research, 
such as LD score regression and PRS analyses.  
2.2 Mendelian randomization 
As discussed in Chapter 1, MR employs an instrumental variable analysis framework, 
with the instrument specifically being genetic variants known as single nucleotide 
polymorphisms (SNPs) (Davey Smith & Ebrahim, 2003). MR can be employed using any 
heritable exposure, assuming a SNP produces an outcome that could equally be produced 
by an environmental exposure (Gage, Davey Smith, et al., 2016; Hemani, Zheng, et al., 
2018). For a graphical illustration of MR see Figure 2:1. Here, Z denotes the genetic 
instrument, X the exposure of interest and Y the outcome. I further use ‘SNP-exposure’ to 




To illustrate an analysis, one example of using MR to overcome biases when 
manipulation of the exposure is not practical is the study of alcohol consumption effects 
on blood pressure and, ultimately, cardiovascular disease (previously described in Davey 
Smith & Ebrahim, 2003 and Davies et al., 2018). Individuals who consume more alcohol 
may differ from individuals who consume less alcohol for other cardiovascular risk 
factors, such as by smoking more heavily. This could therefore introduce spurious 
associations due to bias from confounding by smoking heaviness. Using SNPs associated 
with metabolite responses to alcohol consumption as an instrument for alcohol intake is 
akin to randomizing individuals into higher or lower drinking conditions and MR can 
therefore be used to estimate a causal effect of alcohol consumption (Davey Smith, 2006; 
Lawlor, 2016) (see Figure 2:2). This causal effect is obtained through calculating a Wald 




forms the basis for all MR methods discussed below.  
For all MR methods in this thesis, the SNP-exposure and SNP-outcome associations 
should ideally be derived in distinct non-overlapping samples of participants and can be 
taken from genome-wide association studies (GWAS) estimates, termed GWAS summary 
level data, or derived from individual level cohort data (see Chapter 3) (Lawlor, 2016). 
Estimates from SNP-phenotype regressions are then considered SNP-level, rather than 
individual-level, and can also be termed ‘summary data’. It is preferable for the SNP-
exposure and SNP-outcome GWAS to be adjusted for the same standard covariates to 
minimize bias (Davies, Holmes, et al., 2018). Although I do not use the term here, MR 
with non-overlapping samples has often been called ‘two sample MR’ or ‘two sample 
summary data MR’. Using overlapping samples in the MR methods that I use can 
produce bias towards the observational association estimate, which may be biased by 
confounding (Davies, Holmes, et al., 2018; Hemani, Bowden, & Davey Smith, 2018). 
However, the SNP-exposure and SNP-outcome samples should come from the same 
underlying population (Lawlor, 2016). An additional benefit to using non-overlapping 
samples, is it allows the investigation of relationships where the exposures and outcomes 
of interest have not been measured in the same sample (Gage, Jones, et al., 2016). In 
using non-overlapping samples, data should be harmonized to ensure that the SNP-
exposure and SNP-outcome estimates correspond to the same allele with particular 
attention required for palindromic SNPs. Palindromic SNPs contain alleles represented by 
the same pair of letters on both the forward and reverse DNA strands, therefore causing 





Figure 2:1 Diagram representing a valid MR analysis based on an instrumental variable 
framework.  
 
Figure 2:2 Diagram representing a valid MR analysis for the above example 
investigating the effect of alcohol consumption on cardiovascular disease. 
 
2.2.1 Assumptions of Mendelian randomization 
MR analysis relies on three main assumptions (Lawlor, Harbord, Sterne, Timpson, & 
Davey Smith, 2008). See Figure 2:1 for a diagram illustrating a valid MR analysis in 
terms of these 3 assumptions. Assumption 1 is signified by the arrow between Z and X. 
Assumptions 2 and 3 are represented by the absence of arrows. Here, U denotes the 
combined influence of unmeasured confounders. If measured covariates are included then 




2.2.1.1 Assumption 1: The relevance assumption: the instrument is robustly associated 
with the exposure used in analysis 
In line with this assumption, SNPs used as instrumental variables in MR are identified in 
GWAS to be significantly and independently associated with the exposure at a p-value 
less than 5×10-8 and must be found to replicate in an independent sample (or at least 
explain a significant proportion of the variance in an independent sample). This is 
discussed further in the section on instruments below. 
2.2.1.2 Assumption 2: The independence assumption: the instrument is not associated 
with confounding factors 
By using SNPs as instruments, MR exploits Mendel’s laws of segregation and 
independent assortment by which the inheritance of genetic variants is determined mostly 
independently of other genetic variants and the environment through random allocation at 
conception (Davey Smith & Ebrahim, 2003). This independence has been demonstrated 
through pairwise correlations between nongenetic variables and genetic variables, with 
genetic variants showing little association with each other and non-genetic confounders 
(Davey Smith et al., 2007). This highlights the advantages of using genetic variants as 
proxies of environmental exposure levels to overcome bias due to confounding, to which 
non-genetic observational studies are prone (Davey Smith et al., 2007). However it 
should be noted that this assumption can be affected by ancestry (Davies, Holmes, et al., 
2018) and is more likely to be violated when traits are highly polygenic, as complex 
polygenic traits can be instrumented by many SNPs which may also associate with other 
traits (see below section on instruments) (Pingault et al., 2018). Since genotype is 
determined at conception and fixed for the lifetime, the risk of reverse causality is 
removed in MR (Davey Smith & Ebrahim, 2003; Lawlor et al., 2008).  
2.2.1.3 Assumption 3: The exclusion restriction assumption: the instrument only affects 
the outcome through its effect on the exposure 
This third assumption is violated when the SNP has an effect on the outcome through 
alternative pathways, instead or in addition to, through the exposure and is termed 
horizontal pleiotropy (Bowden et al., 2017; Davey Smith & Hemani, 2014). Horizontal 
pleiotropy is tested for in analyses and can be out ruled further by functional knowledge 
of a SNP (although SNPs are most often selected on the basis of having achieved 
genome-wide significance) (Bowden et al., 2017; Davey Smith & Hemani, 2014). In 
contrast, vertical pleiotropy is used to refer to the effect of a SNP on the outcome via a 
trait that is on the pathway under investigation (Davies, Holmes, et al., 2018; Hemani, 




affects a downstream outcome, and does not violate the exclusion restriction assumption 
(Davey Smith & Davies, 2016; Hemani, Bowden, et al., 2018). It is possible that this 
assumption is violated through dynastic effects whereby a parents’ genotype creates an 
environment via the parents’ phenotype that affects an individual’s outcome being 
measured, opening a pathway between instruments in the individual and their outcome 
via parental environments (Pingault et al., 2018). 
2.2.1.4 Assumption 4: Homogeneity and monotonicity 
If these assumptions are met, effects estimated using MR should be free from bias due to 
confounding and therefore the associations between ZX and ZY (i.e., SNP-exposure and 
SNP-outcome) can be used to estimate the causal effect of X on Y (Bowden et al., 2017; 
Davey Smith & Ebrahim, 2003; Lawlor, 2016). However, there is a fourth assumption of 
instrumental variable analysis that has received little attention for its application to MR 
and is an area under active research (Lawlor et al., 2019; Swanson & Hernán, 2018). This 
fourth assumption refers to homogeneity and monotonicity. For homogeneity, it is 
assumed that the instrument does not modify the causal effect of the exposure on the 
outcome between the exposed and unexposed and, by extension, that this causal effect is 
the same in all individuals (Lawlor et al., 2019; Swanson & Hernán, 2018). This can be 
relaxed so that the effect is only held constant within subgroups, such as the exposed or 
non-exposed for a binary exposure measure (Lawlor et al., 2019). Due to the strength of 
the homogeneity assumption, monotonicity is used instead. For this, it is assumed that 
there is a monotonic relationship between the instrument and exposure and it therefore 
has the same direction of effect across individuals (i.e., the instrument does not increase 
the exposure in some individuals and decrease it in others) (Lawlor et al., 2019). Again, 
the application of this assumption to MR is under active research and currently this 
assumption is rarely considered in analysis. 
2.2.1.5 Summary of assumptions 
It is clear that instrumental variable analysis such as MR relies on strong assumptions and 
unverifiable conditions (Labrecque & Swanson, 2018). Subject knowledge is the most 
common method for concluding that assumptions hold although there are multiple ways 
to further strengthen or refute these assumptions and I discuss these below, such as 
adjusting for principal components of ancestry and triangulating across multiple MR 




2.2.2 Instruments for Mendelian randomization 
As discussed, MR uses SNPs as instruments in analysis. Humans share 99.9% of their 
genetic sequence across the 14.8 billion base pairs of the genome with SNPs contributing 
to part of the non-shared genome (Frazer, Murray, Schork, & Topol, 2009; Venter et al., 
2001). Variation in SNPs can be used in MR analyses to proxy or instrument 
environmental exposures of interest and to investigate the effect of these exposures on 
outcomes. SNPs can proxy directly measured phenotypes (e.g., body mass index (BMI)) 
and in some cases can proxy phenotypes that themselves are proxies for environmental 
exposures (e.g., cortisol for stress). Instruments might predict differing levels of the 
exposure because of direct genetic effects or because of the association with related 
environments. Either way the instrument must robustly predict the environmental 
exposure. Therefore, MR is not usually used to assess the specific effects of a genetic 
variant (Davey Smith & Ebrahim, 2003; Gage, Davey Smith, et al., 2016; Lawlor et al., 
2008). As discussed, identification of SNPs robustly associated with an exposure of 
interest, and hence appropriate for use as instruments to study a given exposure, are 
identified in GWAS. The GWAS is ideally conducted in independent samples from those 
used for the MR analyses (Gage, Davey Smith, et al., 2016). See Figure 2:3 for how 





Figure 2:3 Flow chart for how SNPs are selected as instruments for MR. For the 
methods used in this thesis, SNP-outcome estimates can then be taken from a publicly 
available GWAS for the outcome trait or derived from individual level data. 
 
It is assumed that a SNP that best proxies the exposure, sometimes termed a causal SNP, 
will either be genotyped, imputed, or captured through LD with another SNP included in 
the instrument. LD is defined as non-random correlations between alleles at different loci 
due to the disproportionate co-inheritance of alleles, through their proximity or 
population structure (Lawlor et al., 2019; Pingault et al., 2018). In this way, LD can be 
useful for MR analyses as instruments in MR do not have to be causally associated with 
levels of the exposure but only proxy them (Lawlor et al., 2008). This does not violate the 
assumptions of MR discussed. LD is also useful for identifying proxy SNPs if some 




used together as an instrument are independent of each other (see Figure 2:3 and below 
for discussion on multiple SNP instruments). 
Principal components are used in order to adjust for population structure as this can 
confound relationships between a SNP and a phenotype (Davies, Holmes, et al., 2018; 
Haworth et al., 2019; Timpson, Greenwood, Soranzo, Lawson, & Richards, 2017). 
Specifically, differences in allele frequencies across populations can generate spurious 
associations if in one population the allele is rare (e.g., minor allele frequency (MAF) 
below 1%) as any association between the SNP and outcome could be due to differences 
in ethnicity (Davies, Holmes, et al., 2018; Haworth et al., 2019; Schork, Murray, Frazer, 
& Topol, 2009; Timpson et al., 2017). Additionally, GWAS and MR studies typically 
restrict to populations of common ancestry to further address population structure 
(Davies, Holmes, et al., 2018), as I have done throughout this thesis.  
Typically, a single SNP explains very little of the observed variation in the exposure, and 
most MR studies therefore use multiple genetic variants to increase power (Davies, 
Holmes, et al., 2018; Frazer et al., 2009). These multiple genetic variants can be analysed 
individually, meta-analysed for a single causal effect, or combined into a genetic score 
and then used as a single instrument (Davies, Holmes, et al., 2018). The statistical power 
of MR can be increased further by weighting each SNP by its association with the 
exposure, taken from the GWAS (Davies, Holmes, et al., 2018). Using a single SNP 
instrument is only appropriate if the SNP plays a known and specific role in the pathway 
of interest and has a large effect on the exposure (Gage, Davey Smith, et al., 2016). 
Throughout this thesis I use multiple SNPs as instruments. 
Weak instrument bias may occur when a SNP or genetic score explains little of the 
observed variation in the exposure and/or is used in a study with a small sample size 
(Davies, Holmes, et al., 2018). In the MR methods used throughout this thesis, weak 
instrument bias attenuates results towards the null as SNP-exposure and SNP-outcome 
estimates are derived in non-overlapping samples and there is therefore no over-fitting of 
the data (Lawlor, 2016; Lawlor et al., 2019). The mean F statistic can determine the 
strength of an instrument to assess weak instrument bias, derived as the mean of the 
squared SNP-exposure association divided by the squared standard error (SE) of the SNP-
outcome association for the MR methods here. A value above 10 indicates acceptable 
levels of relative bias (<10%) (Burgess, Butterworth, & Thompson, 2013; Pierce, Ahsan, 
& Vanderweele, 2011). The power of MR analyses is determined by this strength of 




Holmes, et al., 2018). Using multiple SNPs to instrument an exposure is therefore 
important for complex polygenic traits where the effects of many common genetic 
variants are individually weak. However, each individual SNP must be a valid 
instrumental variable, defined by the three main assumptions above, to allow for unbiased 
causal inference (Lawlor et al., 2008).  
2.2.3 Mendelian randomization methods 
I will now discuss each of the MR methods used in this thesis: the inverse variance 
weighted (IVW), MR-Egger regression, weighted median, mode-based estimator (MBE) 
and additional sensitivity analysis methods (see Table 2:1 and Figure 2:5). These 
methods are all extensions of the Wald ratio (defined above) to be used with multiple 
SNPs as instruments for the exposure. They first use the Wald ratio to estimate the causal 
effect per SNP before conducting a meta-analysis for the causal effect of an exposure on 
outcome across SNP instruments (see Bowden & Holmes (2019) for a recent review of 
meta-analyses for MR). Each method uses a varying number of the SNPs as instruments 
due to the different assumptions that each relies on. With these methods relying on 
different assumptions regarding directional horizontal pleiotropy, a consistent direction of 
effect across all methods for the same exposure and outcome relationship increases 
confidence in results, even if some SNPs are invalid instruments (Hemani, Bowden, et al., 
2018). I use a consistent direction of effect to assess the robustness of results and not a 
formal statistical threshold as some methods have limited statistical power (Bowden, Del 
Greco M, et al., 2017; Lawlor, Tilling, & Davey Smith, 2016). As the IVW has the most 
statistical power, I focus on reporting these results throughout. 
2.2.3.1 Inverse variance weighted 
The IVW method is a meta-analysis of Wald ratios across all SNP instruments to provide 
a causal effect of the exposure of the outcome. Figure 2:4 illustrates these ratio estimates 
per SNP from a fictional MR analysis where the slope is equivalent to a weighted average 
of the ratio estimates (Bowden et al., 2017; Pingault et al., 2018). As shown, an IVW 
approach is therefore similar to a weighted regression of SNP-outcome coefficients on 
SNP-exposure coefficients with the intercept constrained to zero (Burgess et al., 2013; 
Gage, Jones, et al., 2016). The gradient provides an estimate of the causal effect, 
indicating the increase in the outcome per unit increase in the exposure (Burgess et al., 
2013). This method uses the inverse SE of the SNP-outcome association estimates as 
weightings (Bowden et al., 2017). By weighting the influence of each SNP by the inverse 
variance of the SNP-outcome association, stronger SNPs make a larger contribution to the 




The IVW is typically used as the main MR analysis as it has the most statistical power, 
due to using all SNP instruments. However, it therefore assumes that all SNP instruments 
are valid (Bowden et al., 2017). An IVW estimate is biased by any violation of the 
exclusion restriction assumption, such as due to heterogeneity or directional horizontal 
pleiotropy. As the gradient for the causal effect is taken from a line of best fit for all SNPs 
with the intercept constrained to zero, any heterogeneity or directional horizontal 
pleiotropy would draw the line away from the true slope (Bowden et al., 2017). 
Heterogeneity occurs when individual SNP estimates do not converge on the same causal 
estimate and may represent pleiotropy (Pingault et al., 2018). Cochran’s Q is a measure of 
heterogeneity, derived as the weighted sum of squared differences between individual 
SNP effects and the pooled effect across SNPs, with the weights being those used in the 
MR method. The degrees of freedom are the number of SNPs minus 1. Overdispersion is 
a term used to indicate high heterogeneity and a Cochran’s Q value greater than the 
degrees of freedom is considered evidence of this (Lawlor et al., 2008; Rees, Wood, & 
Burgess, 2017). However, Cochran’s Q has very high statistical power if the number of 
SNPs is large, meaning that evidence of overdispersion is often found in MR studies, and 
therefore funnel plots are often used to assess heterogeneity and dispersion. Funnel plots 
provide an opportunity to assess if there is heterogeneity and if this heterogeneity is 
balanced across SNPs by plotting SNP estimates against the SE of their effect size 
(Hemani, Zheng, et al., 2018; Sterne et al., 2011). Even in the presence of heterogeneity 
by Cochran’s Q, if symmetry is observed in the funnel plot then pleiotropy is considered 
balanced with a zero mean. 
For an IVW meta-analysis, fixed or random effects methods can be used (Bowden et al., 
2017; Burgess et al., 2013). A fixed effects method assumes all instruments are valid 
(such that none are pleiotropic), whereas a random effects method allows balanced 
horizontal pleiotropy if independent to the SNPs effects on the exposure - termed the 
Instrument Strength Independent of Direct Effect (InSIDE) assumption. This InSIDE 
assumption is not testable. If symmetry is observed in the funnel plot, a fixed effects or 
random effects IVW meta-analysis method should produce similar results (Bowden et al., 
2017; Burgess et al., 2013). If asymmetry is observed in the funnel plot, then directional 
horizontal pleiotropy is likely present and a fixed or random effects method would 
produce different estimates. In this case, both fixed and random effect estimates would 
also differ to the other methods below which better account for directional horizontal 





Figure 2:4 Illustrative plot of SNP-outcome and SNP-exposure associations for an IVW 
approach. Solid dots represent no horizontal pleiotropy. Hollow dots represent balanced, 
as opposed to directional, horizontal pleiotropy. Both scenarios yield an unbiased IVW 
estimate. (credit Bowden et al., 2017). 
 
The IVW method further relies on the No Measurement Error (NOME) assumption where 
SNP-exposure associations are accurate to the true value and can be assessed by the mean 
F statistic value (Bowden et al., 2017).  
In summary, the IVW includes all SNP instruments in a meta-analysis of Wald ratios with 
the intercept constrained to zero and is therefore perhaps the simplest MR method. 
Another strength of the IVW is that it has the most statistical power to detect causal 
effects. However, the method is strongly reliant on the assumption of no directional 
horizontal pleiotropy.  
2.2.3.2 MR-Egger regression 
MR-Egger is an extension of the IVW that also combines Wald ratios per SNP into a 
meta-regression to provide an estimate for the causal effect of the exposure on the 
outcome using the inverse SE of the SNP-outcome association estimates as weightings 
(Bowden et al., 2017). In addition, MR-Egger regression provides the causal estimate for 
the exposure on the outcome adjusted for directional horizontal pleiotropy (Lawlor et al., 




intercept term therefore estimates the average pleiotropic effect across instrument SNPs 
and the gradient of the slope provides an estimate independent of the estimated 
directional horizontal pleiotropy (Bowden et al., 2017). This method therefore allows all 
SNPs to be invalid instruments in that they may have pleiotropic effects although 
pleiotropic effects must satisfy the InSIDE assumption (see above) (Bowden et al., 2017). 
A significant intercept term (using a p-value threshold of 0.05) suggests the presence of 
directional horizontal pleiotropy. The MR-Egger estimate and IVW estimate will 
converge if there is no directional horizontal pleiotropy as both intercepts would then be 
zero. However, if there is the presence of directional horizontal pleiotropy, then the 
slopes and causal effects will differ between these methods (see Figure 2:5).  
MR-Egger further relies on the NOME assumption and failure to meet the NOME 
assumption is most extreme for MR-Egger compared to other methods (Bowden et al., 
2017). It is possible to adjust for this dilution in MR-Egger by employing a Simulation 
Extrapolation (SIMEX) method (Bowden et al., 2017; Bowden, Fabiola Del Greco, et al., 
2016; Hemani, Bowden, et al., 2018). The SIMEX model estimates what would have 
been obtained if NOME was met using information from a series of dummy datasets with 
increasing violations of NOME. The I2GX statistic quantifies the amount of dilution by 
dividing the true SNP-exposure associations by the variance of the SNP-exposure 
association (Bowden, Fabiola Del Greco, et al., 2016). An I2GX value of 0.9 or above 
indicates that a SIMEX adjustment is not required as the relative bias in the estimate is 
less than or equal to 10%, which is equivalent to the assurance given by an F statistic 
above 10 in other analyses (Bowden, Fabiola Del Greco, et al., 2016).  
Overall, if InSIDE and NOME are perfectly satisfied, MR-Egger can provide an unbiased 
causal estimate with the presence of horizontal pleiotropy and this is therefore a key 
strength of the method. Whereas in a situation where InSIDE holds but NOME is 
violated, the estimate will be diluted rather than biased (Bowden, Fabiola Del Greco, et 
al., 2016). The main weakness of MR-Egger is that it suffers from the lowest power of all 
the MR methods discussed here as it requires variation between SNP-exposure estimates 
after all have been coded in the positive direction, and therefore requires a large number 
of SNP instruments (Bowden, Davey Smith, & Burgess, 2015). Additionally, it is less 
efficient than the IVW and also strongly relies on the InSIDE and NOME assumptions 




2.2.3.3 Weighted median 
The weighted median estimate is obtained by first calculating the Wald ratio causal 
estimate for each SNP and then taking the estimate with the median inverse variance 
weight. Whereas in an unweighted analysis it is assumed that at least 50% of the 
instruments are valid, in a weighted analysis it is assumed that instruments forming 50% 
of the weight in the analysis are valid (Bowden, Davey Smith, Haycock, & Burgess, 
2016; Lawlor et al., 2008).  
Overall, low false discovery rates are achieved with this approach (Bowden, Davey 
Smith, et al., 2016). This approach is more robust to directional horizontal pleiotropy than 
the IVW and more robust to outliers than the IVW and MR-Egger methods (Pingault et 
al., 2018). Additionally, the statistical power to detect causal effects is close to that of the 
IVW method, it does not require the InSIDE assumption to be met, and only half of the 
SNPs need to be valid instruments for an unbiased causal estimate (Hemani, Zheng, et al., 
2018). 
2.2.3.4 Mode-based estimator 
The MBE finds the largest cluster of Wald ratios for a meta-analysis and uses inverse 
variance weightings. The simple MBE is an unweighted analysis however this thesis only 
uses the weighted MBE. The majority of instruments can be invalid providing that the 
Zero Modal Pleiotropy Assumption (ZEMPA) is satisfied. ZEMPA states that the largest 
subset of instruments with the same ratio estimate will contain valid instruments and 
therefore that invalid instruments have heterogeneous estimates. In other words, the MBE 
provides a causal estimate when the largest number of similar individual-instrument 
estimates come from valid instruments, even if the majority are invalid (Hartwig, Davey 
Smith, & Bowden, 2017). Benefits of this method is that it is more robust to directional 






Figure 2:5 Illustrative plot of MR methods used.  
The IVW estimate is not biased by balanced horizontal pleiotropy. If there is directional 
horizontal pleiotropy, then the MR-Egger estimate (black line) will be unbiased under the 
InSIDE assumption and differ from the IVW which constrains the intercept to zero (grey 
line). The weighted median will be unbiased if the majority of the instruments are valid 
(black points), with some invalid instruments (grey points) even though this indicates 
directional horizontal pleiotropy which biases the IVW (grey line). The MBE clusters 
SNPs based on their estimates (grey lines) and the cluster with the largest weight (black 
line) is selected as the causal estimate and is unbiased if the black dots are valid 
instruments. (credit Hemani et al., 2018) 
 
2.2.3.5 Additional Mendelian randomization sensitivity methods 
In Chapter 4, I also conducted radial MR-Egger regression and leave-one-out analysis to 
determine if outliers were present. Although similar to MR-Egger regression, the 
intercept is estimated on a scale so that the distance from a SNP estimate to the slope is 
equal to the square root of its contribution to the overall average heterogeneity (measured 
by Cochran’s Q) after adjustment for directional horizontal pleiotropy. Therefore, radial 




will only estimate a causal effect providing that the InSIDE assumption is satisfied. A 
leave-one-out analysis can aid assessment of whether the MR estimate is driven or biased 
by a single SNP, perhaps due to a large horizontal pleiotropic effect. To do so, the method 
re-estimates the causal effect after systematically dropping one SNP at a time. A dramatic 
change in the estimate when one SNP is removed can highlight the sensitivity of the 
estimate to outliers and identify outliers to be investigated further (Hemani, Zheng, et al., 
2018). 
2.2.4 Specialist software 
I use MR-Base and GitHub software within this thesis. MR-Base is an online platform 
(www.mrbase.org) that allows users to conduct the above MR methods with publicly 
available GWAS data (see Chapter 3) or with users own datasets using the R package 
(Hemani, Zheng, et al., 2018). For this thesis, I used the R package to derive some of the 
results in Chapter 5 as well as the leave-one-out analysis in Chapter 4. GitHub is another 
online platform where users can host analysis code. The analysis scripts for published 
results from this thesis are available on the MRC Integrative Epidemiology Unit’s profile 





Table 2:1 A comparison of MR methods and their assumptions. 
     Can be 
relaxed 
MR method Description Additional assumptions Power Invalid variants allowed A2 A3 




weighted by the inverse of the variance of the SNP-
outcome association.  
No pleiotropy or balanced 
pleiotropy conditional on 
the InSIDE assumption. 
NOME 
Has the most 
power if the 
assumptions are 
satisfied.  





An extension of the IVW that relaxes the assumption 
that any pleiotropy must be balanced. A significant 
intercept term (p<0.05) suggests bias from directional 
horizontal pleiotropy, i.e., the average pleiotropic 
effect is not zero. MR-Egger regression provides 
consistent estimates even if all genetic instrumental 
variables are invalid as long as the INSIDE assumption 
is met.  
Strong reliance on InSIDE. 
Strong reliance on NOME. 
Has the lowest 
power. 
100% ✗ ✓ 
Weighted median  The weighted median estimate is obtained by first 
calculating the Wald ratio for each SNP and then 
taking the estimate with the median inverse variance 
weight.  
Consistent when 50% of 
weight contributed by 
genetic variants is valid. 
Similar to that of 
IVW method. 
50% ✓ ✓ 
MBE  Finds the largest cluster of Wald ratios. The majority 
of the genetic instruments can be invalid providing the 
ZEMPA assumption is satisfied. In the weighted mode 
method, the mode is calculated using the inverse 
variance weights of the Wald ratios.  
ZEMPA Less powerful 
than IVW and 
weighted 
median. 
50% ✓ ✓ 
A2 = assumption 2, that all instruments (Z) must not be associated with confounders. A3 = assumption 3, that all instruments (Z) must only be associated with 
the outcome (Y) through the exposure (X). These two columns have a cross if that method requires the assumption to be met and a tick if that assumption can 
be relaxed. Throughout the table, invalid refers to instruments that do not meet the three main assumptions of MR. The various methods can be more or less 
powerful under different models of pleiotropy. 
 
 
2.3 Polygenic risk scores 
Similar to the genetic scores described above, a PRS is a variable that combines SNPs 
associated with an exposure. Each of the risk alleles that a person has for the SNP is 
weighted by effect estimates from a GWAS (Euesden, Lewis, & O’Reilly, 2015). 
However, these scores are typically derived using lower p-value thresholds for the 
association between the SNP and trait of interest than instruments in MR in order to 
capture broader liability for a trait (Euesden et al., 2015; Mullins et al., 2017). This is 
especially useful in under-powered studies where few genome-wide significant SNPs are 
available or only a small sample is used (Euesden et al., 2015). PRSice is a dedicated PRS 
software for deriving scores across multiple p-value thresholds (www.prsice.info) 
(Euesden et al., 2015). I conduct analysis using PRSice in Chapter 5.  
2.4 Linkage disequilibrium score regression 
A final method that I use in this PhD is LD score regression (Chapter 5). This method 
identifies genetic correlations and can be useful for capturing the relationship between 
broader liability for traits of interest after MR analysis, or to highlight potential causal 
relationships between complex traits for further investigation with MR (Bulik-Sullivan, 
Finucane, et al., 2015). Genetic correlations represent shared genetic aetiology of two 
phenotypes which can then be further investigated using MR to assess whether the 
association is due to pleiotropy or a causal effect (Gage, Davey Smith, et al., 2016; 
Pingault et al., 2018). An LD score estimate for a genetic correlation is equivalent to the 
gradient when the product of the GWAS estimates (z-score standardized) of each trait is 
plotted against the LD score of each SNP (the sum of each SNPs LD with all other tagged 
SNPs). A positive value indicates that genetic effects tend to be shared genome-wide. LD 
score regression can be run using GWAS summary data and is not biased by sample 
overlap (Bulik-Sullivan, Finucane, et al., 2015). Instead of focusing on genome-wide 
significant SNPs as in MR analysis or a lower p-value threshold like PRS analysis, this 
method uses genome-wide data and the effects of all SNPs. This is particularly useful for 
complex traits where many common genetic variants have a small effect and the number 
of SNPs that reach genome-wide significance is small. However, for exposures where 
genome-wide significant SNPs explain a large proportion of the variance, then analysing 
the genome-wide significant SNPs will have less noise and can be more powerful (Bulik-
Sullivan, Finucane, et al., 2015; Richardson et al., 2018). Furthermore, this method 




2.5 Chapter summary 
In this chapter, I have described the instruments, assumptions, and various methods of 
MR. If the assumptions discussed hold (with focus on the relevance, independence and 
exclusion restriction), MR allows for stronger inferences of causality for associations 
between an exposure and outcome than standard analytical approaches applied to 
observational data. This is because MR estimates can then be interpreted as free from 
confounding or reverse causation (Lawlor et al., 2008). Different variations of MR rely 
on some additional assumptions for this to be possible: IVW (all instruments are valid 
and NOME), MR-Egger (all instruments may be invalid if InSIDE assumptions holds and 
NOME), weighted median (that a subset are valid instruments) and MBE (that a subset 
are valid instruments and ZEMPA holds). I have further described LD score regression 
and types of PRS that are genetic epidemiological methods used to assess broader liability 
for a trait of interest. In the next chapter I will describe the data that I use when applying 





 Cohort descriptions 
3.1 Chapter overview 
This thesis uses publicly available genome wide summary level data as well as participant 
data from three cohorts: UK Biobank, The Avon Longitudinal Study of Parents and 
Children (ALSPAC), and the Norwegian Mother, Father and Child Cohort Study (MoBa). 
In this chapter, I will briefly describe the publicly available data sources and then 
describe each of the cohorts in turn. In combination, these data offer the opportunity to 
conduct MR by providing phenotypic and genetic data on a large number of participants. 
Such large sample sizes are necessary to detect the small effect sizes common in MR and 
other genetic methods (Gage, Jones, et al., 2016). 
3.2 Publicly available genome wide summary data 
GWAS data is necessary for all analyses in this thesis and I was only able to conduct this 
research because the authors of each GWAS released their data publicly. I downloaded 
the discovery data for each GWAS from the relevant website (see Table 3:1). Using 
estimates from the discovery sample is common in genetic studies as sample sizes are 
smaller for replication analysis and typically only the genome-wide significant SNP 
estimates are published from combined data. Age at menarche data are published on the 
Reproductive Genetics Consortium website. For educational attainment, number of 
children and age at first birth the data was downloaded from the Social Science Genetic 
Association Consortium (SSGAC) website. For Schizophrenia, I used data from the 
Psychiatric Genomics Consortium (PGC). Further details of these GWAS and how they 
are used in my analyses are provided in Table 3:1 and the relevant results chapter 
(Chapter 4 and Chapter 5).  
 
 
Table 3:1 Summary of GWAS used in thesis. 
Trait N Date SNPsa Website Reference Chapter 
Age at menarche 182 416 2014 123 www.reprogen.org/data_download.html (Perry et al., 2014) 4 
Age at menarche 329 345 2017 389 www.reprogen.org/data_download.html (Day et al., 2017) 4 
Age at first 
sexual 
intercourse 
125 667 2016 38 (N/A) 




36 989 cases and 
113 075 controls 
(35 123 cases and 109 657 











293 793 2016 74 www.thessgac.org/data (Okbay et al., 2016) 5 
Number of 
children 
343 072 2016 
(N/A – used 
as outcome) 
www.thessgac.org/data (Barban et al., 2016) Appendix 
a SNPs that reached genome-wide significance (p<5×10-8) 
 
 
3.3 UK Biobank 
3.3.1 Overview and aim 
UK Biobank was established by the Medical Research Council and Wellcome Trust with 
the aim of identifying risk factors for human diseases in middle to older aged individuals 
(Allen, Sudlow, Peakman, & Collins, 2014; Collins, 2012). In order to do so, a wide 
range of measurements were collected, including questionnaire responses, physical 
measurements and biological samples to create this phenotypically rich data source (Allen 
et al., 2014; Collins, 2012). UK Biobank is a population-based prospective cohort and 
therefore a large sample size was needed due to low likelihood of participants developing 
a particular disease (Collins, 2012). Consequently, approximately 500 000 participants 
were recruited (Collins, 2012). Volunteers provided electronic signed consent and UK 
Biobank received ethics approval from the Research Ethics Committee (Allen et al., 
2014; Bycroft et al., 2018). UK Biobank is the largest sample used in this thesis. Further 
details and description are available on the website (www.ukbiobank.ac.uk) and in 
previous publications (Allen et al., 2012; Bycroft et al., 2018; Collins, 2012). Details of 
every available measure are provided at www.biobank.ndph.ox.ac.uk/showcase. Here I 
use the measures presented in Table 3:2, from data application number 6326. 
3.3.2 Participants 
Participants were invited if aged between 40 and 69 years during the recruitment period 
between 2006 and 2010, as well as being registered with the National Health Service and 
living within 25 miles of one of the 22 assessment centres across the UK (Allen et al., 
2014; Collins, 2012; Fry et al., 2017). UK Biobank therefore consists of mostly post-
reproductive participants within a population-based framework not selected on disease 
status. A total of 9.2 million individuals were invited with a response rate of less than 6% 
(Fry et al., 2017; Swanson, 2012).  
3.3.3 Data collection  
At the baseline assessment, participants completed a wide range of questionnaires related 
to their lifestyle, family and medical history as well as having blood samples taken (Allen 
et al., 2014). Repeat assessments for all baseline measures has been conducted on a subset 
of participants since (Allen et al., 2014). Participants also completed questionnaires using 
a computer and were allowed to click on various help prompts. In this thesis, I use data 
from the baseline assessment questionnaires, linkage to National Health Service medical 
records for schizophrenia diagnoses, and genetic data derived from blood samples. I use 




results chapter (see Chapter 4 and 5 and Table 3:2). Below, I describe relevant methods 
pertaining to the genetic data that I use in this thesis. 
3.3.4 Genetic data 
Deoxyribonucleic acid (DNA) was extracted from the blood samples provided by 
participants at the baseline assessment and genotyping was conducted at the Affymetrix 
Research Services Laboratory (Bycroft et al., 2018). Genetic data for UK Biobank was 
released in two waves (May 2015 and July 2017) (Bycroft et al., 2018). The first release 
included ~150 000 participants genetic data (Bycroft et al., 2018). Of this first release, 
there were approximately 50 000 participants genotyped using the Applied Biosystems 
UK Biobank Lung Exome Variant Evaluation Axiom Array by Affymetrix array (Bycroft 
et al., 2018). The remaining participants of the first release and all participants of the 
second release were genotyped using the Applied Biosystems UK Biobank Axiom Array 
(~440 000 participants) (Bycroft et al., 2018). These arrays share 95% of markers 
(Bycroft et al., 2018). In total, the full release data contains 488 377 successfully 
genotyped samples.  
Full details of the imputation as well as the pre-imputation quality control checks are 
published elsewhere (Bycroft et al., 2018). Briefly, multiallelic SNPs or SNPs with MAF 
≤1% were removed. Imputation of genotypes was performed using a reference set of the 
UK10K haplotype and Haplotype Reference Consortium (HRC) (Howie, Marchini, & 
Stephens, 2011; Huang et al., 2015). The MRC IEU in-house team then restricted to 
autosomal variants within the HRC site list using stepwise filtering with changing 
imputation quality for different allele frequencies. This meant that rarer genetic variants 
were required to have a higher imputation info score with MAF and info scores 
recalculated within an in-house defined ‘European’ subset. The in-house ancestry 
restrictions consisted of those who self-report as ‘White British’ and who were shown to 
have similar ancestral backgrounds in a principal component analysis (PCA) (Bycroft et 
al., 2018). Estimated kinship coefficients identified 107 162 pairs of individuals (Bycroft 
et al., 2018; O’Connell et al., 2016) and in-house algorithms were applied to exclude 
individuals related to the greatest number of other individuals until no related pairs 
remain according to the algorithm. Individuals with sex-mismatch between genetic and 
reported sex or individuals with sex-chromosome aneuploidy were excluded. These in-
house quality control procedures have been described elsewhere (Mitchell, Hemani, 




Table 3:2 Summary of measures used from UK Biobank data. 
Measure Question Chapter 
Age at first birth How old were you when you had your 
FIRST child? 
4, 5 
Number of sexual partners About how many sexual partners have 
you had in your lifetime? 
4, 5 
Age at last birth How old were you when you had your 
LAST child? 
4, 5 
Age when left education At what age did you complete your 
continuous full-time education? 
4 
Educational attainment in years 
(derived) 
Which of the following qualifications do 
you have? (You can select more than 
one) 
4, 5 
Alcohol intake About how often do you drink alcohol? 4 
Ever smoked Derived by UK Biobank using: Do you 
smoke tobacco now?; In the past, how 
often have you smoked tobacco? 
4, 5 
Risk-taking Would you describe yourself as someone 
who takes risks? 
4 
 
3.4 The Avon Longitudinal Study of Parents and Children (ALSPAC) 
3.4.1 Overview and aim 
ALSPAC is an ongoing population-based birth cohort that recruited 14 541 pregnancies 
in the greater Bristol area (Boyd et al., 2013; Fraser et al., 2013). An additional 
recruitment of children was later carried out, inviting those that were eligible to take part 
in the original effort, increasing the sample to 15,247 pregnancies (Boyd et al., 2013; 
Fraser et al., 2013). The aim of ALSPAC was to determine how genotype combines with 
environmental pressures to influence health and development and a wide range of 
measures has therefore been collected (Golding, Pembrey, & Jones, 2001). ALSPAC is 
described in detail in Boyd et al. (2013) and Fraser et al. (2013). These papers summarise 
the recruitment process, sample description, available data and measurement occasion. 
The ALSPAC website (www.bristol.ac.uk/alspac/), data dictionary 
(www.bristol.ac.uk/alspac/researchers/access/) and catalogue 
(www.variables.alspac.bris.ac.uk/) provide information on all available measures. 
In this thesis, I use data on both the mothers and the children of the index pregnancy. I 
will refer to the two generations as ALSPAC G0 for the mothers and ALSPAC G1 for the 
children (who are now adults). For a summary of measures used in this thesis, see Table 
3:3. Although not used here, data was also collected from the partners of ALSPAC G0 




and ethical approval was obtained from the ALSPAC Law and Ethics Committee and the 
Local Research Ethics committees.  
3.4.2 Participants 
Pregnant women living in Avon, United Kingdom were eligible if they were due to 
deliver between April 1, 1991, and December 31, 1992 (Boyd et al., 2013; Fraser et al., 
2013). Approximately 85% of invited women enrolled into the study (Pembrey, 2004). If 
a woman was pregnant more than once during the recruitment period, it was possible to 
participate on each occasion. 
3.4.3 Data collection 
Data has been collected through self-completed questionnaires and assessment at 
designated research clinics. Data were collected on a wide range of phenotypes including 
physical and mental health, environmental factors, demographics and biological markers. 
ALSPAC G0 completed multiple questionnaires throughout pregnancy and post-
pregnancy including information on themselves and their children and continue to do so. 
ALSPAC G1 were able to complete their own questionnaires during puberty if they 
wished to do so. Additionally, participants have attended clinics over the years where 
further assessments were carried out (see Boyd et al., 2013, and Fraser et al., 2013, for 
schedules of clinics). In this thesis, I use multiple phenotypic measures from various 
questionnaires and clinics, described in each results chapter (Chapter 4 and 5 and Table 
3:3). I further use genetic data from cord blood samples for both ALSPAC G0 and G1, as 
described below. 
3.4.4 Genetic data 
ALSPAC G0 were genotyped using the Illumina Human660W-quad array conducted at 
the Centre National de Genotypage. ALSPAC G1 were genotyped with the Illumina 
HumanHap550 quad array at the Wellcome Trust Sanger Institute, Cambridge, United 
Kingdom and the Laboratory Corporation of America, Burlington, United States. 
Centrally performed quality control procedures were conducted on the raw genome-wide 
data, similarly for ALSPAC G0 and ALSPAC G1. 
Participants were removed if there was a mismatch between genetic and reported sex, 
insufficient sample replication, minimal or excessive heterozygosity (0.34 and 0.36), 
disproportionate levels of individual missingness (>3%) or insufficient sample replication 
(identical by descent (IBD) < 0.8). Removal of SNPs was based on MAF < 0.01, SNP call 




equilibrium (HWE) p< 5x10-7 for G1 and p< 5x10-6 for G0. Cryptic relatedness was also 
measured (proportion of IBD>0.1 for G1 and >0.125 for G0). Population structure was 
assessed using multidimensional scaling of genome-wide identity by state pairwise 
distances using the four Haplotype map (HapMap) populations as a reference and 
samples showing evidence of population structure were excluded. Non-European 
individuals were removed. A total of 9048 for G0 and 9115 for G1 with 500 527 and 526 
688 SNPs passed these quality controls and were included in phasing and imputation 
(Taylor et al., 2018). Genotype data for G0 and G1 were combined and then SNPs with 
genotype missingness above 1% (11 396 SNPs) were removed due to poor quality. 
Additionally, 321 participants with ID mismatches across G0 and G1 were removed. 
From this, 17 842 participants remained. Imputation of the target data was performed 
using the 1000 genomes reference panel (Phase 1, Version 3). There was 8237 eligible 
from G1 and 8,196 eligible from G0 with available genotype data after exclusion of 
related subjects, using cryptic relatedness measures described, that remained for genetic 
analysis (Taylor et al., 2018). 
Table 3:3 Summary of measures used from ALSPAC data. 
Measure Question Assessed at 
G0   
Parity at 85 months 
post index child 
Derived using: How many times have you been 
pregnant altogether before 
this time?; Since your study child was born, 






Parity at 18 years post 
index child 
Derived using: How many times have you been 
pregnant altogether before 
this time?; Since your study child was born, 
how many times have you been 
pregnant?; Since your study teenager's 7th 





index child; 18 
years post 
index child 
Age at first pregnancy How old were you when you became pregnant 
for the very first time? 
18 weeks 
gestation 




Covariables   
Education Derived by ALSPAC using: What educational 




Ever smoked Have you ever been a smoker? 18 weeks 
gestation 
Age at index delivery Derived by ALSPAC using date of birth  N/A 




Number of sexual 
partners 
Altogether, in your life so far, how many 
people have you had sexual intercourse with? 
21 years old; 
23 years old 
Had child Derived using an ALSPAC measure for 
number of children in relation to: Date of birth 
of first child; Date of birth of fourth child 
21, 22 years 
and 23 years 
old 
Covariables   
Ever smoked Have you ever smoked a whole cigarette? 23 years old 
Note: ALSPAC data was only used in Chapter 5. Responses for G0 education were 1) 
certificate of secondary education, 2) vocational, 3) O level, 4) A level, 5) degree. 
 
3.5 Norwegian Mother, Father and Child Cohort Study (MoBa) 
3.5.1 Overview and aim 
MoBa is a prospective population-based pregnancy cohort study conducted by the 
Norwegian Institute of Public Health and planned in the 1990s (Magnus 2006; 2016). The 
initial aim of the study was to detect causes of disease through investigating various risk 
factors however the aims have been widened since the study’s conception (Rønningen et 
al., 2006). Recruitment for pregnant women was between 1999 and 2008 and data is still 
being collected. More than 95 200 mothers, 75 200 fathers and 114 500 children have 
participated. Throughout this thesis, I used data from the mothers only (see Table 3:4 for 
summary). Informed consent was obtained from each MoBa participant upon recruitment. 
The study was approved by The Regional Committee for Medical Research Ethics in 
South-Eastern (or other, if applicable) Norway. Full details are available in Magnus et al. 
(2016, 2006) and on the study’s website (www.fhi.no/en/studies/moba/). 
3.5.2 Participants 
There were no exclusion criteria for recruitment and all pregnant women in Norway were 
therefore eligible to participate, although the questionnaires were only available in 
Norwegian (Magnus et al., 2016, 2006). Participants were recruited from all over Norway 
and 50, out of a total of 52, hospitals with maternity units were involved by the end of the 
recruitment period. A postal invitation was sent to the mother and father prior to their 
routine ultrasound examinations at approximately 17 weeks gestation (Magnus et al., 
2016, 2006). If a woman was pregnant more than once during the recruitment period, it 
was possible to participate on each occasion. Approximately 41% of those invited then 




3.5.3 Data collection 
This thesis is based on version 11 of the quality-assured data files and uses data from the 
first questionnaire sent to mothers, at 13-17 weeks gestation. This questionnaire related to 
previous pregnancies, medical history and medication, occupation, exposures in the work 
place and home, lifestyle habits and mental health (Magnus et al., 2006). As this was the 
first distributed questionnaire, there was little attrition, with 95% of mothers providing 
responses (Magnus et al., 2006).  
In addition to questionnaire data, variables are available through data linkage to 
mandatory health registries in Norway. For every birth in Norway above 16 weeks 
gestation, a medical record is sent to the Medical Birth Registry Norway (MBRN) 
(Magnus et al., 2006). All MBRN records for the participants of MoBa are available, 
regardless of the number of questionnaires completed. Data from the MBRN was used in 
this thesis. 
A blood sample was taken from participating mothers and fathers at the ultrasound 
assessment. More than 90% of fathers accompany their partner to the examination. At the 
birth, a blood sample was taken from the umbilical cord for mother and child. Blood 
samples were sent to a central biobank for genotyping (described below). Again, for this 
thesis, only the mother’s genetic data was used.  
3.5.4 Genetic data 
As part of the HARVEST project, that includes other Norwegian cohorts, 11 000 
randomly selected trios (mother, father and child) were genotyped from MoBa (Magnus 
et al., 2016). Individuals were only genotyped if they met these additional inclusion 
criteria: singletons, live births, linked with the MBRN and that mothers had completed 
the first questionnaire. Data has been deleted for participants who withdrew consent 
following genotyping. Genotyping was conducted using the Illumina Human Core Exome 
Beach Array and performed at the Norwegian University of Science of Technology 
Genotyping Core Facility. Two versions of the genotype array were used due to one 
version being discontinued during the genotyping period (termed MoBa12 and MoBa24). 
A batch effect was identified on MoBa12 (termed MoBa12-A and MoBa12-B) and I 
therefore adjust for the equivalent of 3 genotype arrays in all analysis.  
Information on the centrally performed quality checks, performed separately for each 





norwegian-mother-and-child-cohort-study-mobagenetics/). Here, I use individuals from 
the ‘core quality-controlled sample’ of these quality checks (around 9400 mothers). These 
were identified as high-quality and ethnically homogenous samples (the HARVEST 
dataset is primarily ethnic Norwegians with approximately 5% from other ethnic 
backgrounds). High-quality samples were identified by genotyping call rate (below 95% 
and autosomal markers below 98%), relatedness (defined by IBD above 0.01 accumulated 
and overall IBD above 10%), and detection of ethnic outliers by PCA using HapMap 
samples. Filters for the markers included: genotyping call rate, HWE (p<0.0001), MAF 
(<5%), removal of ambiguous markers (A/T and C/G), removal of regions with high LD, 
and pruning. I conducted additional quality checks on just the mother’s samples that I was 
using, ensuring that imputation quality was >0.8, MAF>0.05, SNP missingness <0.1, 
individual missingness <0.1 and HWE p>5×10-6.  
Table 3:4 Summary of measures used from MoBa data. 
Measure Question 
Age at first birth 
Age at first pregnancy 
Previous termination 
For all earlier pregnancies. Include all pregnancies that 
ended in abortion, miscarriage or stillbirth as well as 
ectopic pregnancies. State the year the pregnancy 
began, how many kilos you gained during the 
pregnancy and the number of months you breast-fed 
each baby. State whether or not you smoked during 
earlier pregnancies. 
Parity Derived by the MBRN 
Treated infertility Have you ever been treated for infertility? 
Relationship length How long have you and the baby’s father had a sexual 
relationship? 
Pregnancy planned Was this pregnancy planned? 
Contraception was used Did you become pregnant even though you or your 
partner used contraceptives? 
Covariables 
 
Age at index delivery Derived by MoBa using date of birth 
Education What education do you have? (Enter a cross indicating 
the highest level of education you have completed and 
current studies if you are still studying.) 
Ever smoked Have you ever smoked? 
Note: MoBa data was only used in Chapter 5. Responses for education were 1) 9-year 
secondary school, 2) 1-2 year high school, 3) Technical high school, 4) 3-year high 
school general studies, junior college, 5) Regional technical college, 4-year university 
degree (Bachelor’s degree, nurse, teacher, engineer), 6) University, technical college, 




3.6 Chapter summary 
In this chapter, I have provided an overview of the data sources that I use in this thesis. 
These sources included publicly available genome wide summary level data as well as 
participant data from UK Biobank, ALSPAC, and MoBa. In the following two chapters, I 
will implement the methods from Chapter 2 using these data to investigate life history 





 Life History Theory: the effects of age at 
menarche and first sexual intercourse on reproductive and 
behavioural outcomes 
This chapter is based on the publication below 
Lawn, R. B., Sallis, H. M., Wootton, R. E., Taylor, A. E., Demange, P., Fraser, A., 
Penton-Voak, I. S., & Munafò, M. R. (2019). The effects of age at menarche and first 
sexual intercourse on reproductive and behavioural outcomes: a Mendelian randomization 
study. bioRxiv; doi: https://doi.org/10.1101/423251. 
4.1 Background and chapter overview 
In this chapter, I applied MR methods to investigate components of life history theory. 
Life history theory is characterized as a meta-theory and can therefore not be tested in its 
entirety but can generate testable predictions (Ketelaar & Ellis, 2000; Nettle & 
Frankenhuis, 2019). The literature on life history theory has become increasingly large 
and fragmented in recent years (Nettle & Frankenhuis, 2019). The most commonly tested 
prediction is that early life adversity is associated with earlier age at menarche and other 
reproductive traits. There is substantial variation in the timing of significant reproductive 
life events such as menarche and first sexual intercourse and life history theory explains 
this variation as an adaptive response to the developmental environment (Belsky et al., 
1991). In environments characterized by harsh conditions, adopting a fast life history 
strategy, characterized by short term goals (e.g., earlier puberty and age at first child), 
may increase fitness (Belsky et al., 1991; Simpson et al., 2012). In line with this, there is 
evidence demonstrating that greater childhood adversity is associated with earlier age at 
menarche and age at first sexual intercourse (Carlson, Mendle, & Harden, 2014; Ellis, 
2004; Henrichs et al., 2014; Magnus et al., 2018; Mishra, Cooper, Tom, & Kuh, 2009; 
Simpson et al., 2012).  
It is also important to examine how traits within life history strategies affect each other, 
especially when traits such as age at first sexual intercourse may be modifiable via policy 
and environmental changes. I therefore examine another part to life history theory, that 
early menarche and sexual intercourse (markers or results of exposure to early life 
adversity) affect reproductive strategies to increase fitness in certain environments. 
Earlier age at menarche and age at first sexual intercourse can therefore be viewed as 
directing effort towards reproductive goals as part of a fast life history strategy. In line 




components of a suite of adaptations where the future is discounted relative to the present 
and effort is directed towards short-term reproductive goals and increased risky behaviour 
(Day, Helgason, et al., 2016; Ellis & Bjorklund, 2012). For example, short-term 
reproductive goals may include earlier age at first birth, earlier age at last birth, a shorter 
reproductive period, increased number of sexual partners and number of children, and 
less likelihood of being childless. Increased risky behaviour could manifest as increased 
likelihood of smoking and alcohol consumption in the modern day. On the other hand, 
investing in education, despite being evolutionarily novel, can be seen as a slow life 
history trait with delayed benefits. 
Life history theory has previously been investigated in humans using standard analytical 
approaches applied to observational data as it is not possible to manipulate developmental 
environments (Nettle et al., 2012; Richardson et al., 2018). As discussed in Chapter 1, it 
is possible to apply MR to investigate causal associations even when it is impossible to 
manipulate reproductive timings such as age at menarche and age at first sexual 
intercourse. In this chapter, I therefore applied MR to investigate whether there is a causal 
effect of variation in age at menarche and age at first sexual intercourse on outcomes 
related to reproduction, education and risky behaviour within a life history framework.  
For this, I used instruments for age at menarche (and a separate instrument for age at first 
sexual intercourse) and UK Biobank data to independently investigate the effects of age 
at menarche and age at first sexual intercourse on several evolutionary relevant outcomes 
(see Figure 4:1).  
A previous study that included a sub-sample of participants from UK Biobank showed a 
causal effect of earlier age at menarche on earlier age at first birth, earlier age at last birth, 
earlier age at leaving education, increased alcohol intake, lower likelihood of being 
childless, greater number of children (in combined sexes) and decreased likelihood of 
remaining in education after 16 years (Day, Helgason, et al., 2016). Additionally, earlier 
age at first sexual intercourse was causally related to earlier age at first birth, a greater 
number of children, increased likelihood of being an ever smoker, and decreased 
likelihood of attaining a degree. These findings suggest causal relationships between 
traits that characterize a life history strategy and support evolutionary explanations of 
variation in age at menarche and first sexual intercourse. I extend this work by using the 
full release of UK Biobank data (N = 114 883–181 255) and a suite of novel methods to 
more robustly test for horizontal pleiotropy, which would violate one of the key 





Figure 4:1 Diagram representing MR analyses in this chapter. An example confounder in 
this case may be socioeconomic status which could be a common cause of age at 
menarche (James-Todd, Tehranifar, Rich-Edwards, Titievsky, & Terry, 2010; Mishra et 




4.2.1 Exposure instruments 
For the age at menarche instruments, I used independent SNPs associated with age at 
menarche (p<5×10-8) from two GWAS separately (Day et al., 2017; Perry et al., 2014). 
The first identified 123 SNPs and explained approximately 3% of the observed variance 
in age at menarche (N = 182 416) (Perry et al., 2014). The second identified 389 SNPs 
which explained about approximately 7% of the variance (N = 329 345) (Day et al., 
2017). I checked that there were no palindromic SNPs with MAF around 0.5 to ensure 
there were no issues with strand mismatches. I further used SNiPA (Arnold, Raffler, 
Pfeufer, Suhre, & Kastenmüller, 2015) with an LD threshold of 0.2 to check SNP 
independence. One of the 123 SNPs was removed due to high instability in its estimates. 
This resulted in 116 and 305 SNPs as instruments for age at menarche that were available 
in UK Biobank, excluding compound and tricyclic SNPs. The mean F statistic, indicating 
the strength of the instrument, was 60.98 for the 116 SNP instrument and 64.95 for the 
305 SNP instrument. Mean differences and SEs for these SNPs and age at menarche 
associations in the GWAS discovery samples were recorded for each instrument and 




For the instrument of age at first sexual intercourse, I used independent SNPs associated 
with age at first sexual intercourse (p<5×10-8) (Day, Helgason, et al., 2016) in both males 
and females. I recorded these GWAS associations, as done so for age at menarche, to be 
used as the instrument for age at first sexual intercourse (see Appendix 3). I used effect 
estimates identified in the pooled sex GWAS to increase statistical power. Of the 33 
SNPs for the instrument of age at first sexual intercourse, there were 23 SNPs available in 
UK Biobank. These 23 SNPs passed all checks described above for age at menarche. The 
mean F statistic for the instrument was 39.22. 
4.2.2 Outcomes 
The outcome measures included were: age at first birth, age at last birth, reproductive 
period, number of children, childlessness, ever smoked, educational attainment in years, 
age when left education, alcohol intake, risk-taking and number of sexual partners for 
those that indicated they had had sex. These measures were derived similarly to previous 
research (Day, Helgason, et al., 2016; Okbay et al., 2016). I re-coded data as missing if 
age at first sexual intercourse was younger than age at menarche; if age at leaving 
education was answered as having never attended school; at the 99.99th percentile for 
number of children; at the 99.99th percentile for number of sexual partners. Reproductive 
period was derived as the difference between age at last birth and age at first birth for 
those that had more than one child. To account for non-normal or categorical data, I 
included binary measures of childlessness (childlessness coded as 1). I also included a 
measure for ever smoked (coded as 1 if participants had ever smoked in questions ‘Do 
you smoke tobacco now?’ or ‘In the past, how often have you smoked tobacco?’). 
Alcohol intake was a categorical variable indicating ‘never’ (coded as 6), ‘special 
occasions only’, ‘one to three times a month’, ‘once or twice a week’, three to four times 
a week’ and ‘daily or almost daily’ (coded as 1). Risk-taking was measured as ‘yes’ 
(coded as 1) or ‘no’ responses to ‘Would you describe yourself as someone who takes 
risks?’. Only females were used for all outcome data.  
4.2.3 Data analysis 
The exposure associated SNPs described above were extracted from UK Biobank to 
derive SNP-outcome associations for the outcome data. Extraction was done using 
PLINK (v2.00) and best guess algorithms for determining alleles (further genotyping 
information in Chapter 3). Data were harmonized to ensure that the effect of the SNP on 
the exposure and the SNP on the outcome corresponded to the same allele. The age 
increasing allele was used in order to conduct MR analyses and results were then reversed 




SNP-outcome associations for the outcome data, regressions were adjusted for birth year 
and the top 10 genetic principal components of population structure. In sensitivity 
analysis, I additionally adjusted SNP-outcome associations for genotype array. 
I used the 116 SNPs for age at menarche (Perry et al., 2014) for the main analysis as this 
GWAS did not include any UK Biobank data. For the 305 SNP instrument which 
includes some individuals from the UK Biobank (Day et al., 2017), I calculated SNP-
outcome associations and conducted analysis using outcome data from a UK Biobank 
sub-sample that did not overlap with the age at menarche GWAS. However, allocation 
into these sub-samples is related to smoking status (Wain et al., 2015) and division is 
therefore similar to stratifying on smoking. As smoking may be a collider (i.e., a common 
effect of the exposure and outcome) in this analysis then this stratification could introduce 
bias (see Chapter 5 for further discussion). I therefore also derived SNP-outcome 
estimates and conducted analysis for the 305 SNP age at menarche instrument using the 
full UK Biobank sample, which will suffer from bias towards the observational estimate 
due to sample overlap with the GWAS of the exposure (Burgess, Davies, & Thompson, 
2016). It is also not possible to assess the suitability of one MR method, MR-Egger, with 
sample overlap as the suitability value (the I2GX value) cannot be reliably measured.  
The age at first sexual intercourse GWAS (Day, Helgason, et al., 2016) was conducted 
solely in a sub-sample of UK Biobank data and I therefore conducted an unweighted 
analysis due to this sample overlap, using a fixed effects meta-analysis method. I 
conducted a fixed-effects meta-analysis of the SNP-outcome estimates in the full UK 
Biobank sample in addition to MR analysis in the non-overlapping sub-sample of UK 
Biobank. This fixed effects meta-analysis was only conducted for age at first sexual 
intercourse and not also for age at menarche. This fixed-effects meta-analysis is 
equivalent to performing an unweighted allele score analysis (Gill et al., 2018) and 
suffers from less bias than a weighted analysis with overlapping samples as it reduces the 
problem of overfitting and the estimate is therefore similar to one derived from distinct 
samples (Richardson et al., 2018). The units for this fixed effect meta-analysis therefore 
differs to the other MR methods as it is per increase in the number of effect alleles.  
As discussed in Chapter 2, SNP-exposure and SNP-outcome data (i.e., SNP-exposure and 
SNP-outcome associations) were combined using IVW, weighted median, MBE and MR-
Egger regression approaches. In addition to these analyses, I conducted Radial MR and a 




SNPs (see Chapter 2 for details) (Bowden et al., 2018). For binary outcomes, all MR 
results were transformed to odds ratios (ORs) by exponentiating them.  
I calculated Cochran’s Q for these IVW analyses to examine if effects differ across 
genetic variants (Davies, Holmes, et al., 2018). I further calculated the I2GX to assess the 
suitability of MR-Egger where above 0.9 is desired (Bowden, Fabiola Del Greco, et al., 
2016).  
Lastly, in an attempt to account for potential pleiotropic effects of age at menarche SNPs 
with BMI, age at menarche analysis using the 116 SNP instrument was repeated after 
removing SNPs associated with BMI at p<5×10-8  (Gill et al., 2018; Locke, Kahali, 
Berndt, Justice, & Pers, 2015; Sequeira et al., 2017). This resulted in 9 SNPs being 
removed: rs10938397, rs12446632, rs2947411, rs3101336, rs543874, rs7103411, 
rs7138803, rs7514705, rs8050136.  
4.3 Results 
4.3.1 Descriptives 
Mean age in the UK Biobank sample was 57 years (standard deviation (SD): 7.91). Mean 
age at menarche and first sexual intercourse were 13 years (SD: 1.60) and 19 years (SD: 




Table 4:1 Participant characteristics of UK Biobank sample. 
  Total N Mean (SD) or N (%) 
Age at assessment, years 181 358 56.67 (7.91) 
Age at menarche, years 176 262 12.95 (1.60) 
Age at first sex, years 154 599 19.02 (3.44) 
Age first birth, years 124 093 25.39 (4.54) 
Age last birth, years 123 926 30.15 (4.80) 
Reproductive period, years 123 892 4.76 (3.65) 
Number of sexual partners 149 902 4.63 (6.99) 




     Yes  33 242 (18.34) 
     No 148 013 (81.66) 
Age when left education, years 124 279 16.63 (2.03) 




     Daily or almost daily 30 918 (17.06) 
     Three or four times a week 39 346 (21.71) 
     Once or twice a week 47 864 (26.41) 
     One to three times a month 23 723 (13.09) 
     Special occasions only 25 101 (13.85) 




    Yes 101 112 (55.94) 




     Yes  31 973 (18.30) 
     No 142 745 (81.70) 
 
4.3.2 Age at menarche 
Further details of the instruments are provided in Table 4:2. Cochran’s Q values indicate 
that most measures show evidence for overdispersion, although the dispersion appeared 
balanced when plotted (see Appendix 4 and Appendix 5). The age at menarche 305 SNP 
instrument in Table 4:2 is for the non-overlapping UK Biobank sample. For the age at 




Table 4:2 Estimates for the I2GX and Cochran’s Q 
  Age at menarche Age at first sexual 
intercourse   116 SNPs 305 SNPs 
Unweighted I2GX 0.9 0.9 0.6 
  Q p Q p Q p 
Reproduction       
Age first birth 323.47 <0.001 575.69 <0.001 52.01 <0.001 
Age last birth 273.22 <0.001 402.69 <0.001 41.96 0.01 
Reproductive period 139.87 0.06 347.55 0.04 33.28 0.06 
Number of sexual 
partners 
178.63 <0.001 466.96 <0.001 23.87 0.35 
Number of children 203.17 <0.001 414.35 <0.001 52.18 <0.001 
Childlessness 187.30 <0.001 413.68 <0.001 53.89 <0.001 
Education        
Age when left education 233.24 <0.001 442.82 <0.001 33.27 0.06 
Educational attainment 
in years 
259.91 <0.001 468.65 <0.001 30.53 0.11 
Risky behaviours       
Alcohol intake 268.60 <0.001 565.41 <0.001 28.07 0.17 
Ever smoked 227.40 <0.001 561.59 <0.001 67.12 <0.001 
Risk-taking 146.57 0.03 392.27 <0.001 38.48 0.02 
 
Using the 116 SNP instrument for age at menarche, there was consistent evidence of a 
causal effect of earlier age at menarche on earlier age at first birth across all MR methods. 
There was some evidence of an effect of earlier age at menarche on earlier age at last 
birth and all MR methods showed point estimates in a consistent direction. There was no 
clear evidence of an effect of age at menarche on duration of reproductive years, number 
of children, or number of sexual partners, and little evidence for an effect on likelihood of 
being childless with results showing confidence intervals consistent with the null and 
inconsistency for the direction of point estimates across MR methods. These results are 




Table 4:3 Estimates of the causal effect of earlier age at menarche (116 SNP instrument) on life history outcomes using full UK Biobank data. 
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Note: CI: confidence interval 
 
Table 4:4 MR-Egger intercept values for age at menarche (116 SNP instrument) on life history outcomes using full UK Biobank data. 
  MR-Egger intercept 
 β or OR 95% CI p  
Reproduction      
Age first birth 0.0002 -0.011, 0.012 0.98 
Age last birth -0.001 -0.013, 0.011 0.84 
Reproductive period -0.001 -0.011, 0.008 0.82 
Number of sexual partners -0.007 -0.023, 0.009 0.40 
Number of children -0.002 -0.004, 0.001 0.15 
Childlessness 1.003 0.998, 1.009 0.24 
Education      
Age when left education 0.004 -0.001, 0.009 0.11 
Educational attainment in years 0.008 -0.001, 0.017 0.10 
Risky behaviours     
Alcohol intake 0.004 0.001, 0.007 0.01 
Ever smoked 0.999 0.995, 1.004 0.77 




For educational outcomes, there was evidence of an effect of earlier age at menarche on 
lower educational attainment and age at leaving education across most MR methods and 
consistent point estimates for all MR methods (see Table 4:3 and Table 4:4). Alcohol 
intake appeared to decrease with earlier age at menarche, but the MR-Egger intercept 
indicated directional horizontal pleiotropy (p = 0.013), suggesting that this effect does not 
remain when horizontal pleiotropy is accounted for (see Table 4:3 and Table 4:4). No 
clear evidence was found for effects of age at menarche on having ever smoked or risk-
taking behaviour although these measures were binary and hence there was less statistical 
power to detect effects (see Table 4:3).  
After removing SNPs also associated with BMI (Gill et al., 2018; Locke et al., 2015) 
from the genetic risk score, results were broadly similar to the main analysis although 
MR-Egger regression analysis showed decreased estimates and for many outcomes the p-
values increased. This could be due to eliminating a possible pathway via BMI and/or 
reduced statistical power as a result of using fewer SNPs (see Table 4:5 and Table 4:6). 
Note that for this age at menarche instrument after removal of BMI associated SNPs, the 
I2GX statistic was 0.9 and the mean F statistic was 61.07. 
I repeated analyses using the 305 SNP instrument for age at menarche. Results were 
broadly similar to the main analysis (using the 116 SNP instrument) (see Table 4:7, 
Table 4:8, Table 4:9, and Table 4:10). There was slight increased evidence for an effect 
on number of sexual partners, ever smoked and childlessness. This analysis suffers from 
greater bias as it is uses a sub-sample of UK Biobank (described briefly above and further 
in Chapter 5) or alternatively, when using the entire UK Biobank sample in analyses, it 
results in overlap between the exposure and outcome datasets which has shown to bias 




Table 4:5 Estimates of the causal effect of earlier age at menarche (116 SNP instrument) on life history outcomes using full UK Biobank data excluding SNPs 
associated with BMI at p<5×10-8 (9 SNPs excluded). 
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Table 4:6 MR-Egger intercept values for age at menarche (116 SNP instrument) on life history outcomes using full UK Biobank data and excluding SNPs 
associated with BMI at p<5×10-8 (9 SNPs excluded). 
 MR-Egger intercept 
  β or OR 95% CI p 
Reproduction     
Age first birth -0.001 -0.013, 0.010 0.82 
Age last birth -0.002 -0.014, 0.011 0.78 
Reproductive period -0.0001 -0.010, 0.010 0.99 
Number of sexual partners -0.009 -0.025, 0.008 0.29 
Number of children -0.002 -0.004, 0.001 0.19 
Childlessness 1.003 0.998, 1.009 0.26 
Education     
Age when left education 0.003 -0.002, 0.008 0.23 
Educational attainment  0.007 -0.002, 0.016 0.12 
Risky behaviours     
Alcohol intake 0.004 0.001, 0.008 0.01 
Ever smoked 0.999 0.995, 1.004 0.79 






Table 4:7 Estimates of the causal effect of earlier age at menarche (305 SNP instrument) on life history outcomes using non-overlapping UK Biobank data. 
  IVW MR-Egger regression Weighted Median MBE 
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Table 4:8 MR-Egger intercept values for age at menarche (305 SNP instrument) on life 
history outcomes using non-overlapping UK Biobank data. 
 MR-Egger intercept 
  β or OR 95% CI p 
Reproduction     
Age first birth 0.002 -0.005, 0.010 0.55 
Age last birth -0.001 -0.009, 0.007 0.76 
Reproductive period -0.004 -0.010, 0.003 0.25 
Number of sexual partners -0.013 -0.023, -0.003 0.01 
Number of children -0.001 -0.002, 0.001 0.39 
Childlessness 0.999 0.995, 1.002 0.44 
Education      
Age when left education -0.002 -0.005, 0.002 0.35 
Educational attainment  0.005 -0.001, 0.011 0.11 
Risky behaviours     
Alcohol intake 0.001 -0.002, 0.003 0.57 
Ever smoked 0.997 0.994, 1.000 0.05 





Table 4:9 Estimates of the causal effect of earlier age at menarche (305 SNP instrument) on life history outcomes using full UK Biobank data. 
  IVW MR-Egger regression Weighted median MBE 
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Table 4:10 MR-Egger intercept values for age at menarche (305 SNP instrument) on life history outcomes using full UK Biobank data. 
 MR-Egger intercept 
 β or OR 95% CI p 
Reproduction     
Age first birth -0.003 -0.009, 0.004 0.44 
Age last birth -0.005 -0.011, 0.002 0.19 
Reproductive period -0.002 -0.007, 0.003 0.45 
Number of sexual partners -0.004 -0.013, 0.005 0.40 
Number of children 0.0002 -0.001, 0.002 0.74 
Childlessness 0.998 0.994, 1.001 0.12 
Education      
Age when left education 0.0002 -0.003, 0.003 0.90 
Educational attainment  0.004 -0.001, 0.009 0.12 
Risky behaviours     
Alcohol intake 0.0001 -0.002, 0.002 0.92 
Ever smoked 0.998 0.995, 1.000 0.07 




4.3.3 Age at first sexual intercourse 
Further details of the instrument are provided in Table 4:2. Again, Cochran’s Q values 
indicate that most measures show evidence for overdispersion (see Appendix 6). The low 
I2GX value indicates that a SIMEX adjustment for MR-Egger should be conducted. I 
therefore performed and present the results for a SIMEX adjusted unweighted MR-Egger 
regression analysis of age at first sexual intercourse. 
I conducted a fixed effects meta-analysis of the 23 SNP-outcome associations in UK 
Biobank and found evidence of relationships for earlier age at first sexual intercourse 
with earlier age at first birth, earlier age at last birth, a longer reproductive period, 
increased number of sexual partners, a greater number of children, decreased likelihood 
of being childlessness, earlier age at leaving education, lower educational attainment, 
increased likelihood of having ever smoked and increased likelihood of risk-taking 
behaviour (see Table 4:11).  
Table 4:11 Fixed effects meta-analysis of SNP-outcome associations using full UK 
Biobank and SNPs identified for age at first sexual intercourse. 
   Fixed effects meta-analysis 
 N β or OR 95% CI p 
Reproduction 
Age first birth 109 021 – 124 093 -0.061 -0.069, -0.053 <0.001 
Age last birth 108 873 – 123 926 -0.046 -0.055, -0.037 <0.001 
Reproductive period 108 842 – 123 892 0.015 0.008, 0.022 <0.001 
Number of sexual partners 131 643 – 149 902 0.019 0.007, 0.030 0.002 
Number of children 159 140 – 181 247 0.006 0.004, 0.008 <0.001 
Childlessness 159 147 – 181 255 0.986 0.982, 0.990 <0.001 
Education   
Age when left education 109 137 – 124 279 -0.011 -0.015, -0.007 <0.001 
Educational attainment in 
years 
157 817 – 179 731 -0.015 -0.022, -0.008 <0.001 
Risky behaviours  
Alcohol intake 159 137 – 181 233 0.001 -0.001, 0.003 0.409 
Ever smoked 158 702 – 180 751 1.010 1.007, 1.014 <0.001 
Risk-taking 153 432 – 174 718 1.011 1.006, 1.015 <0.001 
 
There appeared to be a consistent effect of earlier age at first sexual intercourse on earlier 
age at last birth and increased likelihood of risk-taking behaviour across MR methods 
(see Table 4:12). In this MR analysis, I took SNP-exposure associations from a GWAS 
(Day, Helgason, et al., 2016) and SNP-outcome associations in a sub-sample of UK 




The MR-Egger intercept showed evidence of directional horizontal pleiotropy for most 
outcomes (see Table 4:13) and, as discussed, this MR analysis may suffer from bias due 
to stratifying the UK Biobank sample. Overall, results for Radial MR and a leave-one-out 
analysis suggested no strong influence of outliers. Although there appeared to be a 
consistent outlier in age at first sexual intercourse analysis (rs538498277) when plotting 
(see Appendix 7), there was no formal evidence of this using radial MR, with second 
order modified weights and a p-value of 0.01 (Bowden et al., 2018), apart from in relation 
to ever smoked as an outcome (see Appendix 8). Another SNP (rs2188151) was most 
often identified as the top outlier in Radial MR (see Appendix 8). I therefore conducted a 
leave-one-out analysis to ensure that no outliers, including rs2188151, were having a 
relatively large effect on estimates (Hemani, Zheng, et al., 2018). This showed that 
estimates with a SNP removed were all within the confidence intervals for every other 




Table 4:12 Estimates of the causal effect of earlier age at first sexual intercourse on life history outcomes using non-overlapping UK Biobank data. 
  IVW SIMEX MR-Egger regression Weighted median MBE 
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Table 4:13 SIMEX unweighted MR-Egger intercept values for age at first sexual intercourse on life history outcomes using non-overlapping UK Biobank 
data. 
 MR-Egger intercept 
 β or OR 95% CI  p 
Reproduction      
Age first birth -0.082 -0.101, -0.063  <0.001 
Age last birth -0.030 -0.048, -0.013  0.002 
Reproductive period 0.052 0.036, 0.069  <0.001 
Number of sexual partners 0.009 -0.008, 0.027  0.30 
Number of children 0.011 0.006, 0.015  <0.001 
Childlessness 0.986 0.977, 0.995  0.01 
Education       
Age when left education -0.025 -0.034, -0.016  <0.001 
Educational attainment in years -0.017 -0.027, -0.006  0.01 
Risky behaviours      
Alcohol intake 0.011 0.006, 0.017  0.001 
Ever smoked 1.026 1.018, 1.035  <0.001 





4.4.1 Summary of results and previous literature 
The results suggest that earlier age at menarche is causally related to some traits that 
characterize a fast life history strategy, such as earlier age at first birth, earlier age at last 
birth, lower educational attainment, and earlier age at leaving education. This is 
consistent with previous findings (Day, Helgason, et al., 2016; Gill et al., 2017). There 
was no clear effect of age at menarche on number of children in this female only sample 
(Day, Helgason, et al., 2016). Here, applying additional MR methods to those used 
previously, the effect of age at menarche on alcohol intake is not robust (Day, Helgason, 
et al., 2016).  
Results show mixed evidence for age at first sexual intercourse on these life history traits, 
with results suggesting possible violation of the exclusion restriction assumption of no 
direct effects of the instrument on the outcome not acting through the exposure (i.e., the 
presence of directional horizontal pleiotropy) (Bowden et al., 2017; Davey Smith & 
Ebrahim, 2003). There is evidence for the presence of directional horizontal pleiotropy on 
multiple outcomes, suggesting that previous findings may have also included pleiotropic 
effects and may be questionable (Day, Helgason, et al., 2016). Results for age at first 
sexual intercourse are therefore not robust and our ability to infer causality is weakened.  
4.4.2 Life history theory 
The effects of earlier age at menarche on these reproductive and educational traits can be 
viewed as directing effort towards short-term reproductive goals and risky behaviour as 
an important part of a fast life history strategy (Ellis & Bjorklund, 2012). Variation in age 
at menarche may therefore represent an important causal component of a suite of 
adaptations (Belsky et al., 1991). Earlier age at first birth as part of a fast life history 
strategy can be considered an adaptive response to early life adversity and the present 
finding of an effect of earlier age at menarche on earlier age at first birth is therefore in 
line with this (Nettle, Coall, & Dickins, 2011). It is, however, interesting that there is an 
effect of earlier age at menarche on earlier age at last birth, with no clear effect on 
reproductive period. This suggests that individuals on a fast life history strategy are not 
just starting their reproductive life earlier but shifting their reproductive life forward in 
time. Nettle highlights that individuals in more deprived areas with short life expectancy, 
likely on a fast life history strategy, need to reproduce earlier than individuals in more 
affluent areas with higher life expectancy to be in good health for an equivalent period of 




and the present finding of a causal effect of earlier age at menarche on decreased 
educational attainment provides important information for determinants of educational 
attainment which should be independent from confounding (Gill et al., 2017). Investing in 
education can be seen as a slow life history trait with delayed benefits (Sng, Neuberg, 
Varnum, & Kenrick, 2017). The effect of age at menarche on educational attainment may 
be due to variation in cognition following variation in age at menarche and gonadal 
hormones, due to menarche, that may influence behaviour during schooling (Gill et al., 
2017; Schulz & Sisk, 2016).  
As a component of life history strategies, it is expected to see an effect of earlier age at 
menarche on increased number of children or likelihood of remaining childless, although 
access to contraception may influence this relationship. Number of sexual partners has 
previously been used as a proxy for reproductive success in a post-contraceptive 
environment, although it should be noted that contraception allows for the decoupling of 
sexual and reproductive partners (Nettle & Clegg, 2006). The present findings did not 
show a clear effect of age at menarche on number of sexual partners although female 
reproductive success is less dependent on number of sexual partners than males. It is 
further possible that the effect of age at menarche on number of children is masked by the 
detrimental effects of risky behaviours, such as substance use, on fertility in the modern 
environment (Anderson, Nisenblat, & Norman, 2010; Eggert, Theobald, & Engfeldt, 
2004). Although these results show no clear evidence for an effect of earlier age at 
menarche on increased risky behaviours and substance use, binary measures of smoking 
and risk-taking were used, resulting in less statistical power. Furthermore, the measure of 
risk-taking was a single item asking whether participants would describe themselves as 
someone who takes risks and may not capture the full extent of risk-taking behaviour. 
There was no clear effect of age at menarche on alcohol intake, another form of substance 
use which has also been shown to be associated with decreased fertility (Anderson et al., 
2010; Eggert et al., 2004). Further research should examine the mediating causal 
relationships between age at menarche and fertility in the modern environment using 
more detailed measures of substance use and larger samples. 
4.4.3 Strengths 
This study highlights how MR can be applied to test predictions within life history theory 
to provide evidence of causality and increase our understanding of health and social 
behaviour. A strength of the present study is the use of multiple MR methods. This 
allowed for extending upon the findings of previous research (Day, Helgason, et al., 




assumptions, to provide greater confidence in results (Lawlor, Tilling, & Davey Smith, 
2016). I was further able to compare evidence using two instruments for age at menarche. 
Additionally, I used a large population-based sample for the analysis to help identify the 
small effects common in genetic studies (Gage, Jones, et al., 2016), although I 
acknowledge that for binary outcomes power was more limited.  
4.4.4 Limitations 
There are also a number of limitations to consider. Most importantly, as there are 
currently no appropriate instruments for early life stress to be used within MR and it is 
therefore not possible to investigate early life stress using MR, I examined the effects of 
two intermediate reproductive traits (age at menarche and age at first sexual intercourse) 
on further reproductive and behavioural outcomes. Taking this life course approach to the 
causal pathways in life history theory by assuming earlier menarche is a proxy for early 
life adversity has limitations. Namely, early menarche is associated with both good 
condition and early life adversity, likely with different developmental pathways. I did not 
stratify analysis on any measure of adversity, or a proxy for adversity such as 
socioeconomic status. There has been a secular trend of decreasing age at menarche in 
recent times, perhaps due to obesity or improved living conditions (Ellis, 2004). This 
trend therefore also includes individuals that are assumed to be on a slow life history 
strategy. The present study therefore cannot fully disentangle those on a fast or slow life 
history strategy although it is assumed that earlier menarche and age at first sexual 
intercourse is a proxy for early life adversity and therefore an indicator of a fast life 
history strategy. I attempted to account for the possibility of effects of age at menarche 
acting via BMI in sensitivity analyses. The multiple possible interpretations of early age 
at menarche and age at first sexual intercourse are a strong limitation of this work 
however it is still important to examine all components of the life history theory 
framework, rather than to focus only on the effects of early life adversity on reproductive 
traits such as age at menarche.  
Second, the age at first sexual intercourse GWAS was conducted in a sub-sample of UK 
Biobank data and I therefore conducted an unweighted analysis due to this sample 
overlap, using a fixed effects meta-analysis method. I additionally conducted MR by 
dividing the outcome sample to avoid overlap of participants, however this may have 
introduced bias as sub-division is related to smoking status and therefore akin to 
stratifying on smoking, which may be affected by the exposure and outcome (see Chapter 




Third, I used SNPs for age at first sexual intercourse, and their associations, identified in 
a pooled sex GWAS, due to reductions in power of using SNPs identified in females 
only, and the exposure and outcome data therefore consist of different populations (not 
advised for MR studies) (Lawlor, 2016). Although most genetic variants showed sex-
concordant associations in the GWAS, six genetic variants in the instrument for age at 
first sexual intercourse showed some evidence of sex-discordant associations (Day, 
Helgason, et al., 2016). The unweighted analysis for age at first sexual intercourse did not 
use GWAS estimates (Burgess & Thompson, 2013; Gill et al., 2018).  
Fourth, UK Biobank data is unrepresentative of the population, with a 5% response rate, 
and therefore suffers from selection bias which may generate spurious associations (see 
Chapter 5 for further discussion) (Allen et al., 2014; Davey Smith & Davies, 2016; 
Munafò, Tilling, Taylor, Evans, & Davey Smith, 2018). Finally, genetic variants are non-
specific and we cannot fully remove population structure, which can induce spurious 
associations through confounding, even within a sample of European ancestry and 
adjusting for principal components of population structure as done so here (Haworth et 
al., 2019). 
4.4.5 Conclusions 
I found some evidence that age at menarche is causally related to other life history traits 
and outcomes. Age at first sexual intercourse was also related to many life history 
outcomes, although there was evidence of directional horizontal pleiotropy which violates 
the exclusion restriction assumption of MR and results should therefore be treated with 
caution (Bowden et al., 2017; Davey Smith & Hemani, 2014). This study highlights how 
analyses techniques from genetic epidemiology can be used to answer how life history 
traits are related within life history strategies, and to better understand determinants of 
reproductive and social behaviour.  
4.5 Chapter summary 
In this chapter, I applied MR methods to investigate life history theory using instruments 
for age at menarche and age at first sexual intercourse and UK Biobank data. The results 
suggest that earlier age at menarche affects some traits that characterize life history 
strategies including earlier age at first and last birth, decreased educational attainment, 
and decreased age at leaving education. Unfortunately, due to evidence of directional 
horizontal pleiotropy, which violates an assumption of MR, the results for age at first 




using multiple data sources will allow for this analysis to be conducted without stratifying 
UK Biobank data and introducing selection bias. Studies using this data will be better 
able to inform interventions on this potentially modifiable trait. 
Overall, this study demonstrates how MR can be applied to test predictions of life history 
theory by providing an example of using MR within an evolutionary research field to 
better understand determinants of reproductive and social behaviour. There is an 
increasing number of GWAS being conducted on evolutionary relevant traits and future 
research could apply these MR techniques to further test predictions of life history theory, 
such as whether age at menarche is a mechanism between early life adversity and these 





 The Schizophrenia Paradox: schizophrenia risk 
and reproductive success 
This chapter is based on the publications below 
Lawn, R. B., Sallis, H. M., Taylor, A. E., Wootton, R. E., Davey Smith, G., Davies, N. 
M., …Munafò, M. R. (2019). Schizophrenia risk and reproductive success: a Mendelian 
randomization study. Royal Society Open Science, 6, 181049. 
Lawn, R. B., Sallis, H. M., Taylor, A. E., Wootton, R. E., Davey Smith, G., Davies, N. 
M., …Munafò, M. R. (2019). Comment on the relationship between common variant 
schizophrenia liability and number of offspring in the UK Biobank. American Journal of 
Psychiatry, 176(7), 573-574. 
5.1 Background and chapter overview 
In this chapter, I applied a range of methods rooted in genetic epidemiology (MR, LD 
score regression and PRS analysis) to investigate the schizophrenia paradox. 
Schizophrenia is a debilitating and heritable mental disorder associated with lower 
reproductive success (Bundy et al., 2011; Essen‐Möller, 1959; Jablensky et al., 1992; 
Nettle & Clegg, 2006; Van Dongen & Boomsma, 2013). However, the prevalence of 
schizophrenia is stable over populations and time, resulting in an evolutionary puzzle: 
how is schizophrenia maintained in the population given its apparent fitness costs (Essen‐
Möller, 1959; Huxley et al., 1964; Power et al., 2013; Shaner et al., 2004)? One 
possibility is that increased genetic liability for schizophrenia, in the absence of the 
disorder itself, may confer some reproductive advantage (Essen‐Möller, 1959; Huxley et 
al., 1964; Lewis, 1958; Nesse, 2004; Nettle, 2001; Shaner et al., 2004). A reproductive 
advantage among healthy individuals with higher genetic liability for the disorder may 
compensate for lower reproductive success of those with the disorder itself, termed cliff-
edge fitness (see Figure 5:1) (Nesse, 2004; Van Dongen & Boomsma, 2013). It is 
suggested that this reproductive advantage is maintained by sexual selection and mediated 
via creativity and/or risky behaviour (Del Giudice et al., 2010; Nettle, 2006; Nettle & 
Clegg, 2006; Shaner et al., 2004; Wang et al., 2016). Genetic variants that have been 
associated with schizophrenia have also been associated with creativity and risk-taking 
(Power et al., 2015; Richardson et al., 2018; Strawbridge et al., 2018). In this chapter, I 
assess the correlation and causal effect of genetic liability for schizophrenia with a range 




samples which are not selected on schizophrenia status and therefore include very few 
cases. 
 
Figure 5:1 Illustration of a cliff-edge fitness function where fitness increases with 
increasing levels of the trait until a peak followed by a steep decline. For schizophrenia 
this peak is estimated at diagnosis and a somewhat linear relationship is assumed up 
until this point (indicated by the grey arrow). (credit Nesse, 2004) 
 
In all main analyses of this paradox, I use genetic variants associated with schizophrenia 
within a MR framework to estimate the causal effect of genetic liability for schizophrenia 
on measures of reproductive success, overcoming some limitations of observational 
studies previously used to investigate this evolutionary paradox by reducing bias from 
confounding and reverse causation. To capture broader genetic liability, I additionally 
conduct LD score regression in UK Biobank and PRS analyses using varying p-value 
thresholds for genetic liability in MoBa and ALSPAC G0. As discussed in Chapter 2, 
these methods capture various aspects of genetic liability and can be used to gain a fuller 
understanding of the evolutionary processes involved. Cliff-edge fitness in those without 
a diagnosis of schizophrenia would predict a linear relationship (see Figure 5:1). 
However, given suggestions from family studies that there may be a fitness decline of 
healthy individuals with high genetic liability for the disorder, I conducted sensitivity 
analyses to investigate possible non-linear relationships where at very high levels of 
genetic score for schizophrenia liability there is decreased reproductive success in 





The principal measure of fitness in this chapter is number of children or parity. However, 
both earlier age at first birth and increased numbers of sexual partners have previously 
been used as indicators of reproductive success, particularly in developed populations in 
which contraception is commonly used to control family size (Mullins et al., 2017; Nettle 
& Clegg, 2006; Tropf, Stulp, et al., 2015; Westendorp & Kirkwood, 1998). Earlier age at 
first birth likely results in a longer reproductive period whereas number of sexual partners 
captures mating success and hence potential reproductive success (Nettle & Clegg, 2006). 
Additionally, earlier age at first pregnancy also captures potential reproductive success, 
similarly to age at first birth, in developed populations where terminations are available. 
Here, I use a range of these measures proxying reproductive success depending on data 
availability in the sample. Results in this chapter are presented in aggregate, by measure 
of reproductive success, however analyses using UK Biobank data was conducted first. 
Following this, I conducted analyses in MoBa and then ALSPAC data (both in ALSPAC 
G0 and ALSPAC G1).  
5.2 Positive control 
As the present studies applied MR in a novel context to this evolutionary paradox, I also 
included a positive control where the estimated relationship is known and I could 
therefore validate the approach to then conduct the analysis on genetic liability for 
schizophrenia. For this positive control, I estimated the effect of genetically predicted 
educational attainment on number of children and age at first birth in UK Biobank. 
Higher genetically predicted education is known to be associated with fewer children and 
delayed age at first birth (Barban et al., 2016; Beauchamp, 2016; Courtiol, Tropf, & 
Mills, 2016; Kong et al., 2017; Sanjak, Sidorenko, Robinson, Thornton, & Visscher, 
2017). I therefore included educational attainment as an exposure with these two 
outcomes (using the same outcome datasets used for the schizophrenia analysis in UK 
Biobank) as a positive control. This positive control was only conducted in UK Biobank 
as UK Biobank was the first analysis that I conducted and therefore the point in time that 
I wanted to validate the approach, as well as having the largest sample size. As I aimed to 
conduct LD score regression in UK Biobank for genetic liability for schizophrenia, I also 
included LD score regression for educational attainment. 
5.2.1 Positive control methods 
5.2.1.1 Exposure instrument 
SNPs associated with educational attainment (p<5×10-8) from a recent GWAS by the 




Biobank, effect estimates from the pooled sex analysis of the discovery sample were used 
to avoid sample overlap. Sixty-seven SNPs were available in UK Biobank data and were 
eligible for inclusion. For exclusion criteria, I checked that there were no palindromic 
SNPs with MAF around 0.5 to ensure there were no issues with strand mismatches. I 
further used SNiPA (Arnold et al., 2015) with an LD threshold of 0.2 to check SNP 
independence. Of the 69 available SNPs in UK Biobank data, 2 palindromic SNPs with 
MAF close to 0.5 were excluded due to strand ambiguities. Effect estimates used for the 
remaining 67 educational attainment SNPs are listed in Appendix 10 and showed a mean 
F statistic of 33.23.  
5.2.1.2 Outcomes 
Participants were either asked how many children they had given birth to or how many 
children they had fathered. I also derived a binary variable to indicate if participants were 
childless or not (childlessness coded as 1). Age at first birth was only measured in 
females in UK Biobank, with participants asked: "How old were you when you had your 
first child?". Although no age restrictions were applied in analyses, the nature of UK 
Biobank data meant that participants were aged towards the end of their reproductive 
lives. 
5.2.1.3 Data analysis 
I used LD score regression (Bulik-Sullivan, Finucane, et al., 2015; Bulik-Sullivan, Loh, et 
al., 2015) to calculate the genome-wide genetic correlation (rg) between predicted 
educational attainment and number of children and age at first birth. Genome-wide 
associations were conducted for these outcomes using linear regression, implemented in 
PLINK v2.00 through the MRC IEU GWAS pipeline. In this, I adjusted for the top 10 
principal components of population structure. For number of children, age and sex were 
also included as covariates. I then filtered results on MAF (>0.01) and imputation quality 
(>0.8) separately.  
The exposure associated SNPs described above were extracted from UK Biobank to 
derive SNP-outcome associations for the outcome data. Extraction was done using 
PLINK (v2.00) and best guess algorithms for determining alleles (full genotyping 
information in Chapter 3). In MR analyses, data were harmonized to ensure that the effect 
of the SNP on the exposure and the SNP on the outcome corresponded to the same allele. 
The increasing allele for the exposure was used. Associations for exposure SNPs and all 
outcome measures were then calculated in R, fitting the same covariates as listed above. 




listed in Appendix 10. As discussed in Chapter 2, SNP-exposure and SNP-outcome data 
(i.e., SNP-exposure and SNP-outcome associations) were combined using IVW, weighted 
median, MBE and MR-Egger regression. MR results of education on childlessness were 
converted to ORs by exponentiating log ORs. I calculated Cochran’s Q and I2GX statistics 
to assess the suitability of an IVW and MR-Egger regression (see Chapter 2 for a 
description of these) (Bowden, Fabiola Del Greco, et al., 2016). All analysis was also 
conducted with SNP-outcome associations additionally adjusted for genotype array. 
5.2.2 Positive control results 
For sample descriptives see Table 5:2 below. There was a modest negative genetic 
correlation between educational attainment and number of children (rg = -0.35, p<0.001) 
and a strong positive genetic correlation between educational attainment and age at first 
birth (rg = 0.81, p<0.001). There was a total of 1 117 154 SNPs included in this analysis. 
Cochran’s Q for an IVW approach of educational attainment and number of children was 
199.54 (p<0.001), and 144.88 (p<0.001) for age at first birth, suggesting overdispersion 
although this appeared balanced (see Appendix 11 for plot). Educational attainment had a 
negative effect on number of children (mean difference: -0.16, 95% CI: -0.21 to -0.12, 
p<0.001 per year increase in educational attainment) and a positive effect on age at first 
birth (mean difference 2.68, 95% CI: 2.40 to 2.95, p<0.001) per year increase in 
educational attainment (Table 5:1). There was also an effect of increased education on 
increased likelihood of being childless (OR: 1.60, 95% CI: 1.47 to 1.75, p<0.001 per year 
increase in educational attainment). Results for all educational attainment analysis with 
genotype array included as a covariate for outcome summary statistics are presented in 
Appendix 12 and Appendix 13. It should be noted that the I2GX statistic for an 
unweighted MR-Egger regression was 0.3, which is deemed too low to conduct a SIMEX 
adjustment, and MR-Egger was therefore not appropriate to conduct (Bowden, Fabiola 




Table 5:1 Estimates of the causal effect of genetically predicted educational attainment 
on number of children and age at first birth using IVW, MBE and weighted median MR 
methods. 
 No. of childrena Age at first birthb Childlessnessc 
Method (67 SNPsd) β (95% CI), p OR (95% CI), p 
IVW 
-0.162 (-0.206, -0.118), 
<0.001 
2.677 (2.401, 2.952), 
<0.001 
1.589 (1.446, 1.746), 
<0.001 
Weighted median 
-0.206 (-0.276, -0.135), 
<0.001 
2.828 (2.387, 3.270), 
<0.001 
1.567 (1.343, 1.829), 
<0.001 
MBE 
-0.249 (-0.478, -0.020), 
0.04 
1.649 (0.303, 2.995), 
<0.001 
1.513 (0.952, 2.404), 
0.09 
a Number of children data from UK Biobank (N = 268 658 – 335 758). b Age at first birth 
data from UK Biobank (N = 99 317 – 124 093). c Childlessness data from UK Biobank (N 
= 268 658 – 335 758). d Educational attainment from the SSGAC GWAS (N = 283 723). 
 
5.2.3 Positive control conclusion 
Results of these positive control analyses were as expected and in line with previous 
genetic research, suggesting that educational attainment is under negative selection 
(Barban et al., 2016; Beauchamp, 2016; Courtiol et al., 2016; Kong et al., 2017; Sanjak et 
al., 2017). Finding results in a positive control analysis that are expected and in line with 
previous research suggests that the overall approach is valid, and I therefore carried 
forward these methods to test genetic liability for schizophrenia with the same outcome 
measures of reproductive success. 
5.3 Methods 
I will first outline methods that were common across all studies of genetic liability for 
schizophrenia using UK Biobank, MoBa and ALSPAC data. For example, the GWAS 
used, the MR methods applied and the non-linear analysis that I conducted. I will then 
outline any methods specific to each study in the order of UK Biobank, MoBa, ALSPAC 
G0 and ALSPAC G1.  
For outcomes, number of children (or parity) was measured in UK Biobank, MoBa and 
ALSPAC G0. A binary measure of whether participants had had a child yet was used for 
ALSPAC G1. Number of sexual partners was included in UK Biobank and ALSPAC G1 
analyses. For age at first pregnancy, data was available in MoBa and ALSPAC G0. Age 
at first birth was measured in UK Biobank and MoBa. Additionally, MoBa included 
multiple secondary outcomes such as whether the pregnancy was planned. Lastly, 
whether participants had previously had a pregnancy termination was available in MoBa 




5.3.1 Across all studies 
5.3.1.1 Schizophrenia GWAS 
In all analyses, I used the PGC GWAS (N = 35 123 cases and 109 657 controls for 
Europeans) (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 
2014). In all MR analyses, independent SNPs associated with schizophrenia (p<5×10-8) 
were used. The 128 originally identified SNPs that reached this genome-wide 
significance threshold explained approximately 3.4% of the observed variance in 
schizophrenia risk. Estimates, on the log-odds scale, and SEs for the SNP and 
schizophrenia associations were recorded using GWAS data (Schizophrenia Working 
Group of the Psychiatric Genomics Consortium, 2014). Again, for exclusion criteria, I 
checked that there were no palindromic SNPs with MAF around 0.5 to ensure there were 
no issues with strand mismatches. I further used SNiPA (Arnold et al., 2015) with an LD 
threshold of 0.2 to check SNP independence. If proxy SNPs were used when any 
originally identified GWAS SNPs were not available, I used a LD r2 of 0.8 or above to 
search for proxies on SNiPA (Arnold et al., 2015) or proxies previously used (Gage et al., 
2017).  
5.3.1.2 MR methods used 
I first conducted regressions between a genetic score for schizophrenia liability, including 
only genome-wide significant SNPs, and each outcome. This can provide evidence as to 
whether there is a causal effect but not the magnitude of this effect (Davies, Holmes, et 
al., 2018) and may suffer from some bias (Richardson et al., 2018). I therefore next 
conducted all MR methods described in Chapter 2 (IVW, weighted median, MBE and 
MR-Egger regression).  
I created additive genetic scores for schizophrenia liability. Apart from in UK Biobank, 
weighted additive genetic scores were created using Plink (version 1.90 in MoBa and 
version 2.0 in ALSPAC) and then standardized. For this, I replaced any missing SNP data 
with the mean for that SNP across individuals in Plink. Due to the format of UK Biobank 
data, I created an unweighted genetic score in R with the same mean imputation for 
missing data. All scores counted the increasing allele. In sum, the Plink scores represent 
the per SD increase in liability for schizophrenia and the R score in UK Biobank 
represents the per allele increase in liability for schizophrenia. These scores are 
comparable and will differ only slightly, with minor increased power for the weighted 
scores (Burgess & Thompson, 2013). The units for the scores to outcome will therefore 
differ between UK Biobank and the remaining studies however the units for the main 




For all studies in this chapter, the I2GX statistic for an unweighted MR-Egger regression 
was below 0.5 which is deemed too low to conduct a SIMEX adjustment, and MR-Egger 
regression was therefore not appropriate to conduct (see Chapter 2) (Bowden, Fabiola Del 
Greco, et al., 2016). The IVW, weighted median and MBE were conducted and results 
were multiplied by 0.693 to represent the causal estimate per doubling in odds of 
schizophrenia risk (Burgess & Labrecque, 2018). For binary outcomes, MR results were 
multiplied by 0.693 on the log-odds scale, and then exponentiated. The reported estimates 
therefore indicate the effect of doubling the odds of schizophrenia on the odds of the 
binary outcome category that is coded as 1. In addition to the I2GX values, Cochran’s Q 
and mean F statistics were calculated for all analyses. Acceptable mean F statistics (above 
10) were obtained in all studies (see Chapter 2). 
I included adjustment for the top 10 principal components of population structure and sex 
(in combined sex analysis). Genotype array and a measure of age were included where 
relevant. Some sex stratified analysis was conducted where data for both sexes were 
available. Results are presented per phenotype and a summary figure for the IVW results 
is presented at the end of each phenotype section. 
5.3.1.3 Non-linear analysis 
As an illustration of shape of the schizophrenia liability-reproductive success relationship, 
I plotted the relationship between the genetic score described above and each primary 
continuous outcome. For this, I divided the score into quintiles and plotted outcomes 
across these categories of the genetic score. Similarly, to further investigate a possible 
peak in reproductive success at intermediate-high genetic liability for schizophrenia, I 
conducted quadratic regression analysis of the genetic score for schizophrenia liability 
and outcomes (adjusted for the top 10 principal components of population structure and 
additionally adjusted for sex, genotype array and a measure of age where appropriate). 
Where a standardized genetic score for schizophrenia liability was used in analysis, the 
unstandardized score was used for the quadratic term. I repeated this quadratic analysis 
separately for each sex in data where data for both sexes were available. Lastly, I plotted 
the unadjusted quadratic regressions.  
5.3.1.4 Covariables 
There is a well-established association between smoking and schizophrenia liability 
(Wootton, Richmond, et al., 2018). I therefore regressed the genetic score in each sample 
with a binary measure for whether participants had ever smoked (‘yes’ coded as 1). This 




genotype array if appropriate. In UK Biobank, ever smokers were identified from items 
asked at baseline assessment on whether participants were currently smoking tobacco 
most days or occasionally, had previously smoked tobacco most days or occasionally, or 
had tried smoking tobacco once or twice. In MoBa and ALSPAC G0, participants were 
asked whether they had ever smoked via questionnaire at approximately 18 weeks 
gestation. For ALSPAC G1, I used an item asked at approximately 23 years old on 
whether participants had ever smoked a whole cigarette.  
5.3.2 UK Biobank 
5.3.2.1 Exposure instrument 
For genetic liability for schizophrenia, 75 of the 128 SNPs were not available in UK 
Biobank. I found proxies for 48 SNPs. After checking that all SNPs were eligible in 
regard to exclusion criteria, discussed above, a total of 101 SNPs remained. The final 101 
SNPs and effect estimates are listed in Appendix 14. The mean F statistic for 
schizophrenia genetic liability was 35.15. 
5.3.2.2 Outcomes 
Number of children, childlessness and age at first birth were derived as they were in the 
positive control analysis for educational attainment. A measure of number of sexual 
partners was also included. If participants indicated that they had had sexual intercourse, 
they were asked “About how many sexual partners have you had in your lifetime?". 
Participants were given the information that “Sexual intercourse includes vaginal, oral or 
anal intercourse” if they activated the help button. I coded responses to missing if above 
the 99th percentile. I then derived a binary measure indicating if participants were in 
approximately the top 10th percentile for the highest number of sexual partners (equal to 
or above 12 partners coded as 1). 
5.3.2.3 Data analysis 
Data analysis for genetic liability for schizophrenia in UK Biobank followed the same 
processes as for the positive control. I used LD score regression (Bulik-Sullivan, 
Finucane, et al., 2015; Bulik-Sullivan, Loh, et al., 2015) to calculate the genome-wide 
genetic correlation between schizophrenia liability and number of children and age at first 
birth and number of sexual partners. For this, I used the same genome-wide associations 
that were calculated for number of children and age at first birth for positive control 
analyses. Genome-wide associations were also calculated for number of sexual partners 




components of population structure, age and sex were included as covariates, as done so 
for number of children.  
I first regressed the genetic score for schizophrenia with the continuous outcomes. Effect 
sizes used in MR analysis for number of children, age at first birth, and number of sexual 
partners analysis are listed in Appendix 14. These regressions and the SNP-outcome 
associations for MR used the same models as the positive control and LD score 
regression above. The I2GX statistic for an unweighted MR-Egger regression was 0.2 for 
genetic liability of schizophrenia (Bowden, Fabiola Del Greco, et al., 2016). As done in 
the positive control, LD score regression and MR analysis was also conducted with SNP-
outcome associations additionally adjusted for genotype array. 
As well as the non-linearity plots discussed above, I additionally plotted the same 
relationships using deciles of the genetic score and with reproductive success on the x-
axis. As further sensitivity analysis to assess if there was any decline in reproductive 
success within the sample at very high levels of genetic liability, I conducted a series of 
regressions between this genetic score for schizophrenia liability and outcomes, 
systematically removing cumulative centiles from the maximum. These regressions 
included adjustment for the top 10 principal components of population structure. 
Quadratic regression was adjusted for the top 10 principal components of population 
structure. Adjustment for age was also included for number of children and number of 
sexual partners. Lastly, sex was included as a covariate in combined sex analysis. 
As there was an available measure on whether participants in UK Biobank had had a 
schizophrenia diagnosis, I repeated analysis after removing the few schizophrenia cases 
in the sample (maximum N = 207).  
5.3.3 MoBa  
5.3.3.1 Exposure instrument 
There were 107 SNPs available in MoBa data and proxies were found for an additional 8 
SNPs. A total of 10 SNPs did not meet additional quality checks and were therefore 
excluded (see Chapter 2 for details). I therefore included 105 SNPs in MoBa analysis (see 
Appendix 15). The mean F statistic for schizophrenia genetic liability was 36.36. 
5.3.3.2 Outcomes 
Primary outcomes in Moba were parity, age at first pregnancy and age at first birth. Parity 




pregnancy cohort, no binary measure of childlessness was derived. Age at first pregnancy 
was derived from age at pregnancy for the index child (taken from the MBRN) and 
questionnaire data for the earliest year of previous pregnancies. Age at first birth was 
similarly derived but restricted to pregnancies resulting in live births. As mentioned in 
Chapter 3, all questionnaire data was taken from the first questionnaire which was sent to 
mothers between 13 and 17 weeks gestation. 
I also included a range of secondary outcomes. Whether the index pregnancy was planned 
was taken from questionnaire data. Mothers were also asked whether they had conceived 
the index pregnancy even though them or their partner used contraceptives. An item 
indicating if mothers had ever been treated for infertility was also taken from 
questionnaire data. These secondary outcomes were binary with ‘yes’ coded as 1. An 
additional secondary measure for the length of sexual relationship the mother had had 
with the index child’s father was derived (coded as a continuous measure in months). I 
also included a binary measure of whether any previous pregnancy resulted in a 
termination (‘yes’ coded as 1). 
5.3.3.3 Data analysis 
There was no available measure for whether participants had been diagnosed with 
schizophrenia and therefore no exclusions were made for this. For regressions between 
the genetic score for schizophrenia liability and outcomes, I included covariates for the 
top 10 principal components of population structure and genotype array. I then further 
adjusted for birth year. I additionally included adjustment for age at delivery of the index 
child in analysis of whether any previous pregnancy had resulted in a termination. For all 
primary outcomes, I conducted MR analysis and used MR-Base to do so (Hemani, Zheng, 
et al., 2018). For this, I used Plink to calculate SNP-outcome associations (see Appendix 
15), adjusted for the top 10 principal components of population structure, genotype array 
and birth year. The SNP-outcome associations were then taken into MR-Base, where they 
were harmonized with exposure SNPs to ensure that the effect of the SNP on the 
exposure and the SNP on the outcome corresponded to the same, increasing, allele. The 
I2GX value for this data was 0.2. 
As additional sensitivity analyses, I assessed if there were associations between liability 
for schizophrenia and outcomes using genetic scores including SNPs with lower p-value 
thresholds from the schizophrenia GWAS (Schizophrenia Working Group of the 
Psychiatric Genomics Consortium, 2014). These scores were derived using PRSice 




following p-value thresholds: 1×10-5, 0.005, 0.05, 0.1, 0.5, 1. Of these, the threshold of 
0.05 has been shown to be the best predictor of schizophrenia (Schizophrenia Working 
Group of the Psychiatric Genomics Consortium, 2014) however I examined evidence 
across all included thresholds. Scores were weighted according to the association 
magnitude of each SNP in the GWAS (Schizophrenia Working Group of the Psychiatric 
Genomics Consortium, 2014) and then averaged across SNPs to provide a score per 
individual. I standardized scores and then regressed each with the outcomes using the 
same models as for the regressions using the score with only genome-wide significant 
SNPs. For quadratic regression, genotype array, the top 10 principal components of 
population structure and additional adjustment for birth year were included. 
5.3.4 ALSPAC G0 
5.3.4.1 Exposure instrument 
There was a total of 115 SNPs available in ALSPAC data (see Appendix 16). There were 
no available proxies for any missing genome-wide significant SNPs in ALSPAC. These 
115 SNPs were eligible in regard to exclusion criteria. The mean F statistic for 
schizophrenia genetic liability was 37.16. 
5.3.4.2 Outcomes 
The primary measures in ALSPAC G0 were parity at 85 months post index child, parity 
at 18 years post index child, and age at first pregnancy. Parity measures were derived 
using questionnaire data for parity at 18 weeks gestation and any additional pregnancies 
reported until 85 months or 18 years later. As ALSPAC was also a pregnancy cohort, no 
binary measure of parity was derived. Age at first pregnancy was derived using 
questionnaire data for ALSPAC G0 age at first pregnancy, asked at approximately 18 
weeks gestation, or the age at index pregnancy if they reported no previous pregnancies. I 
also included a secondary binary measure of whether any previous pregnancy resulted in 
a termination (‘yes’ coded as 1) from questionnaire data at 18 weeks gestation. 
5.3.4.3 Data analysis 
After conducting analysis with and without schizophrenia cases in UK Biobank, I decided 
to remove the few schizophrenia cases in ALSPAC G0 before analyses (maximum N = 
7). For regression between the genetic score for schizophrenia liability and outcomes, I 
included covariates for the top 10 principal components of population structure and then 
further adjusted for birth year. I additionally included adjustment for age at delivery of 




I used Plink to calculate SNP-outcome associations for MR analyses (see Appendix 16), 
adjusted for birth year and the top 10 principal components of population structure. I then 
took these SNP-outcome associations into MR-Base and harmonized the data with 
exposure SNPs to ensure that the effect of the SNP on the exposure and the SNP on the 
outcome corresponded to the same, increasing, allele. The I2GX value for this data was 0.5. 
I included the same additional sensitivity analyses in ALSPAC G0 as done so in MoBa 
data, regressing scores of the same varying p-value thresholds for liability to 
schizophrenia (derived using PRSice) on outcomes. These regressions used the same 
models as above with genome-wide significant SNPs. For quadratic regression, the top 10 
principal components of population structure and birth year were included as covariates. 
5.3.5 ALSPAC G1 
5.3.5.1 Exposure instrument 
As ALSPAC genetic data is similarly quality checked for ALSPAC G0 and ALSPAC G1, 
the SNPs available and those that passed exclusion criteria were the same. I therefore 
included the same 115 SNP list as for ALSPAC G0, with effect estimates for these listed 
in Appendix 17. The mean F statistic for schizophrenia genetic liability was 37.16. 
5.3.5.2 Outcomes 
I derived number of sexual partners using questionnaire data. The main measure was 
taken at 23 years old, and I replaced to missing if responses were above the 99.9th 
percentile. I additionally included a measure where I replaced any missing responses for 
the 23-year questionnaire with data from the same question asked at 21 years old if 
available. A binary measure indicating whether participants were in the top 10th percentile 
for number of sexual partners or not was derived from both the continuous measure of 23-
year data and the continuous measure of 23-year plus 21-year data. Additionally, I 
included a binary measure of whether participants had had a child yet. This was coded as 
1 if participants indicated that they had 1 child or more to questionnaires distributed at 
approximately 21, 22 and 23 years. 
5.3.5.3 Data analysis 
I firstly removed the one schizophrenia case. I then regressed the genetic score for 
schizophrenia liability against each outcome, adjusting for the top 10 principal 
components of population structure, sex and then additionally adjusting for age. For 




years. For number of sexual partners, I adjusted for age at answering the question that the 
data referred to.  
I used Plink to calculate SNP-outcome associations for MR analyses (see Appendix 17) 
by regressing each measure of reproductive success on each SNP, adjusted for the top 10 
principal components of population structure and age as above. For the binary measure of 
being in the highest number of sexual partners (plus 21-year data), the SNP rs1023500 
could not be used to create a reliable association due to the rare outcome with one allele 
and was dropped from this analysis. The SNP-outcome associations were then taken into 
MR-Base (Hemani, Zheng, et al., 2018), where they were harmonized with exposure 
SNPs to ensure that the effect of the SNP on the exposure and the SNP on the outcome 
corresponded to the same, increasing, allele. Note that, again, the I2GX statistic for an 
unweighted MR-Egger regression was 0.5 for genetic liability of schizophrenia and MR-
Egger regression was therefore not appropriate (Bowden, Fabiola Del Greco, et al., 2016). 
For quadratic regression, the top 10 principal components of population structure, age and 
sex (in combines sex analysis) were included as covariates. 
5.4 Results 
5.4.1 Descriptives 
In the sample from UK Biobank, there were more females than males, a majority had 
children, and a minority had college or university degree qualifications. The mean age 
was 56.9 years (SD: 8.0) and the mean years of education was 13.3 (SD: 4.4). For the 
outcomes, the mean number of children was 1.8 (SD: 1.2), mean number of sexual 
partners was 5.8 (SD: 8.6) and the mean age at first birth was 25.4 years (SD: 4.5). See 
Table 5:2 for all UK Biobank descriptives.  
The mean age at delivery of the index child was 29.9 (SD: 4.4) in MoBa and 28.5 years 
(SD: 4.5) in ALSPAC G0. In MoBa, the mean age at first pregnancy was 25.8 years (SD: 
4.7) and 25.5 years (SD: 4.9) in ALSPAC G0. Mean parity was 1.59 (SD: 0.9) in MoBa, 
2.4 (0.9) at 85 months post index child in ALSPAC G0 and 2.5 (SD:4.9) at 18 years post 
index child in ALSPAC G0. In MoBa, mean age at first birth was 26.9 years (SD: 4.4).  




Table 5:2 Participant characteristics in UK Biobank sample. 
 Total N Mean (SD) or N (%) 
Sex   
Females 
337 104 
181 362 (53.80) 
Males 155 742 (46.20) 
Age at assessment, years 337 104 56.87 (8.00) 
Educational attainment, years 333 975 13.34 (4.44) 
College   
No 
333 975 
251 951 (75.44) 
Yes 82 024 (24.56) 
Number of children 335 758 1.79 (1.20) 
Childless   
No 
335 758 
270 084 (80.44) 
Yes 65 674 (19.56) 
Age at first birth, years 124 093 25.39 (4.54) 
Number of sexual partners 275 700 5.76 (8.63) 
Highest number of sexual partners   
No 
275 700 
244 132 (88.55) 





Table 5:3 Participant characteristics in MoBa and ALSPAC G0 samples. 








Mean (SD) or 
N(%) 
Age at index delivery 9444 29.94 (4.42) 7515 28.49 (4.76) 
Age at first birth 9444 26.85 (4.41) - - 
Age at first pregnancy 9444 25.80 (4.71) 7037 25.54 (4.89) 
Parity 9444 1.59 (0.89) - - 
Parity at 85 months post 
index child 
- - 4977 2.41 (0.89) 
Parity at 18 years post index 
child 
- - 2562 2.54 (1.01) 
Education 8940 4.57 (1.21) 6947 3.14 (1.26) 
Ever smoked     





     No 4791 (51.19) 43482 (8.44) 
Infertility     
     Yes 
9354 
769 (8.22) - - 
     No 8585 (91.78) - - 
Relationship 9444 75.83 (48.88)   
Pregnancy planned     
     Yes 
9350 
7800 (83.42) - - 
     No 1550 (16.58) - - 
Contraception was used     
     Yes 
9132 
396 (4.34) - - 
     No 8736 (95.66) - - 
Previous termination     





     No 1283 (13.59) 6128 (85.87) 
 
In ALSPAC G1, the mean number of sexual partners was 8.6 (SD: 10.4) for 23-year data 
and 8.6 (SD: 10.7) for 23-year plus 21-year data. Approximately 11.5% of participants 
had had a child (see Table 5:4).  
Table 5:4 Participant characteristics in ALSPAC G1 sample. 
 Total N Mean (SD) or N(%) 
Sex   
     Female 7749 3772 (48.68) 
     Male  3977 (51.32) 
Age answering 23-year questionnaire 2743 23.86 (0.51) 
Number of partners 2543 8.55 (10.41) 
Number of partners plus 21 years 3032 8.62 (10.69) 
Had child   
     Yes 2546 292 (11.47) 





5.4.2 Ever smoked 
Results for associations between the genetic scores for schizophrenia liability and 
whether participants had ever smoked are presented in Appendix 18. As expected, all 
ORs indicated an increased likelihood of having ever smoked with increased genetic 
liability for schizophrenia. There was clear evidence of an association when using 
genome-wide significant SNPs in UK Biobank and weak evidence in ALSPAC G1. For 
MoBa and ALSPAC G0, evidence became stronger with lower p-value thresholds for 
genetic liability than when using the genome-wide significant SNPs. 
5.4.3 Number of children or parity 
5.4.3.1 UK Biobank 
Using LD score regression, I found little evidence of a genetic correlation between 
schizophrenia liability and number of children (rg = 0.002, p = 0.84). The analysis 
included 1 114 456 SNPs. Results for these analyses with genotype array included as a 
covariate in generating outcome summary statistics are presented in Appendix 19. 
There was little evidence of associations between the genetic score for schizophrenia 
liability and outcomes in regression analyses (see Table 5:5). Cochran’s Q was 156.48 
(p<0.001) for genetic liability of schizophrenia and number of children, suggesting 
overdispersion although this appeared balanced (see Appendix 20). Cochran’s Q was 
172.79 (p<0.001) for genetic liability of schizophrenia and childlessness with a similar 
pattern. There was little evidence that higher genetic liability for schizophrenia increased 
number of children (mean difference: 0.003 increase in number of children per doubling 
in the natural log OR of schizophrenia liability, 95% CI: -0.003 to 0.009, p = 0.39). I 
further tested childlessness as an outcome and found no strong evidence of an effect of 
genetic liability for schizophrenia on childlessness (see Table 5:6). When I repeated the 
MR analysis after removing the few schizophrenia cases in the sample, there was no clear 
change in results (see Appendix 21). Results for these analyses with genotype array 
included as a covariate in the outcome summary statistics are presented in Appendix 22. 
Table 5:5 Estimates of the association between the genetic score for schizophrenia 
liability and number of children in UK Biobank data. 
Genetic score for schizophrenia liability 
Number of children 
N β (95% CI), p 
Combined sexes  335 758 0.0002 (-0.0004, 0.0008), 0.53 
Females 181 255 0.0006 (-0.0002, 0.0014), 0.16 





Table 5:6 Estimates of the causal effect of genetic liability for schizophrenia on number 
of children and childlessness using IVW, MBE and weighted median MR methods. 
 No. of childrenb Childlessnessc 
Method (101 SNPsa) β (95% CI), p OR (95% CI), p 
IVW 0.003 (-0.003, 0.009), 0.39 0.998 (0.985, 1.012), 0.79 
Weighted median 0.006 (-0.004, 0.015), 0.23 0.995 (0.975, 1.016), 0.65 
MBE 0.020 (-0.012, 0.052), 0.22 0.992 (0.924, 1.065), 0.83 
a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 
controls); b Number of children data from UK Biobank (N = 318 921 – 335 758). c 
Childlessness data from UK Biobank (N = 318 921 – 335 758). 
 
Sensitivity analysis investigating a possible non-linear relationship is presented in Figure 
5:2, showing the mean number of children for quintiles of an unweighted additive genetic 
score for schizophrenia liability. As shown, there is little evidence of heterogeneity across 
values of the schizophrenia score. Similar patterns are seen across deciles of the genetic 
score for schizophrenia liability and when plotting these measures of reproductive success 
on the x-axis (see Appendix 23 and Appendix 24). A series of regressions between the 
genetic score and number of children, systematically removing cumulative centiles, 
showed that estimates became slightly stronger although there was little statistical support 
(see Table 5:7). This analysis was repeated after removing the few schizophrenia cases, 
which did not alter results (see Appendix 25). Regression of the genetic score for 
schizophrenia liability and number of children further showed no clear evidence when 
including a quadratic term for genetic liability for schizophrenia and when stratified by 
sex (see Table 5:8). This quadratic relationship suggested a slight peak in fitness at 
intermediate levels of genetic liability, particularly for females, but again with little 





Figure 5:2 Genetic score for schizophrenia liability (in quintiles) and mean number of 
children in UK Biobank data showing little evidence of heterogeneity across values of the 
score. 
 
Table 5:7 Estimates of the association between the genetic score for schizophrenia 
liability and number of children removing cumulative deciles of the genetic score.  
Genetic score for schizophrenia liability 
Number of children 
N β (95% CI), p 
Highest 10% removed 302 190 0.0005 (-0.0003, 0.0013), 0.19 
Highest 20% removed 268 604 0.0002 (-0.0007, 0.0011), 0.70 
Highest 30% removed 235 030 0.0005 (-0.0006, 0.0016), 0.35 
Highest 40% removed 208 433 0.0006 (-0.0006, 0.0019), 0.30 
Highest 50% removed 167 860 0.0008 (-0.0006, 0.0023), 0.27 
 
Table 5:8 Quadratic regression of the genetic score for schizophrenia liability with 
number of children in UK Biobank data.  
Genetic score for schizophrenia liability  
(including quadratic term for the score) 
Number of children 
N β (95% CI), p 
Combined sexes  335 758 0.0025 (-0.0108, 0.0157), 0.72 
Females 181 255 -0.0001 (-0.0174, 0.0172), 0.99 
Males 154 503 0.0055 (-0.0149, 0.0259), 0.60 
 
5.4.3.2 MoBa 
There was a positive relationship between genetic liability for schizophrenia and parity 
using a genetic score consisting of genome-wide significant SNPs (see Table 5:9). 
Subsequently, MR results indicated a positive effect on parity with increasing genetic 




































in the positive direction although the MBE resulted in a small negative point estimate. 
The Cochran’s Q for this IVW analysis was 79.74 (p = 0.96) (see Appendix 29).  
Conversely, associations did not remain in sensitivity analysis looking across p-value 
thresholds for genetic liability for schizophrenia although most point estimates were in 
the positive direction (see Table 5:11). 
Table 5:9 Estimates of the association between the genetic score for schizophrenia 
liability and number of children in MoBa data. 
 
Parity 
(N = 9439) 
Genetic score for schizophrenia liability β (95% CI), p 
Model 1 0.021 (0.003, 0.039), 0.02 
Model 2 0.021 (0.003, 0.039), 0.02 
Model 1 is adjusted for the top 10 principal components of population structure and 
genotype array. Model 2 is additionally adjusted for mothers’ birth year. 
 
Table 5:10 Estimates of the causal effect of genetic liability for schizophrenia on parity 
using IVW, MBE and weighted median MR methods. 
 Parityb 
Method (105 SNPsa) β (95% CI), p 
IVW 0.031 (0.005, 0.057), 0.02 
Weighted median 0.012 (-0.025, 0.049), 0.54 
MBE -0.001 (-0.093, 0.092), 0.98 
a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 





Table 5:11 Estimates for associations between genetic scores with varying p-value 
thresholds and parity in MoBa data. 
 Parity 
(N = 9439) 
 β (95% CI), p 
Genetic score for schizophrenia liability 
Model 1    
p<1x10-5 0.010 (-0.008, 0.028), 0.29 
p<0.0005 -0.0001 (-0.018, 0.018), 0.99 
p<0.005 0.008 (-0.011, 0.027), 0.43 
p<0.05 0.006 (-0.012, 0.024), 0.53 
p<0.1 0.005 (-0.014, 0.024), 0.63 
p<0.5 0.003 (-0.016, 0.022), 0.74 
p<1 0.004 (-0.016, 0.023), 0.72 
Model 2    
p<1x10-5 0.010 (-0.008, 0.027), 0.29 
p<0.0005 0.00004 (-0.018, 0.018), 0.99 
p<0.005 0.007 (-0.011, 0.026), 0.44 
p<0.05 0.006 (-0.013, 0.024), 0.55 
p<0.1 0.004 (-0.015, 0.023), 0.65 
p<0.5 0.003 (-0.016, 0.022), 0.77 
p<1 0.003 (-0.016, 0.023), 0.75 
Model 1 is adjusted for the top 10 principal components of population structure and 
genotype array. Model 2 is additionally adjusted for mothers’ birth year. 
 
As shown in Figure 5:3, the relationship between the genetic score for schizophrenia 
liability (using genome-wide significant SNPs) and parity suggests a somewhat linear 
relationship. In line with this, there was no clear statistical evidence for a relationship 
between genetic liability for schizophrenia and parity when including a quadratic term for 
the genetic score although the unadjusted quadratic plot suggested a possible J-shaped 





Figure 5:3 Genetic score for schizophrenia liability (in quintiles) and mean parity in 
MoBa data showing a slight linear trend across values of the score. 
 
Table 5:12 Quadratic regression of the genetic score for schizophrenia liability with 
parity in MoBa data. 
 
Parity 
(N = 9439) 
 β (95% CI), p 
Genetic score for schizophrenia liability  
(including quadratic term for the unstandardized score) 
Model 1  -0.232 (-0.650, 0.185), 0.28 
Model 2 -0.231 (-0.649, 0.187), 0.28 
Model 1 is adjusted for the top 10 principal components of population structure and 
genotype array. Model 2 is additionally adjusted for mothers’ birth year. 
 
5.4.3.3 ALSPAC G0 
There was no clear evidence for associations between liability for schizophrenia and 
parity using a genetic score consisting of genome-wide significant SNPs (see Table 
5:13). In line with this, there was no clear effects across all MR methods (see Table 
5:14). In sensitivity analyses using varying p-value thresholds for genetic liability, there 
was no clear evidence of associations with parity at 85 months or 18 years post index 
child (see Table 5:15). Cochran’s Q for an IVW method for parity at 85 months post 
index child was 97.77 (p = 0.86) and 91.72 (p = 0.94) for parity at 18 years post index 































Table 5:13 Estimates of the association between the genetic score for schizophrenia 
liability and parity in ALSPAC G0 data. 
 Parity 85m post index child Parity 18y post index child 
 (N = 4977) (N = 2562) 
 β (95% CI), p 
Genetic score for schizophrenia liability 
Model 1 0.008 (-0.016, 0.033), 0.51 0.003 (-0.035, 0.042), 0.86 
Model 2 0.008 (-0.017, 0.032), 0.55 0.006 (-0.033, 0.044), 0.77 
Model 1 is adjusted for the top 10 principal components of population structure. Model 2 
is additionally adjusted for ALSPAC G0 birth year. 
 
Table 5:14 Estimates of the causal effect of genetic liability for schizophrenia on parity 
using IVW, MBE and weighted median MR methods 
 Parity at 85 monthsb Parity at 18 yearsc 
Method (115 SNPsa) β (95% CI), p 
IVW 0.011 (-0.023, 0.045), 0.53 0.008 (-0.046, 0.062), 0.78 
Weighted median -0.004 (-0.054, 0.046), 0.86 0.012 (-0.064, 0.087), 0.76 
MBE -0.045 (-0.168, 0.078), 0.47 0.039 (-0.152, 0.230), 0.69 
a Schizophrenia genetic data from the PGC GWAS (N = 35 123 cases and 109 657 
controls); b Parity at 85 months post index child from ALSPAC G0 (N = 4977). c Parity at 
18 years post index child from ALSPAC G0 (N = 2562). 
 
Table 5:15 Estimates for associations between genetic scores with varying p-value 
thresholds and parity in ALSPAC G0 data. 
 Parity at 85 months 
(N = 4977) 
Parity at 18 years 
(N = 2562) 
 β (95% CI), p 
Genetic score for schizophrenia liability 
Model 1       
p<1x10-5 0.010 (-0.014, 0.034), 0.42 0.025 (-0.014, 0.064), 0.21 
p<0.0005 0.004 (-0.020, 0.029), 0.74 0.033 (-0.006, 0.073), 0.10 
p<0.005 0.013 (-0.012, 0.037), 0.32 0.035 (-0.004, 0.075), 0.08 
p<0.05 0.022 (-0.003, 0.047), 0.08 0.033 (-0.007, 0.073), 0.11 
p<0.1 0.018 (-0.007, 0.043), 0.15 0.025 (-0.015, 0.065), 0.21 
p<0.5 0.012 (-0.013, 0.037), 0.36 0.025 (-0.015, 0.065), 0.22 
p<1 0.011 (-0.014, 0.036), 0.40 0.019 (-0.020, 0.059), 0.34 
Model 2       
p<1x10-5 0.008 (-0.016, 0.033), 0.50 0.028 (-0.011, 0.068), 0.15 
p<0.0005 0.002 (-0.022, 0.027), 0.84 0.036 (-0.004, 0.075), 0.08 
p<0.005 0.012 (-0.013, 0.036), 0.35 0.035 (-0.004, 0.075), 0.08 
p<0.05 0.021 (-0.004, 0.045), 0.10 0.035 (-0.005, 0.074), 0.09 
p<0.1 0.017 (-0.008, 0.042), 0.19 0.028 (-0.012, 0.068), 0.17 
p<0.5 0.010 (-0.015, 0.035), 0.42 0.027 (-0.013, 0.066), 0.19 
p<1 0.009 (-0.015, 0.034), 0.46 0.021 (-0.018, 0.061), 0.29 
Model 1 is adjusted for the top 10 principal components of population structure. Model 2 




There was little evidence of heterogeneity of mean parity across quintiles of the genetic 
score for schizophrenia liability when investigating the possibility of a non-linear 
relationship (see Figure 5:4 and Figure 5:5). Although an unadjusted quadratic plot 
suggested a non-linear relationship for each measure of parity, there was no clear 
statistical support for these (see Appendix 32 and Appendix 33 and Table 5:16).  
 
Figure 5:4 Genetic score for schizophrenia liability (in quintiles) and mean parity at 85 
months post index child in ALSPAC G0 data showing little evidence of heterogeneity 
across values of the score. 
 
 
Figure 5:5 Genetic score for schizophrenia liability (in quintiles) and mean parity at 18 
years post index child in ALSPAC G0 data showing little evidence of heterogeneity across 

























































































Table 5:16 Quadratic regression of the genetic score for schizophrenia liability with 
parity in ALSPAC G0.  
 Parity 85m post index child Parity 18y post index child 
 (N = 4977) (N = 2562) 
 β (95% CI), p 
Genetic score for schizophrenia liability (including quadratic term for the 
unstandardized score) 
Model 1 -0.337 (-0.985, 0.312), 0.31 0.628 (-0.384, 1.639), 0.22 
Model 2 -0.341 (-0.988, 0.307), 0.30 0.598 (-0.410, 1.607), 0.25 
Model 1 is adjusted for the top 10 principal components of population structure. Model 2 
is additionally adjusted for ALSPAC G0 birth year. 
 
5.4.3.4 ALSPAC G1 
As shown in Table 5:17, there was evidence of an effect in the positive direction for 
increasing genetic liability for schizophrenia on the likelihood of having had a child in 
females. However, in combined sexes or males only, there was no clear evidence of such 
an effect (see Table 5:17 and Table 5:18). Cochran’s Q values for the IVW method 
indicated only weak evidence for overdispersion (138.38, p = 0.06) (see Appendix 34). 
Table 5:17 Estimates of associations between the genetic score for schizophrenia liability 
and whether participants had had a child yet in ALSPAC G1 data. 
  Had child 
Genetic score for schizophrenia liability N OR (95% CI), p 
Combined sexes 1956 1.123 (0.970, 1.301), 0.12 
Females 1299 1.214 (1.027, 1.434), 0.02 
Males 657 0.872 (0.639, 1.189), 0.39 
 
Table 5:18 Estimates of the causal effect of genetic liability for schizophrenia on whether 
participants had had a child yet using IVW, MBE and weighted median MR methods. 
  Had child
b 
Methods (115 SNPsa) OR (95% CI), P 
IVW 1.173 (0.948, 1.451), 0.14 
Weighted Median 1.172 (0.875, 1.569), 0.29 
MBE 0.937 (0.467, 1.881), 0.28 
a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 





5.4.3.5 Summary across all studies 
All IVW point estimates for the effect of genetic liability for schizophrenia on number of 
children or parity were in the positive direction. There was statistical support for an effect 
in MoBa, whereas confidence intervals for the other studies included the null. For 
childlessness, there was no clear evidence in either UK Biobank or ALSPAC G1 and the 
point estimate for UK Biobank was very close to the null value, possibly due lower 
statistical power with using binary measures.  
 
 
Figure 5:6 IVW estimates for genetic liability for schizophrenia on number of children or 
parity across studies. 
 
Figure 5:7 IVW estimates for genetic liability for schizophrenia on likelihood of being 
childless across studies. ALSPAC G1 estimates are for the reverse coding of having had a 





5.4.4 Number of sexual partners 
5.4.4.1 UK Biobank 
There was no clear evidence of a genetic correlation between schizophrenia liability and 
number of sexual partners (rg = 0.007, p = 0.42). Again, the analysis included 1 114 456 
SNPs. Results for these analyses with genotype array included as a covariate in the 
outcome summary statistics are presented in Appendix 19. 
There was clear evidence of a positive association between genetic liability for 
schizophrenia and number of sexual partners (see Table 5:19). Cochran’s Q was 301.88 
(p<0.001) for genetic liability of schizophrenia and number of sexual partner and 250.33 
(p<0.001) for genetic liability of schizophrenia and being in the highest number of sexual 
partners for IVW analysis, again suggesting overdispersion although this also appeared 
balanced (see Appendix 20 for an example). I found that higher genetic liability for 
schizophrenia had a positive effect on number of sexual partners (mean difference: 0.165 
increase in number of sexual partners per doubling in the natural log OR of schizophrenia 
liability, 95% CI: 0.117 to 0.212, p<0.001) (see Table 5:20). A positive effect was also 
seen in analysis of the binary measure for the highest number of sexual partners (see 
Table 5:20). No clear change in results was seen when analysis was repeated without the 
few schizophrenia cases (shown in Appendix 21). Results for these analyses with 
genotype array included as a covariate in the outcome summary statistics are presented in 
Appendix 22. 
Table 5:19 Estimates of the association between the genetic score for schizophrenia 
liability and number of sexual partners in UK Biobank data. 
Genetic score for schizophrenia liability 
Number of sexual partners 
N β (95% CI), p 
Combined sexes  275 700 0.016 (0.011, 0.021), <0.001 
Females 148 630 0.005 (0.002, 0.009), 0.004 





Table 5:20 Estimates of the causal effect of genetic liability for schizophrenia on number 
of sexual partners and a binary measure of this using IVW, MBE and weighted median 
MR methods. 
 Number of sexual 
partnersb 
Highest number of 
sexual partnersc 
Method (101 SNPsa) β (95% CI), p OR (95% CI), p 
IVW 
0.165 (0.117, 0.212), 
<0.001 
1.057 (1.038, 1.077), 
<0.001 
Weighted median 
0.172 (0.092, 0.230), 
<0.001 
1.034 (1.003, 1.066), 
0.03 
MBE 
0.389 (-0.032, 0.810), 
0.07 
1.010 (0.884, 1.154), 
0.88 
a Schizophrenia genetic data from the PGC GWAS (N = 35 123 cases and 109 657 
controls); b Number of sexual partners data from UK Biobank (N = 261 931- 275 700); c 
Highest number of sexual partners data from UK Biobank (N = 261 931- 275 700). 
 
In sensitivity analysis, the relationship between the genetic score for schizophrenia 
liability and number of sexual partners appears linear (see Figure 5:8). Similar patterns 
are seen across deciles of the genetic score for schizophrenia liability and when plotting 
these measures of reproductive success on the x-axis (see Appendix 35 and Appendix 
36). Furthermore, a relationship was consistently shown when removing cumulative 
deciles from the maximum of the genetic score (see Table 5:21 and Appendix 25). 
Furthermore, there was no clear evidence for a relationship between genetic liability for 
schizophrenia and number of sexual partners when including a quadratic term, again 
suggesting the relationship is linear (see Table 5:22 and Appendix 37-39). 
 
Figure 5:8 Genetic score for schizophrenia liability (in quintiles) and mean number of 




Table 5:21 Estimates of the association between the genetic score for schizophrenia 
liability and number of sexual partners removing cumulative deciles of the genetic score. 
 Genetic score for schizophrenia liability 
Number of sexual partners 
N β (95% CI), p 
Highest 10% removed 248 251 0.011 (0.005, 0.017), <0.001 
Highest 20% removed 220 847 0.012 (0.005, 0.020), <0.001 
Highest 30% removed 193 353 0.017 (0.008, 0.025), <0.001 
Highest 40% removed 171 567 0.015 (0.006, 0.025), <0.001 
Highest 50% removed 138 280 0.012 (0.001, 0.024), 0.04 
 
Table 5:22 Quadratic regression of the genetic score for schizophrenia liability with 
number of sexual partners in UK Biobank data. 
Genetic score for schizophrenia liability 
(including quadratic term for genetic score) 
Number of sexual partners 
N β (95% CI), p 
Combined sexes  275 700 -0.046 (-0.148, 0.056), 0.38 
Females 148 630 -0.017 (-0.092, 0.057), 0.65 
Males 127 070 -0.085 (-0.289, 0.118), 0.41 
 
5.4.4.2 ALSPAC G1 
There was little evidence of associations between the genetic score for schizophrenia 
liability and outcomes in regression analyses (see Table 5:23). Cochran’s Q values 
indicated little evidence for overdispersion across IVW analyses (see Table 5:24 and 
Appendix 34 for example plot). As shown in Table 5:25, there was little evidence for a 
causal effect of increasing genetic liability of schizophrenia on number of sexual partners 
across MR methods. 
Table 5:23 Estimates of the association between the genetic score for schizophrenia 
liability and number of sexual partners in ALSPAC G1 data. 
 Number of sexual partners 
Number of sexual partners (plus 21-
year data) 
 N β (95% CI), p N β (95% CI), p 
Combined sexes 2474 0.203 ( -0.206, 0.613), 0.33 2963 0.219 (-0.169, 0.607), 0.27 
Females only 1623 -0.050 (-0.443, 0.344), 0.81 1911 -0.064 (-0.433, 0.305), 0.73 









Outcome Q p 
Number of sexual partners 130.14 0.14 
Number of sexual partners (plus 21-year data) 122.33 0.28 
Highest number of sexual partners 126.28 0.19 
Highest number of sexual partners (plus 21-year data) 131.87 0.12 
 
Table 5:25 Estimates of the causal effect of genetic liability for schizophrenia on number 


















































a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 
controls); b Number of sexual partners data from ALSPAC G0 (N = 2474); c Number of 
sexual partners (plus 21-year data) from ALSPAC G0 (N = 2963). The number of SNPs 
for c is 114. 
 
In Figure 5:9 and Figure 5:10, there is some suggestion of a peak in number of sexual 
partners even in this general population sample. Results from regression analysis 
including a quadratic term for the genetic score supported this peak, particularly in 





Figure 5:9 Genetic score for schizophrenia liability (in quintiles) and mean number of 
sexual partners in ALSPAC G1 data suggesting a possible non-linear relationship. 
 
 
Figure 5:10 Genetic score for schizophrenia liability (in quintiles) and mean number of 


























































































Table 5:26 Quadratic regression of the genetic score for schizophrenia liability with 
number of sexual partners in ALSPAC G1 data. 
Genetic score for 
schizophrenia liability  
(including quadratic term 
for the unstandardized 
score) 
Number of sexual partners 
Number of sexual partners 
(plus 21-year data) 
N β (95% CI), p N β (95% CI), p 
Combined sexes 2474 6.264 (-3.852, 16.380), 
0.23 
2963 9.479 (-0.137, 19.094), 
0.05 
Females only 1623 10.824 (0.724, 20.924), 
0.04 
1911 9.983 (0.498, 19.468), 
0.04 
Males only 851 -3.171 (-24.57, 18.23), 
0.77 
1052 6.977 (-13.142, 27.096), 
0.50 
 
5.4.4.3 Summary across all studies 
All IVW point estimates for the effect of genetic liability for schizophrenia on number of 
sexual partners were in the positive direction. There was a clear effect in UK Biobank, 
whereas confidence intervals for ALSPAC G1 results were wide and consistent with the 
null. It is likely that the smaller sample sizes for ALSPAC G1 data resulted in reduced 
power to clearly detect an effect, although sensitivity analysis also suggested a possible 
non-linear relationship (see above). 
 
Figure 5:11 IVW estimates for genetic liability for schizophrenia on number of sexual 






Figure 5:12 IVW estimates for genetic liability for schizophrenia on a binary measure of 
number of sexual partners across studies. 
 
5.4.5 Age at first pregnancy and age at first birth 
5.4.5.1 UK Biobank 
Using LD score regression, there was little evidence of a genetic correlation between 
schizophrenia liability and age at first birth (rg = -0.007, p = 0.45). Again, there were 1 
114 456 SNPs included in this analysis. Results for these analyses with genotype array 
included as a covariate in the outcome summary statistics are presented in Appendix 19. 
Regression of the genetic score for schizophrenia liability on age at first birth showed no 
clear evidence of an association (mean difference: -0.001 decrease in age at first birth per 
allele increase in genetic liability for schizophrenia, CI: -0.005 to 0.003, p = 0.54, N = 
124 093). Cochran’s Q was 286.64 for genetic liability of schizophrenia and age at first 
birth (p<0.001) which again suggests the presence of overdispersion although this did 
appear balanced (see Appendix 20 for example). There was little evidence that higher 
genetic liability for schizophrenia decreased age at first birth (mean difference: -0.004 
years lower age at first birth per doubling in the natural log OR of schizophrenia liability, 
95% CI: -0.043 to 0.034, p = 0.82) (see Table 5:27). After removing the few 
schizophrenia cases in the sample, there was no clear change in results (as shown in 
Appendix 21). For results of these analyses with genotype array included as a covariate 




Table 5:27 Estimates of the causal effect of genetic liability for schizophrenia on age at 
first birth using IVW, MBE and weighted median MR methods. 
 Age at first birthb 
Method (101 SNPsa) β (95% CI), p 
IVW -0.004 (-0.043, 0.034), 0.82 
Weighted median 0.023 (-0.042, 0.089), 0.49 
MBE 0.060 (-0.175, 0.294), 0.62 
a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 
controls); b Age at first birth data from UK Biobank (N = 117 844 – 124 093). 
 
Sensitivity analysis investigating a possible non-linear relationship is presented in Figure 
5:13 and Appendix 46, showing the mean age at first birth for quintiles of an unweighted 
additive genetic score for schizophrenia liability. Although these figures are somewhat 
suggestive of a non-linear relationship between the genetic score for schizophrenia 
liability and mean age at first birth, there is little evidence of heterogeneity across values 
of the schizophrenia score. A series of regressions between the genetic score and age at 
first birth, systematically removing cumulative centiles from the maximum, suggests that 
the relationship is strongest at intermediate levels (see Table 5:28). This analysis was 
repeated after removing the few schizophrenia cases, which did not alter these results (see 
Appendix 25). There was a weak association when including a quadratic term for the 
genetic score, suggesting the lowest age at first birth was seen at intermediate levels of 
genetic liability (mean difference: -0.088 decrease in age at first birth per allele increase 
in genetic liability for schizophrenia, CI: -0.171 to -0.004, p = 0.54, N = 124,093) (also 





Figure 5:13 Genetic score for schizophrenia liability (in quintiles) and mean age at first 
birth in women from UK Biobank data showing some evidence of a non-linear trend. 
 
Table 5:28 Associations of the genetic score for schizophrenia liability and age at first 
birth removing cumulative deciles of the score.  
  
Genetic score for schizophrenia liability 
 Age at first birth 
N β (95% CI), p 
Highest 10% removed 111 632 -0.004 (-0.009, 0.001), 0.15 
Highest 20% removed 99 134 -0.005 (-0.010, 0.001), 0.11 
Highest 30% removed 86 620 -0.008 (-0.014, -0.001), 0.03 
Highest 40% removed 76 833 -0.009 (-0.016, -0.001), 0.02 
Highest 50% removed 61 822 -0.008 (-0.018, 0.001), 0.08 
 
5.4.5.2 MoBa 
No clear associations were seen between genetic liability for schizophrenia and age at 
first pregnancy or age at first birth (see Table 5:29). Furthermore, there were no clear 
effects of genetic liability for schizophrenia on age at first pregnancy or age at first birth 
across MR methods (see Table 5:30). The Cochran’s Q was 98.79 (p = 0.63) for age at 
first pregnancy and 89.67 (p = 0.84) for age at first birth (see Appendix 29 for an 
example).  
In sensitivity analysis varying the p-value threshold for genetic liability to schizophrenia, 
there was evidence of negative associations with age at first pregnancy (see Table 5:31). 


































evidence was seen. Evidence for age at first birth was weaker however results for a p-
value threshold of 0.05 suggested a relationship when including adjustment for birth year. 
Table 5:29 Estimates of the association between the genetic score for schizophrenia 
liability and age at first pregnancy and age at first birth in MoBa data. 
 
Age at first pregnancy 
(N = 9444) 
Age at first birth 
(N = 9444) 
Genetic score for schizophrenia 
liability 
β (95% CI), p 
Model 1 0.029 (-0.067, 0.124), 0.55 0.022 (-0.066, 0.111), 0.62 
Model 2 0.006 (-0.079, 0.092), 0.88 -0.004 (-0.078, 0.071), 0.93 
Model 1 is adjusted for the top 10 principal components of population structure and 
genotype array. Model 2 is additionally adjusted for mothers’ birth year. 
 
Table 5:30 Estimates of the causal effect of genetic liability for schizophrenia on age at 
first pregnancy and age at first birth using IVW, MBE and weighted median MR methods. 
 Age at first pregnancyb Age at first birth
c 
Method (105 SNPsa) β (95% CI), p 
IVW 0.010 (-0.114, 0.133), 0.88 -0.006 (-0.114, 0.103), 0.92 
Weighted median -0.028 (-0.209, 0.155), 0.77 0.092 (-0.061, 0.245), 0.24 
MBE -0.067 (-0.610, 0.476), 0.81 0.202 (-0.171, 0.577), 0.29 
a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 
controls); b Age at first pregnancy data from MoBa (N = 9444); c Age at first birth data 






Table 5:31 Estimates for associations between genetic scores with varying p-value 
thresholds and age at first pregnancy and age at first birth in MoBa data. 
 Age at first pregnancy 
(N=9444) 
Age at first birth 
(N = 9444) 
 β (95% CI), p β (95% CI), p 
Schizophrenia       
Model 1       
p<1x10-5 -0.085 (-0.181, 0.010), 0.08 -0.060 (-0.149, 0.029), 0.19 
p<0.0005 -0.107 (-0.203, -0.011), 0.03 -0.045 (-0.134, 0.045), 0.33 
p<0.005 -0.126 (-0.225, -0.028), 0.01 -0.035 (-0.127, 0.057), 0.46 
p<0.05 -0.145 (-2.45, -0.045), 0.004 -0.053 (-0.146, 0.040), 0.27 
p<0.1 -0.156 (-0.258, -0.053), 0.003 -0.062 (-0.158, 0.034), 0.21 
p<0.5 -0.132 (-0.234, -0.031), 0.01 -0.032 (-0.127, 0.063), 0.51 
p<1 -0.125 (-0.229, -0.022), 0.02 -0.023 (-0.119, 0.074), 0.65 
Model 2       
p<1x10-5 -0.086 (-0.172, -0.001) 0.05 -0.060 (-0.135, 0.015), 0.11 
p<0.0005 -0.098 (-0.184, -0.012), 0.03 -0.034 (-0.110, 0.041), 0.37 
p<0.005 -0.140 (-0.228, -0.052), 0.002 -0.051 (-0.128, 0.027), 0.20 
p<0.05 -0.184 (-0.274, -0.095), <0.001 -0.098 (-0.176, -0.019), 0.02 
p<0.1 -0.187 (-0.279, -0.095), <0.001 -0.099 (-0.179, -0.018), 0.02 
p<0.5 -0.171 (-0.262, -0.080), <0.001 -0.077 (-0.156, 0.003), 0.60 
p<1 -0.170 (-0.262, -0.077), <0.001 -0.074 (-0.155, 0.008), 0.08 
Model 1 is adjusted for the top 10 principal components of population structure and 
genotype array. Model 2 is additionally adjusted for mothers’ birth year. 
 
There appeared to be little evidence of heterogeneity for mean age at first pregnancy 
across quintiles of the genetic score for schizophrenia liability (see Figure 5:14) whereas 
a possible peak was observed for age at first birth (see Figure 5:15). Quadratic regression 






Figure 5:14 Genetic score for schizophrenia liability (in quintiles) and mean age at first 
pregnancy in MoBa data showing little heterogeneity across values of the score. 
 
Figure 5:15 Genetic score for schizophrenia liability (in quintiles) and mean age at first 


































































Table 5:32 Quadratic regression of the genetic score for schizophrenia liability with age 
at first pregnancy and age at first birth in MoBa. 
 
Age at first pregnancy 
(N = 9444) 
Age at first birth 
(N = 9444) 
 β (95% CI), p 
Genetic score for schizophrenia liability  
(including quadratic term for the unstandardized score) 
Model 1  0.183 (-2.042, 2.408), 0.87 1.192 (-0.888, 3.273), 0.26 
Model 2 0.342 (-1.658, 2.342), 0.74 1.375 (-0.376, 3.127), 0.12 
Model 1 is adjusted for the top 10 principal components of population structure. Model 2 
is additionally adjusted for mothers’ birth year. 
 
5.4.5.3 ALSPAC G0 
There was no clear evidence for associations between liability for schizophrenia and age 
at first pregnancy using a genetic score consisting of genome-wide significant SNPs (see 
Table 5:33). Cochran’s Q for this IVW analysis was 125.14 (p = 0.22) (see Appendix 31 
for an example). There was weak evidence for a negative effect of increasing liability for 
schizophrenia on age at first pregnancy using a weighted median approach (see Table 
5:34).  
Table 5:33 Estimates of the association between the genetic score for schizophrenia 
liability and age at first pregnancy in ALSPAC G0 data. 
Genetic score for 
schizophrenia liability 
Age at first pregnancy 
(N = 7036) 
β (95% CI), p 
Model 1 0.033 (-0.081, 0.147), 0.57 
Model 2 -0.028 (-0.117, 0.060), 0.53 
Model 1 is adjusted for the top 10 principal components of population structure. Model 2 
is additionally adjusted for ALSPAC G0 birth year. 
 
Table 5:34 Estimates of the causal effect of genetic liability for schizophrenia on age at 
first pregnancy using IVW, MBE and weighted median MR methods. 
  Age at first pregnancy
b 
Methods (115 SNPsa) β (95% CI), p 
IVW -0.040 (-0.169, 0.089), 0.54 
Weighted median -0.184 (-0.373, 0.006), 0.06 
MBE -0.254 (-0.667, 0.159), 0.23 
a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 





In sensitivity analyses using a p-value threshold of below 0.05 for genetic liability, I 
found weak evidence for a negative association between liability for schizophrenia and 
age at first pregnancy. Results showed congruent direction of point estimates and varying 
strengths of evidence for this negative association across the varying p-value thresholds 
for genetic liability for schizophrenia (see Table 5:35).  
Table 5:35 Estimates for associations between genetic scores with varying p-value 
thresholds and age at first pregnancy in ALSPAC G0 data. 
 Age at first pregnancy 
(N = 7036) 
 β (95% CI), p 
Genetic score for schizophrenia liability 
Model 1    
p<1x10-5 -0.045 (-0.158, 0.068), 0.44 
p<0.0005 -0.038 (-0.152, 0.076), 0.51 
p<0.005 -0.111 (-0.226, 0.003), 0.06 
p<0.05 -0.099 (-0.214, 0.015), 0.09 
p<0.1 -0.082 (-0.197, 0.032), 0.16 
p<0.5 -0.084 (-0.199, 0.030), 0.15 
p<1 -0.103 (-0.217, 0.012), 0.08 
Model 2    
p<1x10-5 -0.099 (-0.188, 0.011), 0.03 
p<0.0005 -0.073 (-0.162, 0.016), 0.11 
p<0.005 -0.107 (-0.196, -0.018), 0.02 
p<0.05 -0.143 (-0.232, -0.053), 0.002 
p<0.1 -0.138 (-0.228, -0.049), 0.002 
p<0.5 -0.132 (-0.221, -0.043), 0.004 
p<1 -0.142 (-0.232, -0.053), 0.002 
Model 1 is adjusted for the top 10 principal components of population structure. Model 2 
is additionally adjusted for ALSPAC G0 birth year. 
 
Sensitivity analysis investigating a possible non-linear relationship between genetic 
liability for schizophrenia and age at first pregnancy showed little evidence when plotting 
the mean age across quintiles of the genetic score or in regression analysis including a 





Figure 5:16 Genetic score for schizophrenia liability (in quintiles) and mean age at first 
pregnancy in ALSPAC G0 data showing little heterogeneity across values of the score. 
 
Table 5:36 Quadratic regression of the genetic score for schizophrenia liability with age 
at first pregnancy in ALSPAC G0.  
 Age at first pregnancy 
(N = 7036) 
 β (95% CI), p 
Genetic score for schizophrenia liability 
(including quadratic term for the score) 
Model 1 2.081 (-0.934, 5.096), 0.18 
Model 2 1.398 (-0.952, 3.749), 0.24 
Model 1 is adjusted for the top 10 principal components of population structure. Model 2 
is additionally adjusted for ALSPAC G0 birth year. 
 
5.4.5.4 Summary across all studies 
Across all studies, the IVW results for a causal effect of genetic liability for schizophrenia 
on age at first pregnancy and age at first birth obtained confidence intervals consistent 
with the null (see Figure 5:17). For UK Biobank and ALSPAC G0 data, point estimates 






































Figure 5:17 IVW estimates for genetic liability for schizophrenia on age at first 
pregnancy and age at first birth across studies. 
 
5.4.6 Secondary measures of reproductive success in MoBa 
When using a genetic score that included only genome-wide significant SNPs for 
schizophrenia liability, there was no clear evidence of associations between liability and 
any secondary outcome (whether the index pregnancy was planned, whether mothers had 
conceived the index pregnancy even though them or their partner used contraceptives, if 
mothers had ever been treated for infertility, and length of sexual relationship the mother 
had had with the index child’s father) (see Table 5:37). However, there was evidence of 
an increased likelihood of having conceived the index pregnancy whilst them of their 
partner used contraceptives with increasing liability for schizophrenia across varying p-
value thresholds for the SNPs included in the score (see Table 5:37). There was further 
weak evidence for a decrease in relationship length with the index pregnancies father with 
increasing genetic liability for the disorder using p-value thresholds of 0.005 and 0.1 with 
adjustment for birth year. There was no clear evidence that participants were less likely to 






Table 5:37 Estimates for associations between genetic scores with varying p-value thresholds and secondary measures of reproductive success in MoBa data. 
  
Pregnancy planned Contraception was used Treated infertility 
Length of relationship with 
father 
(N = 9350) (N = 9132) (N = 9354) (N = 7134) 
 OR (95% CI), p β (95% CI), p 
Genetic score for schizophrenia liability 
Model 1 - adjusted for the top 10 principal components of population structure and genotype array  
Plink score 
p<5×10-8 0.980 (0.928, 1.036), 0.48 0.979 (0.885, 1.083), 0.68 0.971 (0.902, 1.046), 0.44 0.123 (-0.873, 1.120), 0.81 
PRSice scores 
p<1x10-5 0.996 (0.943, 1.052), 0.88 1.013 (0.915, 1.121), 0.81 0.957 (0.889, 1.031), 0.25 -0.650 (-1.647, 0.348), 0.20 
p<0.0005 0.959 (0.907, 1.013), 0.14 1.074 (0.969, 1.190), 0.18 0.986 (0.915, 1.063), 0.72 -0.748 (-1.754, 0.258), 0.15 
p<0.005 0.949 (0.898, 1.005), 0.07 1.129 (1.016, 1.255), 0.02 1.017 (0.942, 1.098), 0.67 -0.819 (-1.852, 0.214), 0.12 
p<0.05 0.968 (0.914, 1.025), 0.26 1.104 (0.993, 1.228), 0.07 0.989 (0.915, 1.068), 0.77 -0.482 (-1.529, 0.565), 0.37 
p<0.1 0.974 (0.918, 1.033), 0.38 1.142 (1.023, 1.274), 0.02 0.989 (0.913, 1.071), 0.79 -0.653 (-1.730, 0.424), 0.24 
p<0.5 0.972 (0.917, 1.031), 0.34 1.118 (1.004, 1.247), 0.04 0.996 (0.920, 1.078), 0.92 -0.456 (-1.521, 0.609), 0.40 
p<1 0.978 (0.921, 1.037), 0.45 1.116 (0.100, 1.246), 0.05 0.998 (0.921, 1.082), 0.97 -0.457 (-1.541, 0.627), 0.41 
Model 2 - additionally adjusted for mothers’ birth year 
Plink score 
p<5×10-8 0.976 (0.924, 1.031), 0.39 0.983 (0.888, 1.088), 0.74 0.963 (0.894, 1.038), 0.33 -0.832 (-1.023, 0.856), 0.86 
PRSice scores 
p<1x10-5 0.996 (0.943, 1,053), 0.89 1.009 (0.911, 1.118), 0.86 0.953 (0.884, 1.026), 0.20 -0.700 (-1.641, 0.240), 0.14 
p<0.0005 0.961 (0.909, 1.016), 0.158 1.068 (0.963, 1.184), 0.22 0.983 (0.912, 1.060), 0.65 -0.754 (-1.702, 0.195), 0.12 
p<0.005 0.947 (0.894, 1.003), 0.07 1.130 (1.015, 1.258), 0.03 1.007 (0.932, 1.088), 0.86 -1.015 (-1.989, -0.042), 0.04 
p<0.05 0.963 (0.909, 1.020), 0.20 1.110 (0.997, 1.236), 0.06 0.972 (0.899, 1.051), 0.48 -0.859 (-1.846, 0.128), 0.09 
p<0.1 0.971 (0.914, 1.030), 0.33 1.145 (1.025, 1.278), 0.02 0.974 (0.898, 1.055), 0.52 -0.969 (-1.984, 0.047), 0.06 
p<0.5 0.968 (0.912, 1.027), 0.28 1.122 (1.006, 1.252), 0.04 0.979 (0.904, 1.060), 0.60 -0.825 (-1.829, 0.179), 0.11 




5.4.7 Previous pregnancy termination 
In analysis of MoBa data using a genetic score of only genome-wide significant SNPs for 
schizophrenia liability, there was no clear statistical support for an increased likelihood of 
having had a previous termination, although estimates were in this direction (Table 5:38). 
In ALSPAC G0, there was weak evidence of an increased likelihood of having previously 
had a termination with increasing genetic liability for schizophrenia using genome-wide 
significant hits (see Table 5:38). In sensitivity analyses, clear associations for an 
increased likelihood of having had a previous termination with increasing genetic liability 
for schizophrenia were seen across all p-value thresholds for genetic liability in both 
studies apart from a threshold of p<1 in MoBa (see Table 5:38).   
Table 5:38 Estimates for associations between genetic scores with varying p-value 
thresholds and having ever had a previous termination. 
 Previously had termination 
 MoBa  
(N = 9444) 
ALSPAC G0 
(N = 7134) 
 OR (95% CI), p OR (95% CI), p 
Genetic score for schizophrenia liability 
Model 1       
Plink score       
p<5×10-8 1.023 (0.965, 1.086), 0.44 1.064 (0.996, 1.138), 0.07 
PRSice scores       
p<1x10-5 1.105 (1.041, 1.173), 0.001 1.098 (1.026, 1.176), 0.01 
p<0.0005 1.138 (1.069, 1.212), <0.001 1.081 (1.011, 1.157), 0.02 
p<0.005 1.137 (1.070, 1.209), <0.001 1.139 (1.065, 1.219), <0.001 
p<0.05 1.144 (1.074, 1.218), <0.001 1.148 (1.074, 1.228), <0.001 
p<0.1 1.146 (1.076, 1.220), <0.001 1.164 (1.088, 1.245), <0.001 
p<0.5 1.151 (1.079, 1.228), <0.001 1.180 (1.104, 1.262), <0.001 
p<1 1.054 (0.993, 1.119), 0.08 1.190 (1.114, 1.272), <0.001 
Model 2       
Plink score       
p<5×10-8 1.021 (0.963, 1.083), 0.49 1.062 (0.994, 1.136), 0.08 
PRSice scores       
p<1x10-5 1.106 (1.042, 1.174), <0.001 1.096 (1.023, 1.173), 0.01 
p<0.0005 1.136 (1.067, 1.210), <0.001 1.080 (1.009, 1.155), 0.03 
p<0.005 1.134 (1.067, 1.205), <0.001 1.139 (1.065, 1.219), <0.001 
p<0.05 1.141 (1.072, 1.215), <0.001 1.147 (1.072, 1.227), <0.001 
p<0.1 1.143 (1.073, 1.217), <0.001 1.161 (1.086, 1.242), <0.001 
p<0.5 1.147 (1.075, 1.224), <0.001 1.178 (1.102, 1.260), <0.001 
p<1 1.054 (0.993, 1.119), 0.09 1.189 (1.112, 1.271), <0.001 
Model 1 is adjusted for the top 10 principal components of population structure (and 






5.4.8 Summary of results and previous literature 
I find some evidence that genetic liability for schizophrenia increases parity in MoBa 
using the IVW method, and further evidence of an association for increased likelihood of 
having had a child in ALSPAC G1 females. In UK Biobank, ALSPAC G0 and ALSPAC 
G1 (both sexes), results do not indicate a linear causal effect on number of children using 
MR techniques. In UK Biobank, results also do not indicate a genetic correlation between 
liability for schizophrenia and number of children using LD score regression. The 
majority of results are therefore inconsistent with cliff edge-fitness maintaining 
schizophrenia in the population, which would predict an increase in fitness with increased 
genetic liability in the general population. These results support previous research 
suggesting no strong evidence of a relationship between genetic liability for 
schizophrenia and number of children (Beauchamp, 2016; Mullins et al., 2017). In 
sensitivity analyses in UK Biobank, I found some suggestion of a possible peak in fitness 
at intermediate to high levels of genetic liability, but there was no statistical evidence for 
this, suggesting that if this non-linear association exists it is very weak, and not reliably 
detectable even in a large study such as UK Biobank. Hints of a non-linear relationship 
was seen across the datasets used here with no statistical support. A previous study also 
showed little evidence of quadratic associations between genetic liability for 
schizophrenia and number of children (Mullins et al., 2017).  
For number of sexual partners, I find an effect of increasing genetic liability for 
schizophrenia on increasing number of sexual partners in UK Biobank, suggesting 
liability for the disorder increases mating success in the wider population and could 
reflect potential reproductive success (Nettle & Clegg, 2006). Although confidence 
intervals in ALSPAC G1 were consistent with the null, the IVW point estimate was also 
in the positive direction. Sensitivity analyses further suggest that the relationship between 
genetic liability for schizophrenia and number of sexual partners is linear in healthy 
populations although some evidence of non-linearity, particularly in females, was seen for 
ALSPAC G1. 
Also consistent with previous research, I found no clear evidence for a linear association 
between genetic liability for schizophrenia and age at first birth (Mullins et al., 2017) and 
weak evidence of a non-linear association in UK Biobank (Ni et al., 2017). There was 
some evidence of a negative effect of increasing genetic liability for schizophrenia on age 




analyses using MoBa and ALSPAC G0 data with lower p-value thresholds for genetic 
liability, there was evidence for associations between increasing liability and decreasing 
age at first pregnancy. The evidence was weaker for age at first birth in MoBa in this 
sensitivity analysis. 
Sensitivity analysis results for secondary measures (in MoBa) further suggest that 
increased genetic liability for schizophrenia is associated with increased risky sexual 
behaviour indicated by the index pregnancy being more likely conceived on contraception 
and some evidence of a shorter length of relationship with the index pregnancy’s father. 
Additionally, there was evidence for a positive effect of liability to the disorder and 
likelihood of having ever had a previous termination (in MoBa and ALSPAC G0). This 
may indicate potential reproductive success that is not captured by other measures and 
support previous suggestions of increased risky sexual behaviour, as well as help to 
explain stronger evidence for age at first pregnancy than age at first birth in MoBa. 
5.4.9 Cliff-edge fitness 
Cliff-edge fitness suggests that schizophrenia prevalence is sustained because the 
negative reproductive effects in those with an underlying genetic liability and the disorder 
are offset by a reproductive advantage to those who have an underlying genetic liability 
but do not develop the disorder (Mullins et al., 2017). This reproductive advantage may 
act via creativity or risky behaviour, with schizotypy in healthy adults predicting interest 
in short-term mating (Del Giudice et al., 2010) and overlapping genetic factors between 
schizophrenia and HIV infection, which are related to risky sexual behaviour (Wang et 
al., 2016). To note, I only examined part of the cliff-edge hypothesis as I use data that 
likely includes very few cases, and therefore I only investigate whether there is a linear 
effect on reproductive success with increasing genetic liability that could compensate for 
the negative reproductive effects in those with an underlying genetic liability and the 
disorder (Keller & Miller, 2006; Nesse, 2004; Nettle & Clegg, 2006; Van Dongen & 
Boomsma, 2013). I do not investigate these negative reproductive effects in those with 
the disorder. Although it is hard to estimate the size of effect on fecundity necessary to 
sustain the prevalence of schizophrenia (or indeed whether this effect size may fall within 
the confidence intervals of estimates across studies), these results overall provide little 
support for a cliff edge fitness effect maintaining schizophrenia prevalence with only an 
effect on parity found in one dataset using the IVW method. However, in the modern 
environment (with available contraception), there are limits to the conclusions we can 
make about historical evolutionary forces on schizophrenia-associated alleles from these 




increasing genetic liability for schizophrenia in UK Biobank, and congruent estimates in 
ALSPAC G1. Mating success may proxy reproductive success in past environments and 
partly explain how the disorder has been maintained in the population. In both UK 
Biobank and ALSPAC G1, there was stronger evidence for a positive association between 
genetic liability for schizophrenia and number of sexual partners in males than females, in 
line with sex differences in reproductive strategies (Nettle & Clegg, 2006). As variance in 
reproductive success is higher in males than in females, it has been argued that males 
obtain higher reproductive benefits from additional mating’s than females (Trivers, 
1972). It has been suggested that creative displays are a form of sexual competition that 
reflect these evolutionary pressures (Miller, 1999; Nettle & Clegg, 2006). It is possible 
that the associations seen in females here are a by-product of male reproductive behaviour 
although there are of course also benefits to females of attracting additional mates, such 
as higher mate quality (Mullins et al., 2017). I assume that, on average, increasing 
numbers of sexual partners is a reasonable proxy for fitness however number of sexual 
partners has likely also undergone changes since the introduction of contraception, which 
has allowed for decoupling of sexual and reproductive partners. It therefore cannot be 
concluded that cliff-edge fitness has sustained the prevalence of schizophrenia within the 
population without clear effects on fecundity, for which I provide no clear evidence for a 
cliff edge effect on current fitness.  
Two phenotypes colocalize in a genetic region when it contains variants that associate 
with both phenotypes, and can reflect causality (i.e., the SNP effect on one phenotype is 
mediated by its effect on the second phenotype), pleiotropy (the same SNP independently 
affects both phenotypes), or LD (two or more SNPs in LD affect different phenotypes) 
(Pingault et al., 2018). The sensitivity analysis lowering the p-value threshold for genetic 
liability can increase the power to detect small effects common in genetic analyses (Gage, 
Jones, et al., 2016). However, lowering the p-value threshold can also introduce 
horizontal pleiotropic effects, when genetic variants have an effect on the outcome 
through alternative pathways, instead or in addition to, through the exposure (Bowden et 
al., 2017; Davey Smith & Hemani, 2014). Using genome-wide significant SNPs as 
instruments is therefore the most suitable for causal inference whereas more lenient 
thresholds increase false discovery rates (Richardson et al., 2018). This has been 
demonstrated in recent simulations for liability for schizophrenia on multiple outcomes 
using the same schizophrenia GWAS as done so here (Richardson et al., 2018). Cliff-
edge fitness maintaining the prevalence of schizophrenia suggests that an increased 
reproductive advantage is obtained through sexual selection, acting via creativity and/or 




I find a trend for evidence of risky sexual behaviour, for sexual selection I argue that we 
should expect an effect specific to schizophrenia liability (Keller & Miller, 2006; Shaner 
et al., 2004) and relaxing the p-value threshold may therefore capture other forms of 
selection. A recent comment by Escott-Price and colleagues argue that a specific causal 
effect is not required when assessing whether schizophrenia is maintained through a 
reproductive advantage (Escott-Price et al., 2019b). 
5.4.10 Alternative theories 
This leaves two further main theories for how schizophrenia prevalence is maintained. 
One is that as schizophrenia is a highly heterogenous disorder and exhibits a highly 
polygenic architecture, with effects of genetic variants being individually too weak to be 
under negative selection (Loh et al., 2015; Mullins et al., 2017; Van Dongen & 
Boomsma, 2013). The present results are consistent with this possibility and suggest that 
identified schizophrenia genetic risk variants are not under strong selection in the general 
population. Another explanation is that mutation-selection balance maintains the 
prevalence of schizophrenia; rare recurrent DNA copy number variants which are also 
risk factors for schizophrenia are filtered out of the population by selection and 
replenished by de novo mutations (Rees et al., 2011). Rare copy number genetic variants 
conferring risk to psychiatric illness are under strong negative selection (Mullins et al., 
2017; Rees et al., 2011), with most persisting in the population for only two generations 
(Rees et al., 2011). I used results from GWAS, which mainly detect common alleles and 
therefore cannot determine whether mutation-selection balance sustains the prevalence of 
schizophrenia through rare genetic variants, although schizophrenia-associated rare 
genetic variants have been shown to associate with number of children (Mullins et al., 
2017; Van Dongen & Boomsma, 2013). Other explanations could include an increased 
likelihood of symptom diagnosis, changes in the environment (Gage et al., 2017; 
Weinstein et al., 2018) and/or selection bias (discussed below).  
5.4.11 Strengths 
The use of MR here can provide stronger evidence of causality than observational studies 
(Davey Smith & Ebrahim, 2003; Gage, Munafò, & Davey Smith, 2016). Firstly, I 
included a positive control analysis to confirm that this approach was valid. I evaluated 
results between various MR methods that rely on differing assumptions for agreement 
between methods providing greater confidence in the robustness of the results (Lawlor et 
al., 2016). Furthermore, I conducted multiple sensitivity analyses to capture broader 
genetic liability and investigate possible non-linearity in relationships. Additionally, this 




common in such genetic analysis and I have conducted analysis across multiple cohort 
studies to compare results (Gage, Jones, et al., 2016). 
5.4.12 Limitations 
There are also some limitations that should be considered with the current evidence. First, 
MR relies on genetic variants naturally randomizing an exposure, and therefore inferring 
causality from genetic liability for schizophrenia as the exposure requires careful 
interpretation. The outcome sample was not selected on schizophrenia status, so it 
contained only few cases of diagnosed schizophrenia. Therefore, I assume that 
schizophrenia SNPs are associated with sub-diagnostic schizophrenia traits that could 
cause a reproductive advantage within the wider population (Crow, 2008; Del Giudice et 
al., 2010; Nettle & Clegg, 2006). Although debated (Van Os, Linscott, Myin-Germeys, 
Delespaul, & Krabbendam, 2009; Zammit et al., 2013), schizophrenia symptoms have 
been suggested to exist on a continuum, and this assumption could therefore be met 
(Kendler et al., 1993; Poulton et al., 2000; Taylor et al., 2016; Van Os et al., 2009). 
Within this, I assume that the instrumental variable assumptions are satisfied for this 
continuous liability to provide a valid test of causality using the binary exposure (Burgess 
& Labrecque, 2018). Second, as genetic variants are non-specific, it is difficult to fully 
remove population structure which can induce spurious associations through 
confounding, even within a sample of European ancestry and adjusting for principal 
components of population structure as I have done (Curtis, 2018; Haworth et al., 2019). 
Third, the exposure and outcome samples were each quality controlled for relatedness 
however it is not possible to determine whether participants had relatives across the 
samples due to using summary level GWAS data for our exposures. 
Fourth, age at first birth was only measured in females in all studies, and therefore 
consists of a different population to the exposure data (which includes data from both 
females and males). However, the correlation between male and female estimates for age 
at first birth in a recent GWAS was high (Barban et al., 2016). Similarly, the 
schizophrenia-associated genetic variants used in the sex stratified analyses were 
identified from a mixed sex population although in UK Biobank I used an unweighted 
genetic score which would also help to minimize any bias. Lastly, the present study uses 
data from the mothers of two pregnancy cohorts, therefore including only females that 





5.4.13 Selection bias and UK Biobank 
As discussed in Chapter 3, genetic data for UK Biobank was released in two waves (May 
2015 and July 2017). The first wave comprised ~150,000 participants in total, and was 
selected based on smoking behaviour (Wain et al., 2015). As previously demonstrated 
(Day, Loh, Scott, Ong, & Perry, 2016; Gkatzionis & Burgess, 2018; Hughes, Davies, 
Davey Smith, & Tilling, 2018; Munafò et al., 2018), this can yield biased estimates in 
analyses through collider bias. Collider bias occurs when a variable (termed the collider) 
is caused by each the exposure and the outcome and therefore controlling for the variable 
induces a spurious association between the exposure and outcome. Escott-Price and 
colleagues (2019) report an association between genetic liability for schizophrenia and 
number of children in UK Biobank. They interpret this as consistent with sexual 
selection. They used the most recent GWAS for schizophrenia, but the reported sample 
size suggests that only data from the first release was used. Further previous research also 
found evidence of an association between genetic liability for schizophrenia and age at 
first birth using the first release of data (Ni et al., 2017).  
Initially, when using the first release of UK Biobank, I found results similar to those 
reported by Escott-Price and colleagues – a weak positive relationship between genetic 
liability for schizophrenia and number of children. However, given concerns about 
conditioning on this sub-sample (with well-established associations between smoking and 
both schizophrenia risk and fertility) (Wootton, Richmond, et al., 2018), I repeated the 
analyses in the full release. Strikingly, these results were quite different, with no clear 
evidence of a relationship between genetic liability for schizophrenia and number of 
children. The results for the two waves of UK Biobank data, and the full release as 
presented in the main results section, are shown in Table 5:39. Similarly, I did not 
support previous evidence for a relationship between genetic liability for schizophrenia 
and age at first birth in the full release (shown in the main results section Table 5:27). I 
also previously used GWAS summary data for number of children to conduct this 
analysis (methods and results are in Appendix 51, and tables are presented in Appendix 
52). This data contained a substantial proportion of the first wave of UK Biobank data as 
well as some overlap between data in the schizophrenia and number of children GWAS, 
which biases the result towards the observational association (Burgess, Scott, Timpson, 
Davey Smith, & Thompson, 2015). Overall, it appeared that these results therefore 
supported balancing selection sustaining the prevalence of schizophrenia, likely due to 




Table 5:39 Estimates of the causal effect of genetic liability for schizophrenia on number 
of children using an IVW MR approach. 
  Number of Children 
  N β (95% CI), p 
Genetic liability for schizophreniaa   
First release 90 058 to 94 792 0.012 (0.00003, 0.023), 0.05 
Second release 228 863 to 240 966 -0.001 (-0.008, 0.006), 0.81 
Full UK Biobank data (as above) 318 921 to 335 758 0.003 (-0.003, 0.009), 0.39 
a Schizophrenia genetic data from the PGC GWAS (N = 35 123 cases and 109 657 
controls; 101 SNP instrument). 
 
It is possible that discrepancy between results are due to differences in the methodology, 
MR or a PRS analysis with varying p-value thresholds for genetic liability (discussed 
above), or an artefact of conditioning on the first, selective, release of UK Biobank data. 
A recent response by Escott-Price and colleagues suggests that their results differ due to 
using a lower p-value threshold (Escott-Price et al., 2019a, 2019b). It is still possible that 
the differences in Table 5:39 are due to conditioning on the first, selective, release of UK 
Biobank data. On the other hand, UK Biobank data as a whole is unrepresentative of the 
population, given a response rate of approximately 5%, which may introduce selection 
bias in itself (Allen et al., 2014; Fry et al., 2017). This can generate spurious results in 
genotypic associations when selection is based on phenotypes associated with the genetic 
variants and could attenuate associations towards the null in the full release if 
schizophrenia-proneness and increased number of children reduced participation (Conde 
et al., 2017; Munafò et al., 2018; Taylor et al., 2018). Previous studies have found that 
higher genetic liability for schizophrenia is associated with lower participation in cohort 
studies which could bias estimates between genetic liability and traits that lead to 
nonparticipation in genetic associations and MR (Martin et al., 2016; Taylor et al., 2018). 
Therefore, it is possible that results in the first wave that is enriched for smokers are more 
representative of the general population.  
It is therefore important that I conducted this study across multiple datasets. Although a 
smaller sample, MoBa had a response rate of 41% and this study used the first distributed 
questionnaire where 95% of mothers provided responses (Magnus et al., 2006). 
Moreover, all MBRN records for the participants of MoBa are available, regardless of the 
number of questionnaire data that was completed. This high response rate and mandatory 
health registries therefore mean that you can somewhat avoid the loss to follow up 




rate (Fraser et al., 2013), although there was attrition for the measures used in the present 
study, particularly for parity measured 18 years post-recruitment for ALSPAC G0. Age at 
first pregnancy was derived from data collected at recruitment and 18 weeks gestation, 
leading to a much larger sample size, and one possibility for why I found more 
associations for age at first pregnancy than parity measures in ALSPAC G0. Data for 
ALSPAC G1 was asked at the last assessment (approximately 23 years) and therefore 
suffered attrition. Nevertheless, some argue that valid assessment of exposure-outcome 
relationships may be widely generalizable even if data is not representative of the 
population at large and these results are strengthened by assessing multiple datasets (Fry 
et al., 2017). 
5.4.14 Conclusions 
Whether genetic risk for psychiatric disorders is associated with a reproductive advantage 
is an important question, as it may explain the persistence of these disorders despite 
deleterious effects. The present study highlights the continued importance of investigating 
differential fertility and contributes to understanding the maintenance of schizophrenia, 
and educational attainment, in the population (Essen‐Möller, 1959; Lewontin, 2016; 
Polanczyk, Willcutt, Salum, Kieling, & Rohde, 2014; Tropf, Stulp, et al., 2015). It is 
important to consider that, in the modern environment, we can make limited conclusions 
about historical evolutionary forces on these schizophrenia-associated alleles from these 
present-day fitness associations. This is further highlighted by the present findings for 
increased liability to each disorder and increased likelihood of having had a termination. 
Educational attainment has previously been shown to predict human longevity (Marioni 
et al., 2016) and this work highlights how even traits with a positive effect on longevity 
can be maladaptive, although other influences on educational attainment in the population 
are also acknowledged (Sanjak et al., 2017). This work additionally demonstrates how 
epidemiological methods can be repurposed to study evolutionary theories. Future 
research should investigate causal methods for estimating non-linear relationships as well 
as other explanations for this evolutionary paradox, such as mutation-selection balance. 
5.5 Chapter summary 
In this chapter, I aimed to apply a range of methods with roots in genetic epidemiology 
(MR, LD score regression and PRS analysis) to investigate the schizophrenia paradox. I 
assessed the correlation and causal effect of genetic liability for schizophrenia with a 
range of reproductive outcomes, such as number of children, in multiple population-based 




cases. MR indicated no robust evidence of a causal effect of genetic liability for 
schizophrenia on number of children across all but one cohort study. I find some evidence 
of a positive effect of genetic liability for schizophrenia on other measures of potential 
reproductive success such as number of sexual partners. These results suggest that, 
overall, increased genetic liability for schizophrenia does not confer a fitness advantage 
but does increase mating success and risky sexual behaviour. Results therefore suggest 
that schizophrenia may be being sustained in the population through other explanations 






This thesis explored the application of MR and other related methods to two areas of 
evolutionary human behaviour research – life history theory and the schizophrenia 
paradox. Previous research has been limited as standard methods in evolutionary 
approaches to behaviour cannot easily test causality and examine both psychological 
mechanisms and reproductive success (which are required for a direct test of evolutionary 
hypotheses). I have demonstrated how epidemiological methods can be repurposed to 
study evolutionary theories and provide a new form of evidence. Specifically, MR 
combines genetic and phenotypic information to investigate psychological and key 
evolutionary traits with fitness outcomes using a causal framework that does not rely on 
manipulating the exposure. Genetic information has largely been ignored in tests of 
evolutionary hypotheses, through the phenotypic gambit and/or the assumption that 
fitness associated traits will not show heritable variation (Hadfield et al., 2007; Mills & 
Tropf, 2015; Nettle, 2006; Rubin, 2016). This thesis is novel in its application of 
epidemiological methods that support strong causal inference to test these hypotheses, 
and highlights the potential that incorporating genetic information and such methods has 
for evolutionary epidemiology (Pelletier et al., 2017). I believe that an integrative 
research approach from the fields of genetics and social sciences is important for 
predicting reproductive and other evolutionarily relevant outcomes. 
As each results chapter included a discussion, here I summarise the main findings from 
this thesis before more broadly evaluating the potential for MR to test evolutionary 
hypotheses. Following this, I discuss the future for evolutionary epidemiology. 
6.1.1 Summary of findings and implications 
6.1.1.1 Life history theory 
I applied MR to test for causal effects within a life history theory framework in Chapter 4. 
There are currently no appropriate instruments for early life adversity that can be used 
within an MR framework and hence it is not possible to investigate early life stress using 
MR. I therefore examined the effects of two intermediate reproductive traits (age at 
menarche and age at first sexual intercourse) on later reproductive and behavioural 
outcomes. Taking this life course approach to the causal pathways in life history theory 
by assuming that earlier menarche is a proxy for adversity has limitations. Namely, early 
menarche is associated with both markers that are associated with good phenotypic 
condition in many species (e.g., weight, size) and early life adversity with different 




Results showed that earlier age at menarche is causally related to some traits that 
characterize a fast life history strategy, such as earlier age at first birth, earlier age at last 
birth, lower educational attainment, and earlier age at leaving education. The effects of 
earlier age at menarche on these reproductive and educational traits can be viewed as 
directing effort towards short-term reproductive goals and risky behaviour as an 
important part of a fast life history strategy (Ellis & Bjorklund, 2012). There was no clear 
effect of age at menarche on number of children or alcohol intake. For age at first sexual 
intercourse, results were mixed and suggested violation of the exclusion restriction 
assumption of no direct effects of the instrument on the outcome not acting through the 
exposure (i.e., the presence of horizontal pleiotropy) (Bowden et al., 2017; Davey Smith 
& Ebrahim, 2003). Results for age at first sexual intercourse must therefore be treated 
with caution and causal inference is weakened. 
This study highlights how analyses techniques from genetic epidemiology can be used to 
answer how life history traits are related within life history strategies, and to better 
understand determinants of health and social behaviour. Life history theory has 
implications for how we view apparently negative and assumingly maladaptive 
behaviour, such as decreased educational attainment. For example, the present finding of 
a causal effect of earlier age at menarche on decreased educational attainment suggests 
that decreased educational attainment may be considered a consequence of a suite of 
adaptive behaviours as part of a fast life history strategy. This finding therefore provides 
important information for determinants of educational attainment today, which is a key 
predictor of positive later life outcomes in the UK (Gill et al., 2017). The implications of 
a causal effect of earlier age at menarche on decreased educational attainment is 
particularly important due to secular trends of age at menarche decreasing in recent years 
(Ellis, 2004).  
There have also been recent shifts in the timing of first birth in females to later ages with 
advanced age at first birth associated with health consequences for mother and offspring 
(Barban et al., 2016; Fall et al., 2015; Mills, Rindfuss, McDonald, & te Velde, 2011). The 
present finding of an effect of later age at menarche on later age at first birth and later age 
at last birth is therefore important for improving understanding of the causes in this 
reproductive delay in recent years (Mills et al., 2011; Pelletier et al., 2017).  
6.1.1.2 The schizophrenia paradox 
In Chapter 5, I applied a range of methods rooted in genetic epidemiology (MR, LD score 




correlation and causal effect of genetic liability for schizophrenia on a range of 
reproductive outcomes in multiple population-based samples, I found no clear robust 
association or effect of genetic liability for schizophrenia on number of children. There 
was evidence of a positive causal effect of genetic liability for schizophrenia on other 
measures of potential reproductive success such as number of sexual partners. These 
results suggest that, overall, increased genetic liability for schizophrenia does not have a 
clear effect on fitness but does increase mating success and risky sexual behaviour. As 
discussed in Chapter 5, it is difficult to quantify the size of effect on fitness necessary to 
sustain the prevalence of schizophrenia and it is also possible that mating success may 
proxy reproductive success in past environments (pre-contraception) and partly explain 
how the disorder has been maintained in the population. However, number of sexual 
partners has likely also undergone changes since the introduction of contraception as 
sexual partners do not have to equate to reproductive partners. It is therefore difficult to 
conclude that cliff-edge fitness has sustained the prevalence of schizophrenia within the 
population without clear effects on fitness. Therefore, these findings suggest that it is 
possible that schizophrenia is sustained in the population through other explanations than 
cliff-edge effects on fitness (e.g., mutation-selection balance), which future research 
should focus on.  
This research highlights the continued importance of investigating differential fertility. As 
schizophrenia is such a debilitating disorder, it is important to investigate how the 
prevalence is sustained (Essen‐Möller, 1959; Lewontin, 2016; Polanczyk et al., 2014; 
Tropf, Barban, Mills, Snieder, & Mandemakers, 2015). The present results for 
educational attainment showing a negative effect on number of children (Chapter 5) also 
re-frame perceptions of maladaptive behaviour. Educational attainment has previously 
been shown to predict human longevity and is considered a predictor of positive later life 
outcomes in the UK (Gill et al., 2017; Marioni et al., 2016). This work therefore shows 
how even desirable traits with a positive effect on longevity can be maladaptive by 
having a negative effect on fitness (Sanjak et al., 2017). 
6.2 Mendelian randomization to test evolutionary hypotheses 
As discussed, I have attempted research within a novel field of evolutionary 
epidemiology for these hypotheses within life history theory (that earlier age at menarche 
and age at first sexual intercourse can be viewed as directing effort towards reproductive 
goals as part of a fast life history strategy and therefore show causal effects on 




heritable disorder, is maintained in the population despite being associated with lower 
reproductive success for those diagnosed). Broadly, there are strengths and weaknesses to 
doing so. As MR was developed to test modifiable risk factors for disease outcomes, 
issues can arise when applying the method to social and psychological traits to test 
evolutionary questions. Here I will summarise the strengths of the method before 
discussing potential limitations of MR for testing evolutionary theories of human 
behaviour.  
6.2.1 Strengths 
MR allows investigation of psychological, behavioural and other trait and fitness 
outcomes. It therefore integrates both ultimate and proximate explanations and potentially 
provides a direct test of evolutionary hypotheses. Through using observational data, the 
method allows investigation of traits that cannot be manipulated, for ethical and other 
reasons, such as reproductive timing or measures of early life adversity. Even so, by using 
genetic variants that are fixed and randomized at conception, the ability to make causal 
inference is stronger than when applying standard analytical methods to observational 
data. Using genetic variants also allows investigation of genetic liability for a 
psychological trait in the wider population rather than only within families, in relation to 
fitness outcomes (as done so in Chapter 5). Furthermore, the availability of GWAS for 
evolutionary relevant traits is increasing, meaning that this method can be applied to test 
further hypotheses and possible mediating pathways. Online platforms such as MR-Base 
have also recently been introduced that make it easier to conduct these analyses 
(www.mrbase.org) (Hemani, Zheng, et al., 2018). 
6.2.2 Weaknesses 
As with most methods, it is first worth noting the strong assumptions underlying MR 
(discussed in detail in Chapter 2). If these assumptions do not hold, then confounding can 
be present and causal inference is weakened. MR is therefore plagued by the same biases 
as standard analytical approaches applied to observational data when assumptions break 
down. It is more difficult to meet the assumptions of MR with complex traits as complex 
traits are typically highly polygenic, and it is therefore possible that some of the genetic 
variants are pleiotropic (Pingault et al., 2018). Additionally, the biological pathways are 
not always known for complex social traits meaning it is more difficult to assess if 
assumptions are met (Conley, 2009). However, complex social traits such as educational 
attainment (which may proxy social status) are what evolutionary researchers are 
interested in investigating within an MR framework, particularly because they are not 




defined model and subsequent predictions, with knowledge of the genetic function and 
developmental pathways (Pingault et al., 2018). For the schizophrenia studies here, the 
biological function of the genetic variants has been thoroughly investigated and the model 
is well-defined (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 
2014). However, for age at first sexual intercourse the biological basis is less well known. 
Additionally, as discussed above, the age at menarche model is more difficult to interpret 
as early menarche is associated with both good condition and early life adversity. Overall, 
MR is therefore only as good as the likelihood of satisfying the assumptions, the 
instruments available and whether these instruments lead to strong models and 
predictions. Within this thesis, the work on schizophrenia meets the requirements and 
interpretations more easily.  
Second, it is common that genetic instruments explain only a small proportion of variance 
in the exposure (Gage, Davey Smith, et al., 2016). This is particularly common for 
psychological traits such as schizophrenia used here, where only 3.4% of the variance 
was explained by genome-wide significant SNPs (Schizophrenia Working Group of the 
Psychiatric Genomics Consortium, 2014). Without very large sample sizes as used in this 
thesis, which can be hard to obtain, this leads to low powered studies and makes it hard to 
assess whether a null result might reflect low power (Davey Smith & Ebrahim, 2004; 
Gage, Davey Smith, et al., 2016). 
Third, genetic variants are randomized conditional on parental genotype. Therefore, 
assortative mating can violate the MR method (Hartwig, Davies, & Davey Smith, 2018). 
Assortative mating occurs when partners are chosen based on particular characteristics 
rather than at random (Lawlor et al., 2019). Assortative mating can be on the same trait 
(termed single trait) or when individuals with higher value for one trait mate with 
individuals that are higher (or lower) on another trait (termed cross-trait assortative 
mating) (Lawlor et al., 2019). Assortative mating on traits used within MR can lead to a 
spurious genetic correlation and subsequent bias (Lawlor et al., 2019). Hartwig and 
colleagues (2018) conducted simulations to estimate the bias in MR studies due to 
assortative mating. They found that assortative mating lead to bias that accumulated over 
generations, even for methods robust to horizontal pleiotropy (Hartwig et al., 2018). 
However, these simulations also showed that data from mother–father–offspring trios 
could be used to correct for this bias (Hartwig et al., 2018). It is likely that assortative 
mating is more of a problem for social traits that are evolutionarily relevant than for 
certain health traits which MR was originally developed for (e.g., C-reactive protein) and 




(Hartwig et al., 2018). For this thesis, considerable partner resemblances have been found 
for psychiatric disorders however no clear patterns of assortative mating has been seen for 
schizophrenia and any assortative mating is unlikely to balance the impact of reduced 
fecundity of patients with psychiatric disorders in the long term (Goddard et al., 2018; 
Peyrot, Robinson, Penninx, & Wray, 2016). Educational attainment does show evidence 
of assortative mating although it appears to be stable over generations (Conley et al., 
2016; Goddard et al., 2018). For other evolutionary relevant traits, it is important to 
consider the potential for assortative mating and to use data from trios to account for this, 
although datasets with genetic data on trios are limited.  
Fourth, population structure is a similar, although distinct issue in MR which can also 
lead to spurious associations and bias (discussed in Chapter 2) (Goddard et al., 2018). For 
testing evolutionary hypotheses, population structure becomes an issue when 
investigating traits that are associated with migration and selection into a dataset 
(Haworth et al., 2019). Selection on traits is more likely to occur for social traits than 
biological traits. In ALSPAC, for example, Haworth and colleagues (2019) found higher 
educational attainment in more geographically distant lineages to the study catchment 
area. They suggest that educational attainment of people who migrate for economic 
reasons likely differs from people who do not and this creates effects of ancestry even in 
a geographically and ethnically homogeneous sample (Haworth et al., 2019). In UK 
Biobank, genetic variants are associated with birth location and, given regional 
differences in traits, this can again cause covariance between genotypes and traits that can 
bias analyses (Haworth et al., 2019). The increasing sample sizes in GWAS increases the 
power to detect genetic instruments for MR studies however it also increases 
susceptibility to bias due to subtle population structure (Lawson et al., 2019). Adjusting 
for principal components may not be adequate for fully removing population structure 
(see Chapter 2) (Lawson et al., 2019). Studies typically also restrict to individuals of 
European ancestry to further address this, which can limit the study of evolutionary 
theories to human behaviour by restricting cross-cultural studies (Davey Smith & 
Hemani, 2014). The issue of population structure is highly topical and methods are being 
developed to overcome the biases, such as trans-ethnic modelling and chromosome 
painting which provide greater understanding of the traits-population structure 
relationship (Lawson et al., 2019). 
Fifth, many GWAS are conducted in mixed sex samples to increase sample sizes. In MR, 
the SNP-exposure and SNP-outcome associations should be derived in similar underlying 




a mixed sex GWAS this can limit the ability for sex stratified analysis. For many traits, 
the genetic correlation between sexes is likely high and therefore the instrument and SNP-
exposure associations can be used for sex stratified analysis without much concern. 
However, investigating sex differences is a key aspect of many evolutionary hypotheses 
and that GWAS, and subsequently MR, are not always easily set up to do so is a 
limitation. 
Sixth, MR relies on an instrumental variable framework which was developed to estimate 
the effect of an exposure at a point in time (Labrecque & Swanson, 2019). As MR utilises 
genetic variants that are fixed at conception it is said to estimate the ‘lifetime effect’, 
defined as the average change in outcome at time t when the entire exposure trajectory 
from conception to time t is shifted by 1 unit (Labrecque & Swanson, 2019). However, 
MR only estimates this ‘lifetime effect’ when the effect of the genetic variants on the 
exposure does not change over time such as when the trait is fixed over the life course 
(e.g., eye colour) (Labrecque & Swanson, 2019; Lawlor, 2016). Otherwise the 
denominator in the Wald ratio to derive a causal estimate varies depending on the 
timepoint measured and there is the potential for pleiotropy to occur via the exposure trait 
at another timepoint (Labrecque & Swanson, 2019). This becomes more complicated as 
GWAS studies often conduct meta-analysis over multiple samples with varying ages. 
This has implications for using MR to test evolutionary theories of human behaviour 
where exposure traits are unlikely to be fixed over the life course. Although this is said to 
affect the validity of findings, methods to overcome this issue are still under development 
and MR can still be used to provide a valid test of the null hypothesis with time-varying 
exposures.  
Lastly, MR methods are typically designed to test linear relationships, as done so 
throughout this thesis, with continuous exposures. As discussed in Chapter 5, when using 
a binary exposure (e.g., schizophrenia status), the instrumental variable assumptions need 
to be satisfied for an underlying continuous liability (Burgess & Labrecque, 2018). As 
many psychological traits are binary measures in GWAS (e.g., diagnosis of a psychiatric 
disorder), then these additional assumptions will often have to be considered when testing 
evolutionary hypotheses that integrate psychological exposures with fitness outcomes. 
6.3 The future of evolutionary epidemiology 
Methods from genetic epidemiology, particularly MR, have great potential for testing 




relevant traits show heritable genetic variation and genetic variants can therefore be used 
to mimic these traits in analyses (Conley, 2009; Gage, Davey Smith, et al., 2016; Nettle, 
2006). Here, I have successfully applied MR and related methods to test hypotheses 
within life history theory and the schizophrenia paradox. Recently, the number of 
evolutionary relevant traits that GWAS studies are being conducted on has increased 
exponentially (Gage, Davey Smith, et al., 2016). As examples, GWAS have now been 
conducted on risk-taking and personality measures which could be used to test 
evolutionary hypotheses of human behaviour (Karlsson Linnér et al., 2019; Nagel et al., 
2018). The rapid increase in GWAS studies is in part due to the decreasing cost of 
genotyping and, subsequently, the availability of large datasets (Conley, 2009). However, 
GWAS on social traits must be well thought out for the results to be carried into MR 
analyses, such as knowledge of the possible biological pathways to the trait of interest 
(Conley, 2009). Moreover, phenotyping of social traits is often less precise as the traits 
are more difficult to measure and this measurement error can lead to noise in GWAS 
analyses (Karlsson Linnér et al., 2019; Tropf et al., 2017).  
As discussed, MR was developed for health traits and there are additional considerations 
to be made when applying the method to social and evolutionarily relevant traits. 
However, new methods are under development to assess the potential bias of doing so 
(Brumpton et al., 2019; Hartwig et al., 2018; Labrecque & Swanson, 2019). 
Unfortunately, many of these methods require genetic data on mother-father-offspring 
trios which is less easily available (Hartwig et al., 2018). For example, family data is 
required to overcome bias from assortative mating or dynastic effects (when parental 
genotypes directly affect offspring phenotypes) (Brumpton et al., 2019; Hartwig et al., 
2018; Kong et al., 2018; Pingault et al., 2018). For most cohorts with this trio data, such 
as MoBa, the offspring are still too young to investigate reproductive outcomes such as 
complete fitness and therefore many evolutionary hypotheses are not yet possible to test. 
However, when this data does become available, the wealth of prospective measures on 
these individuals during key developmental stages will be very valuable. As discussed in 
Chapter 5, it will still be important to think carefully about the representativeness and 
possible selection bias of the data, as well as the assumptions discussed above for MR 
analyses. In general, genetic research is in a period of rapid change with increasing data 
availability and methodological developments. Although this can make it challenging to 
keep up to date with these advances, it also means that it is an exciting time for a potential 




With the advances of many genetic epidemiological methods, it is crucial to again 
highlight that a single method for causal inference in observational settings will not 
provide a definitive causal effect (Pingault et al., 2018). Instead, genetic epidemiological 
methods, such as MR, can improve the strength of evidence on a continuum from 
association to causal effect and triangulation across multiple methods can increase 
confidence in these results (Lawlor et al., 2016; Pingault et al., 2018). For example, 
Davies et al. (2018) employed an MR framework for educational attainment alongside 
regression discordant analysis with a non-genetic instrument of policy change in age at 
leaving school to triangulate across results, tying together policy and genetics. 
6.3.1 Conclusion 
Causal inference using genetically informed designs has undergone rapid and exciting 
developments in recent years with potential for evolutionary approaches to human 
behaviour to reap these benefits (Pingault et al., 2018). The findings from this thesis 
suggest that MR can be applied to directly test evolutionary hypotheses of human 
behaviour by combining proximate and ultimate level explanations in a causal framework 
without the need to manipulate an exposure experimentally. There is some indication that 
earlier age at menarche is causally related to traits that characterize a fast life history 
strategy, such as earlier age at first birth, earlier age at last birth, lower educational 
attainment, and earlier age at leaving education. Additionally, it appears that increased 
genetic liability for schizophrenia does not confer a fitness advantage and therefore the 
disorder is likely sustained in the population through other explanations than cliff-edge 
effects. However, with additional considerations that need to be made when applying MR 
to evolutionary relevant social traits and the current lack of large samples with trio data 
on relevant measures to overcome some biases, the field of evolutionary epidemiology 
remains in infancy. Nevertheless, there is great potential for the application of MR within 
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Appendix 1 List of SNPs (p<5×10-8) used in the 116 SNP analysis and their associations 
with age at menarche. 
 Age at menarche 
SNP β SE 
rs10144321 0.04 0.006 
rs1038903 0.04 0.006 
rs10423674 0.04 0.005 
rs10453225 0.09 0.005 
rs10739221 0.08 0.006 
rs10789181 0.03 0.005 
rs1079866 0.07 0.007 
rs10816359 0.04 0.008 
rs10895140 0.04 0.005 
rs10938397 0.04 0.005 
rs10980854 0.06 0.011 
rs10980921 0.09 0.009 
rs11022756 0.05 0.006 
rs11165924 0.03 0.006 
rs11215400 0.04 0.006 
rs1129700 0.03 0.005 
rs11578152 0.03 0.005 
rs11715566 0.05 0.005 
rs11767400 0.04 0.006 
rs11792861 0.04 0.005 
rs12148769 0.05 0.008 
rs12446632 0.04 0.007 
rs12472911 0.04 0.006 
rs1254337 0.04 0.005 
rs12571664 0.04 0.006 
rs12607903 0.04 0.005 
rs12915845 0.03 0.005 
rs13053505 0.04 0.007 
rs13067731 0.04 0.007 
rs13179411 0.06 0.007 
rs13196561 0.04 0.006 
rs1324913 0.03 0.005 
rs1364063 0.05 0.005 
rs1400974 0.05 0.005 
rs1461503 0.05 0.005 
rs1469039 0.05 0.007 
rs1532331 0.03 0.005 
rs16860328 0.04 0.005 
rs16896742 0.04 0.005 
rs16918254 0.05 0.009 




rs17086188 0.07 0.013 
rs17171818 0.04 0.006 
rs17233066 0.09 0.014 
rs17236969 0.05 0.008 
rs17266097 0.04 0.005 
rs1915146 0.03 0.005 
rs1958560 0.03 0.005 
rs2063730 0.05 0.007 
rs2137289 0.05 0.005 
rs2153127 0.08 0.005 
rs2274465 0.03 0.005 
rs239198 0.03 0.005 
rs244293 0.03 0.005 
rs246185 0.04 0.006 
rs2479724 0.03 0.005 
rs251130 0.04 0.006 
rs2600959 0.04 0.005 
rs268067 0.04 0.006 
rs2687729 0.04 0.006 
rs2688325 0.03 0.006 
rs2947411 0.06 0.007 
rs3101336 0.04 0.005 
rs3733631 0.05 0.007 
rs3743266 0.04 0.005 
rs4369815 0.06 0.01 
rs466639 0.08 0.007 
rs4840086 0.04 0.005 
rs4895808 0.03 0.005 
rs543874 0.05 0.006 
rs6009583 0.03 0.006 
rs6427782 0.03 0.005 
rs652260 0.03 0.005 
rs6555855 0.04 0.006 
rs6563739 0.03 0.005 
rs6747380 0.07 0.007 
rs6758290 0.04 0.005 
rs6762477 0.04 0.006 
rs6770162 0.04 0.005 
rs6933660 0.03 0.005 
rs6938574 0.04 0.007 
rs6964833 0.04 0.006 
rs7037266 0.03 0.005 
rs7103411 0.04 0.006 
rs7104764 0.03 0.006 
rs7138803 0.04 0.005 
rs7141210 0.03 0.005 
rs7215990 0.04 0.006 




rs7514705 0.04 0.005 
rs7642134 0.04 0.005 
rs7647973 0.05 0.006 
rs7701886 0.03 0.005 
rs7759938 0.12 0.005 
rs7821178 0.04 0.005 
rs7828501 0.04 0.005 
rs7853970 0.03 0.005 
rs7865468 0.03 0.005 
rs7955374 0.04 0.008 
rs8032675 0.04 0.005 
rs8050136 0.04 0.005 
rs852069 0.04 0.005 
rs889122 0.04 0.006 
rs900400 0.03 0.005 
rs913588 0.03 0.005 
rs929843 0.04 0.006 
rs9321659 0.06 0.008 
rs939317 0.04 0.006 
rs9447700 0.03 0.005 
rs9475752 0.04 0.006 
rs951366 0.03 0.005 
rs9560113 0.05 0.006 
rs9635759 0.05 0.005 
rs9647570 0.05 0.007 
rs9849248 0.04 0.007 





Appendix 2 List of SNPs (p<5×10-8) used in the 305 SNP analysis and their associations 
with age at menarche. 
 Age at menarche 
SNP β SE 
rs10136330 -0.06 0.010 
rs10138913 0.06 0.004 
rs10143972 -0.04 0.005 
rs10145469 -0.06 0.009 
rs10156597 0.10 0.004 
rs10175423 -0.02 0.004 
rs10205969 -0.04 0.005 
rs10237306 0.03 0.004 
rs1023955 -0.03 0.004 
rs10268051 0.02 0.005 
rs1030015 -0.02 0.004 
rs1032682 0.02 0.004 
rs10400136 -0.03 0.004 
rs10422323 0.04 0.006 
rs10521021 -0.02 0.004 
rs1054442 0.04 0.004 
rs10750766 -0.03 0.004 
rs10782777 -0.03 0.004 
rs1079866 -0.07 0.006 
rs10832021 -0.05 0.004 
rs10885077 0.02 0.004 
rs10906395 -0.02 0.004 
rs10931831 -0.05 0.004 
rs10933 -0.02 0.004 
rs10934420 -0.05 0.004 
rs10959016 -0.03 0.005 
rs10959552 -0.04 0.006 
rs10978641 -0.03 0.005 
rs10992769 0.03 0.004 
rs11031040 -0.04 0.005 
rs11065822 0.03 0.004 
rs11079810 0.04 0.006 
rs11165924 0.03 0.004 
rs11209331 0.02 0.004 
rs11209943 0.04 0.004 
rs11210871 0.04 0.004 
rs11240695 -0.03 0.004 
rs112991346 -0.04 0.006 
rs113388806 -0.06 0.010 
rs1148006 -0.03 0.004 
rs115260227 -0.16 0.024 
rs11534296 -0.04 0.004 
rs115435316 0.11 0.011 




rs11606190 0.04 0.006 
rs11619721 -0.04 0.007 
rs11668587 -0.03 0.004 
rs11711674 0.02 0.004 
rs117143374 -0.05 0.006 
rs1172955 -0.04 0.004 
rs117530880 -0.07 0.012 
rs11756746 0.02 0.005 
rs11767400 0.03 0.004 
rs11786868 0.03 0.005 
rs11792861 0.03 0.004 
rs11852771 0.02 0.004 
rs11873906 -0.05 0.004 
rs12040029 -0.04 0.006 
rs12125335 -0.05 0.006 
rs12200565 0.03 0.004 
rs12460047 -0.03 0.004 
rs12467441 -0.04 0.006 
rs12571664 0.04 0.005 
rs12603280 -0.04 0.005 
rs12663002 0.04 0.006 
rs12894936 -0.05 0.004 
rs12915845 -0.04 0.004 
rs12937034 -0.03 0.004 
rs13023912 -0.05 0.004 
rs13043968 -0.04 0.006 
rs13120031 0.03 0.004 
rs13199764 0.04 0.005 
rs13233916 -0.05 0.008 
rs13278754 -0.03 0.004 
rs13283567 -0.04 0.006 
rs1329767 -0.03 0.004 
rs13322435 0.04 0.004 
rs1414186 -0.04 0.005 
rs141847393 0.04 0.007 
rs142058842 -0.07 0.005 
rs142643995 0.06 0.012 
rs1428120 0.03 0.004 
rs1435753 -0.03 0.004 
rs1449543 0.02 0.004 
rs145438026 -0.07 0.008 
rs1456031 0.02 0.004 
rs150821390 0.07 0.012 
rs1512238 -0.05 0.004 
rs151680 0.03 0.004 
rs1535252 -0.03 0.004 
rs153793 -0.02 0.004 




rs1566385 0.06 0.008 
rs15671 -0.02 0.004 
rs1571536 0.03 0.004 
rs157877 -0.08 0.006 
rs1601615 -0.03 0.004 
rs16841867 0.05 0.006 
rs169080 -0.03 0.004 
rs16917237 0.04 0.005 
rs16918378 0.05 0.006 
rs16937956 -0.04 0.004 
rs17035311 0.04 0.005 
rs1704528 -0.05 0.004 
rs17171852 -0.04 0.005 
rs17390720 0.03 0.004 
rs17563472 -0.06 0.011 
rs17564430 -0.04 0.004 
rs1815811 -0.03 0.004 
rs184033703 -0.05 0.009 
rs1885740 -0.03 0.005 
rs1925047 -0.03 0.004 
rs1971554 0.03 0.004 
rs1984870 0.04 0.004 
rs2066323 -0.02 0.004 
rs2108753 0.03 0.004 
rs222440 -0.03 0.005 
rs2267812 0.04 0.005 
rs2271758 -0.02 0.004 
rs2295094 0.04 0.005 
rs2300922 0.04 0.004 
rs2312205 0.03 0.005 
rs2343507 0.02 0.004 
rs2378100 -0.02 0.004 
rs2461794 0.03 0.004 
rs247520 0.04 0.005 
rs2546959 0.03 0.005 
rs2558101 -0.02 0.004 
rs256350 -0.02 0.004 
rs2604265 0.04 0.004 
rs2659007 -0.03 0.004 
rs2661339 0.05 0.009 
rs2679894 0.05 0.004 
rs2688326 -0.04 0.004 
rs2723065 -0.02 0.004 
rs2724961 -0.05 0.004 
rs2770957 0.03 0.005 
rs2780243 -0.02 0.004 
rs28757192 -0.06 0.011 




rs29941 0.03 0.004 
rs3021057 0.02 0.004 
rs3113862 -0.04 0.004 
rs34437050 0.24 0.020 
rs34513772 0.02 0.004 
rs35436838 -0.07 0.011 
rs35485457 -0.04 0.004 
rs35935052 0.04 0.005 
rs360495 0.04 0.007 
rs36093651 0.04 0.005 
rs3733632 -0.05 0.005 
rs3743266 0.04 0.004 
rs3746037 0.04 0.005 
rs3746619 0.05 0.007 
rs3764002 -0.03 0.005 
rs3782120 0.03 0.004 
rs3809624 -0.03 0.004 
rs3815212 0.03 0.005 
rs395962 0.13 0.004 
rs4303811 -0.04 0.006 
rs4327718 -0.03 0.005 
rs4340786 0.04 0.004 
rs4359170 0.03 0.004 
rs437836 0.04 0.005 
rs443252 0.06 0.009 
rs4448948 -0.04 0.008 
rs446745 -0.03 0.005 
rs4487799 0.02 0.004 
rs4561063 0.03 0.004 
rs4588499 -0.02 0.004 
rs467379 0.02 0.004 
rs4701140 0.02 0.004 
rs474463 -0.03 0.005 
rs4746113 -0.02 0.004 
rs4751614 0.03 0.005 
rs4778356 0.04 0.006 
rs4801809 -0.04 0.007 
rs4804025 -0.04 0.004 
rs4813429 0.03 0.005 
rs4836984 0.03 0.004 
rs484353 0.03 0.004 
rs4845364 0.02 0.004 
rs4859001 0.04 0.006 
rs4875424 -0.03 0.004 
rs4877387 0.02 0.004 
rs4886140 0.03 0.004 
rs4945266 -0.04 0.005 




rs4970598 0.06 0.011 
rs4976623 0.03 0.005 
rs506589 0.07 0.005 
rs552491 -0.03 0.004 
rs55680968 -0.05 0.008 
rs55784701 0.03 0.005 
rs56367141 -0.04 0.006 
rs56409371 -0.03 0.005 
rs5742915 -0.02 0.004 
rs5753377 -0.03 0.004 
rs582780 0.03 0.004 
rs59246405 0.03 0.004 
rs59543819 -0.03 0.004 
rs59652033 -0.03 0.004 
rs61817552 -0.03 0.005 
rs61828391 -0.03 0.006 
rs61846901 -0.03 0.004 
rs6185 -0.03 0.004 
rs62104180 0.11 0.010 
rs62229372 0.05 0.006 
rs62316795 0.04 0.005 
rs62342064 0.06 0.007 
rs62361685 0.05 0.009 
rs62379978 -0.06 0.005 
rs62391851 -0.06 0.009 
rs6415872 0.02 0.004 
rs6434162 -0.04 0.005 
rs643428 -0.02 0.004 
rs6439371 -0.03 0.004 
rs6439713 0.03 0.004 
rs6445624 0.04 0.006 
rs6575806 -0.03 0.006 
rs6590889 -0.04 0.004 
rs660549 -0.02 0.004 
rs66508321 -0.03 0.004 
rs6661100 0.05 0.007 
rs6678140 -0.03 0.004 
rs6735626 0.02 0.004 
rs68002803 0.03 0.004 
rs6803264 0.03 0.005 
rs6864818 0.04 0.005 
rs6878910 0.04 0.006 
rs6911407 0.03 0.004 
rs6911527 0.03 0.005 
rs6927679 0.03 0.004 
rs6931884 0.06 0.006 
rs6933660 -0.03 0.004 




rs7077302 0.05 0.007 
rs709488 -0.02 0.004 
rs7108556 0.03 0.005 
rs7115444 0.03 0.005 
rs7132908 -0.04 0.004 
rs7178532 0.04 0.004 
rs7218751 0.03 0.005 
rs7239114 -0.02 0.004 
rs72756954 0.06 0.008 
rs72787511 0.06 0.011 
rs72842141 -0.06 0.009 
rs73035994 -0.09 0.012 
rs73187215 -0.04 0.007 
rs73435048 -0.04 0.008 
rs7359336 -0.05 0.004 
rs73820560 -0.03 0.006 
rs7426534 -0.02 0.004 
rs7431217 0.02 0.004 
rs74499585 0.06 0.008 
rs7516763 0.02 0.004 
rs7542538 0.03 0.005 
rs7576624 -0.07 0.005 
rs758747 -0.03 0.004 
rs7587651 -0.02 0.004 
rs7649124 0.03 0.005 
rs7712046 -0.03 0.004 
rs77530428 -0.12 0.017 
rs77532868 0.06 0.010 
rs7753896 0.03 0.004 
rs7757654 -0.03 0.004 
rs77955256 -0.04 0.006 
rs7826872 0.03 0.004 
rs7849973 0.02 0.004 
rs7852169 -0.10 0.007 
rs7853970 0.04 0.004 
rs78928932 -0.06 0.009 
rs7907759 0.04 0.004 
rs79084266 -0.04 0.007 
rs7912468 -0.02 0.004 
rs79541760 0.04 0.005 
rs7971408 0.05 0.006 
rs7979001 0.02 0.004 
rs80170948 -0.07 0.011 
rs8040272 0.04 0.006 
rs8051833 -0.04 0.004 
rs813301 0.03 0.004 
rs8136272 0.04 0.004 




rs852061 -0.04 0.004 
rs910425 -0.02 0.004 
rs913588 -0.03 0.004 
rs9330454 -0.03 0.004 
rs9349203 -0.04 0.004 
rs9382676 0.04 0.005 
rs9403051 0.04 0.004 
rs941520 -0.02 0.004 
rs9427116 0.02 0.004 
rs953230 0.03 0.004 
rs9548873 -0.03 0.004 
rs9568123 -0.03 0.005 
rs9614460 -0.02 0.004 
rs9635759 0.06 0.004 
rs9647570 -0.04 0.006 
rs970179 0.02 0.004 
rs975642 -0.02 0.004 
rs9758500 -0.05 0.004 
rs9834893 -0.05 0.007 
rs9972653 -0.05 0.004 





Appendix 3 List of SNPs (p<5×10-8) used in analysis and their associations with age at 
first sexual intercourse. 
 
Age at first sexual 
intercourse 
SNP β SE 
rs10800813 0.02 0.004 
rs115552537 0.03 0.005 
rs12522910 0.04 0.005 
rs1264194 0.03 0.004 
rs12714592 0.03 0.004 
rs1344293 0.03 0.004 
rs2188151 0.03 0.004 
rs2248699 0.02 0.004 
rs341521 0.03 0.004 
rs369230 0.03 0.004 
rs4129322 0.04 0.007 
rs4324362 0.03 0.004 
rs4443996 0.02 0.004 
rs4702 0.02 0.004 
rs4840367 0.03 0.004 
rs538498277 0.31 0.051 
rs58749137 0.02 0.004 
rs6058613 0.03 0.005 
rs6549665 0.03 0.005 
rs658385 0.02 0.004 
rs726281 0.03 0.004 
rs76513770 0.03 0.006 





Appendix 4 Funnel plot for Cochran's Q values using the age at menarche 116 SNP 






Appendix 5 Funnel plot for Cochran's Q values using the age at menarche 305 SNP 
instrument. Here shown with number of children as an outcome for illustration, using 






Appendix 6 Funnel plot for Cochran's Q values using the age at first sexual intercourse 






Appendix 7 MR Plot illustrating rs538498277 as a potential outlier in analyses of age at 
first sexual intercourse. Here shown for increasing age at first sexual intercourse on age 






Appendix 8 Radial MR plot identifies rs2188151 as the strongest potential outlier. Here 






Appendix 9 Leave-one-out analysis indicates that all estimates were within the 
confidence intervals of all other estimates. Here shown for increasing age at first sexual 






Appendix 10 List of SNPs associated with educational attainment (p<5×10-8), number of 
children and age at first birth for UK Biobank analyses. 
SNP 
Educational attainmenta Number of childrenb Age at first birthc 
β SE β SE β SE 
rs10061788 0.021 0.004 -0.002 0.004 0.033 0.025 
rs1008078 -0.016 0.003 0.006 0.003 -0.077 0.019 
rs1043209 0.018 0.003 0.008 0.003 0.052 0.019 
rs10496091 -0.018 0.003 -0.003 0.003 -0.066 0.020 
rs11191193 0.018 0.003 0.005 0.003 0.063 0.019 
rs11210860 0.017 0.003 0.001 0.003 0.065 0.019 
rs112634398 0.036 0.007 -0.013 0.007 0.069 0.046 
rs113520408 0.017 0.003 0.000 0.003 0.023 0.020 
rs11588857 0.020 0.003 0.011 0.004 0.034 0.022 
rs11689269 0.016 0.003 -0.003 0.003 0.061 0.019 
rs11690172 0.015 0.003 -0.004 0.003 0.027 0.019 
rs11712056 0.024 0.003 -0.013 0.003 0.138 0.018 
rs11768238 -0.017 0.003 -0.002 0.003 -0.010 0.020 
rs12531458 0.014 0.003 -0.003 0.003 0.014 0.018 
rs12646808 0.016 0.003 0.001 0.003 0.054 0.020 
rs12671937 0.016 0.003 -0.003 0.003 0.034 0.018 
rs12772375 -0.015 0.003 -0.003 0.003 0.006 0.019 
rs12969294 -0.016 0.003 0.011 0.003 -0.063 0.019 
rs12987662 0.027 0.003 -0.007 0.003 0.069 0.019 
rs13294439 -0.023 0.003 0.010 0.003 -0.090 0.018 
rs13402908 -0.018 0.003 0.002 0.003 -0.037 0.018 
rs1402025 0.017 0.003 0.004 0.003 0.028 0.022 
rs1606974 0.022 0.004 -0.008 0.004 0.091 0.028 
rs165633 -0.018 0.003 0.000 0.004 0.004 0.022 
rs16845580 0.016 0.003 -0.006 0.003 0.039 0.019 
rs17119973 -0.019 0.003 0.005 0.003 -0.054 0.021 
rs17167170 0.020 0.003 -0.005 0.004 0.073 0.023 
rs1777827 0.015 0.003 -0.004 0.003 0.032 0.019 
rs17824247 -0.016 0.003 0.007 0.003 -0.057 0.019 
rs1871109 -0.016 0.003 0.000 0.003 -0.019 0.018 
rs2245901 -0.016 0.003 0.000 0.003 -0.052 0.019 
rs2431108 0.016 0.003 0.006 0.003 0.024 0.019 
rs2456973 -0.020 0.003 0.010 0.003 -0.096 0.019 
rs2457660 -0.017 0.003 0.002 0.003 -0.061 0.019 
rs2568955 -0.017 0.003 0.009 0.004 -0.022 0.024 
rs2610986 -0.016 0.003 -0.007 0.003 -0.014 0.020 
rs2615691 -0.037 0.007 0.019 0.008 0.095 0.050 
rs2837992 0.015 0.003 -0.006 0.003 0.050 0.019 
rs2964197 0.015 0.003 -0.007 0.003 0.032 0.018 




rs301800 0.019 0.003 -0.004 0.004 0.058 0.024 
rs3101246 -0.015 0.003 0.004 0.003 -0.024 0.019 
rs324886 -0.015 0.003 0.009 0.003 -0.056 0.019 
rs34072092 0.024 0.004 -0.007 0.005 0.074 0.029 
rs34305371 0.035 0.005 -0.006 0.005 0.073 0.030 
rs35761247 0.034 0.006 -0.020 0.006 0.197 0.039 
rs4493682 0.019 0.004 -0.010 0.004 0.082 0.024 
rs4500960 -0.016 0.003 0.001 0.003 0.021 0.018 
rs4851251 -0.017 0.003 0.004 0.003 -0.067 0.021 
rs4863692 0.018 0.003 0.001 0.003 0.090 0.019 
rs55830725 -0.022 0.004 -0.011 0.004 -0.006 0.024 
rs56231335 -0.017 0.003 0.001 0.003 -0.047 0.019 
rs572016 0.014 0.003 0.005 0.003 0.042 0.018 
rs61160187 -0.017 0.003 -0.002 0.003 -0.060 0.019 
rs62259535 0.048 0.008 -0.011 0.008 0.251 0.049 
rs62263923 -0.016 0.003 0.021 0.003 -0.052 0.019 
rs62379838 0.016 0.003 -0.004 0.003 -0.007 0.020 
rs6739979 -0.015 0.003 0.001 0.003 -0.048 0.019 
rs7131944 0.015 0.003 -0.001 0.003 -0.015 0.019 
rs7306755 0.023 0.003 0.004 0.004 0.039 0.023 
rs76076331 0.020 0.004 -0.001 0.004 0.092 0.028 
rs7767938 0.017 0.003 0.000 0.003 0.024 0.021 
rs7854982 -0.015 0.003 0.000 0.003 -0.019 0.018 
rs7945718 0.015 0.003 -0.003 0.003 0.021 0.019 
rs7955289 0.017 0.003 -0.006 0.003 0.027 0.019 
rs895606 0.015 0.003 0.002 0.003 0.075 0.018 
rs9537821 0.024 0.003 -0.006 0.003 0.073 0.020 
a Educational attainment from the SSGAC GWAS; b Number of children data from UK 





Appendix 11 Funnel plot for Cochran's Q values for genetically predicted educational 







Appendix 12 Genetic correlations of genetically predicted educational attainment and 
number of children and age at first birth using LD score regression with outcome 
summary statistics also adjusted for genotype array (UK Biobank analyses). 
  No. of childrena Age at first birthb 
  rg SE p rg SE p 
Genetically predicted educational attainmentc -0.35 0.03 <0.001 0.81 0.02 <0.001 
a Number of children data from UK Biobank (N = 333 628); b Age at first birth data from 






Appendix 13 Estimates of the causal effect of genetically predicted educational 
attainment on outcomes using IVW, MBE and weighted median MR methods with 
outcome summary statistics also adjusted for genotype array (UK Biobank analyses). 
 No. of childrena Age at first birthb Childlessnessc 
Method 
(67 SNPsd) 
β (95% CI), p OR (95% CI), p 
IVW 
-0.162 (-0.206, -0.118), 
<0.001 
2.663 (2.388, 2.938), 
<0.001 




-0.206 (-0.278, -0.134), 
<0.001 
2.842 (2.378, 3.306), 
<0.001 
1.570 (1.349, 1.828), 
<0.001 
MBE 
-0.249 (-0.477, -0.021), 
0.04 
1.621 (0.260, 2.981), 
<0.001 
1.520 (0.964, 2.399), 
0.08 
a Number of children data from UK Biobank (N = 268 658 – 335 758). b Age at first birth 
data from UK Biobank (N = 99 317 – 124 093). c Childlessness data from UK Biobank (N 
= 268 658 – 335 758). Childlessness was coded as 1. Results were converted to ORs by 




Appendix 14 List of SNPs associated with schizophrenia (p<5×10-8) and associations with number of children, age at first birth and number of sexual 
partners for UK Biobank analyses. 
SNP 











ln(OR) SE β SE β SE β SE 
rs1009080 rs1498232 0.99 -0.071 0.012 0.004 0.003 -0.018 0.020 -0.021 0.024 
rs1023500   0.076 0.014 0.002 0.004 -0.024 0.023 -0.025 0.028 
rs10412446 rs56873913 0.97 0.057 0.013 0.001 0.003 0.040 0.022 0.021 0.027 
rs10503253   0.072 0.013 0.004 0.004 0.008 0.023 -0.030 0.028 
rs10504857 rs7819570 1.00 -0.074 0.014 0.002 0.004 -0.018 0.024 -0.026 0.030 
rs10520163   0.058 0.011 -0.004 0.003 0.007 0.018 0.019 0.022 
rs10779702 chr1_8424984_D 0.97 0.063 0.011 0.002 0.003 -0.049 0.019 -0.021 0.023 
rs10791097   0.077 0.011 0.007 0.003 -0.024 0.018 0.009 0.022 
rs10803138   -0.072 0.013 0.006 0.003 -0.053 0.021 -0.086 0.026 
rs10860964   0.063 0.011 0.005 0.003 -0.035 0.019 0.026 0.023 
rs10900851 rs10043984 0.99 -0.064 0.012 0.008 0.003 -0.052 0.021 0.023 0.026 
rs10933068 rs11685299 1.00 -0.063 0.012 -0.008 0.003 0.015 0.020 -0.083 0.024 
rs11027857   0.064 0.011 0.005 0.003 0.007 0.018 -0.002 0.022 
rs1106568   -0.069 0.013 -0.005 0.003 0.070 0.021 0.020 0.026 
rs11139497   0.066 0.012 -0.005 0.003 -0.050 0.019 0.032 0.024 
rs11210892   -0.068 0.012 -0.001 0.003 0.084 0.019 -0.083 0.024 
rs1160682 rs12129573 1.00 -0.068 0.011 -0.003 0.003 0.053 0.019 -0.003 0.023 
rs11632947 rs12903146 0.99 0.066 0.011 0.001 0.003 0.012 0.018 0.023 0.022 
rs11682175   -0.073 0.011 0.002 0.003 -0.076 0.018 0.043 0.022 
rs11683083 chr2_146436222_I 1.00 -0.078 0.014 0.007 0.004 -0.039 0.024 -0.043 0.029 
rs12063329 rs140505938 1.00 0.088 0.015 -0.001 0.004 0.014 0.024 0.036 0.030 
rs12148337   0.057 0.011 0.002 0.003 0.001 0.018 -0.028 0.022 
rs12325245   -0.086 0.016 -0.001 0.004 -0.058 0.026 -0.019 0.032 
rs12421382   -0.065 0.012 -0.004 0.003 -0.024 0.020 -0.029 0.024 




rs12619354 rs59979824 0.87 0.059 0.012 -0.004 0.003 0.040 0.019 0.062 0.024 
rs12654855 rs79212538 0.95 -0.128 0.025 -0.010 0.007 0.023 0.043 -0.083 0.053 
rs12659129 chr5_140143664_I 1.00 0.052 0.011 -0.002 0.003 -0.019 0.018 -0.037 0.022 
rs12716972 rs12691307 0.98 0.063 0.011 -0.002 0.003 -0.0004 0.018 -0.014 0.023 
rs13074054 chr3_180594593_I 0.99 0.077 0.014 0.008 0.004 -0.008 0.022 -0.041 0.027 
rs13107325 rs35518360 0.85 0.152 0.022 0.001 0.006 -0.038 0.035 -0.134 0.043 
rs1501357   -0.069 0.014 -0.002 0.004 0.050 0.024 -0.065 0.029 
rs16867576   0.096 0.017 -0.009 0.004 -0.028 0.027 0.149 0.033 
rs17049247 rs75575209 0.97 -0.103 0.019 0.008 0.005 -0.091 0.032 0.024 0.039 
rs17149781 chr7_24747494_D 0.91 -0.086 0.017 0.004 0.005 -0.083 0.029 0.007 0.036 
rs17194490   0.097 0.015 -0.003 0.004 0.034 0.025 0.048 0.030 
rs17273111 rs4330281 1.00 0.056 0.011 -0.001 0.003 -0.025 0.018 0.020 0.022 
rs17594526 rs78322266 1.00 0.169 0.031 -0.003 0.009 0.053 0.056 0.169 0.069 
rs17602354 rs72934570 0.92 0.141 0.021 -0.001 0.005 0.010 0.033 0.188 0.040 
rs1782810 rs1702294 0.99 0.118 0.014 0.003 0.004 0.004 0.023 0.000 0.029 
rs2007044   -0.092 0.011 0.002 0.003 -0.015 0.019 -0.007 0.023 
rs2053079   -0.072 0.013 0.004 0.003 -0.037 0.021 0.058 0.026 
rs2057070 rs9607782 0.81 -0.068 0.012 0.006 0.003 -0.051 0.020 0.029 0.025 
rs2068012   -0.070 0.013 -0.002 0.003 0.048 0.022 -0.007 0.027 
rs211829   0.054 0.011 -0.005 0.003 0.001 0.019 0.022 0.023 
rs215411   0.069 0.012 -0.002 0.003 0.003 0.020 0.017 0.024 
rs2239063   0.069 0.012 -0.0002 0.003 0.003 0.020 0.053 0.025 
rs2296569 rs55833108 0.83 -0.068 0.014 0.001 0.004 -0.007 0.023 0.074 0.028 
rs2514218   -0.072 0.012 -0.0004 0.003 0.027 0.019 0.005 0.024 
rs2535627   0.070 0.011 -0.0004 0.003 -0.019 0.018 -0.019 0.023 
rs2693698   -0.062 0.011 0.001 0.003 0.025 0.018 -0.006 0.023 
rs2796275 rs7523273 0.98 0.053 0.012 0.001 0.003 -0.002 0.019 0.037 0.024 
rs2851447   -0.084 0.012 -0.002 0.003 -0.035 0.021 -0.048 0.026 
rs2955357 rs8082590 1.00 0.064 0.012 -0.001 0.003 0.031 0.020 -0.038 0.024 




rs2973161 rs2973155 0.97 -0.069 0.011 -0.006 0.003 0.006 0.019 -0.033 0.023 
rs324015 rs324017 0.81 -0.069 0.013 0.003 0.003 0.005 0.021 -0.016 0.026 
rs3802924 rs75059851 0.95 0.088 0.014 -0.0003 0.004 -0.041 0.023 0.005 0.029 
rs3849046   0.062 0.011 -0.008 0.003 0.010 0.019 0.005 0.023 
rs4128242 chr18_52749216_D 1.00 0.067 0.011 0.003 0.003 -0.024 0.019 0.021 0.023 
rs4129585   0.079 0.011 0.003 0.003 -0.035 0.018 0.036 0.022 
rs4240748   -0.057 0.011 0.009 0.003 0.030 0.019 -0.027 0.023 
rs436124 rs679087 1.00 0.061 0.011 0.002 0.003 0.012 0.019 0.034 0.023 
rs4388249   0.067 0.014 0.001 0.004 -0.037 0.025 0.104 0.031 
rs4391122   -0.078 0.011 -0.001 0.003 0.068 0.018 0.027 0.023 
rs4518583 rs3735025 1.00 0.061 0.011 -0.004 0.003 0.061 0.019 0.035 0.023 
rs4523957   0.070 0.012 -0.005 0.003 -0.007 0.019 0.055 0.024 
rs4648845   0.067 0.012 0.002 0.003 0.015 0.018 -0.010 0.023 
rs4664442 rs2909457 0.98 0.059 0.011 0.002 0.003 0.029 0.018 0.017 0.022 
rs4702   -0.081 0.012 -0.006 0.003 0.026 0.018 -0.132 0.022 
rs6065094   -0.075 0.012 -0.003 0.003 -0.008 0.019 -0.062 0.024 
rs6461049 chr7_2025096_I 0.93 0.080 0.011 0.006 0.003 0.033 0.018 0.077 0.023 
rs6466056 rs6466055 1.00 0.068 0.011 -0.0005 0.003 -0.052 0.019 0.062 0.023 
rs6579959 rs111294930 0.96 -0.067 0.012 -0.003 0.003 -0.018 0.020 -0.103 0.025 
rs6670165   0.074 0.014 -0.001 0.004 0.004 0.023 0.066 0.029 
rs6704641   0.075 0.015 0.006 0.004 0.008 0.023 -0.071 0.029 
rs6704768   -0.077 0.011 -0.003 0.003 -0.051 0.018 -0.007 0.023 
rs7085104 rs11191419 0.99 0.098 0.011 0.002 0.003 -0.001 0.019 -0.067 0.024 
rs7140568 rs12887734 1.00 0.085 0.012 0.002 0.003 -0.004 0.020 0.036 0.025 
rs715170   -0.067 0.012 -0.001 0.003 0.025 0.021 -0.061 0.025 
rs7267348   -0.066 0.013 0.003 0.003 -0.003 0.021 -0.005 0.026 
rs7432375   -0.071 0.011 -0.004 0.003 0.017 0.019 -0.006 0.023 
rs7499750 rs7405404 1.00 0.077 0.013 -0.005 0.003 0.018 0.022 0.069 0.027 
rs7730110 rs11740474 0.81 -0.059 0.011 0.002 0.003 0.021 0.019 -0.014 0.024 
rs7801375   -0.083 0.015 0.0003 0.004 0.018 0.025 0.009 0.031 




rs787983 rs6434928 0.98 -0.073 0.012 -0.004 0.003 -0.014 0.019 -0.019 0.024 
rs7893279   0.112 0.018 0.008 0.005 0.083 0.029 0.106 0.035 
rs7927176 rs77502336 0.96 -0.059 0.012 0.00001 0.003 0.017 0.019 0.053 0.024 
rs8042374   0.090 0.013 -0.009 0.003 -0.005 0.022 -0.049 0.027 
rs8044995   0.077 0.014 0.002 0.004 -0.022 0.025 0.017 0.030 
rs832187   -0.070 0.011 0.0002 0.003 -0.037 0.019 0.021 0.023 
rs867743 rs6984242 1.00 -0.062 0.011 -0.003 0.003 -0.029 0.019 0.020 0.023 
rs884808 rs14403 0.86 -0.054 0.013 0.003 0.004 0.040 0.022 -0.058 0.027 
rs9420   0.058 0.011 -0.002 0.003 -0.007 0.019 0.024 0.024 
rs950169   -0.079 0.012 -0.003 0.003 0.038 0.021 -0.023 0.025 
rs9636107   -0.080 0.011 -0.003 0.003 0.063 0.018 -0.034 0.023 
rs982256 rs13240464 0.98 0.078 0.012 -0.001 0.003 0.030 0.019 -0.043 0.024 
rs9841616   -0.074 0.015 -0.001 0.004 -0.021 0.024 -0.051 0.030 
rs9876421 rs75968099 0.93 0.079 0.011 -0.007 0.003 0.021 0.019 0.043 0.024 
rs9922678     0.068 0.012 -0.001 0.003 0.008 0.020 -0.008 0.025 
a Schizophrenia genetic data from the PGC GWAS; b Number of children data from UK Biobank; c Age at first birth data from UK Biobank; d Number of 





Appendix 15 List of SNPs associated with schizophrenia (p<5×10-8) and associations with number of children, age at first birth and number of sexual 
partners for MoBa mothers analyses. 
       Schizophreniaa Parityb Age at first pregnancyc Age at first birthd 
SNP Proxy for Effect allele Other allele ln(OR) SE β SE β SE β SE 
rs10043984  T C 0.064 0.012 -0.003 0.013 0.070 0.073 -0.046 0.064 
rs1023500  T C 0.076 0.014 -0.015 0.015 0.063 0.080 0.147 0.070 
rs10503253  A C 0.072 0.013 0.024 0.014 -0.068 0.075 -0.056 0.066 
rs10520163  T C 0.058 0.011 0.010 0.011 -0.015 0.061 -0.030 0.053 
rs10777339 rs4240748 A G 0.056 0.011 0.030 0.012 0.017 0.064 -0.133 0.056 
rs10779702  A G 0.063 0.011 0.005 0.012 0.005 0.063 -0.009 0.055 
rs10791097  T G 0.077 0.011 -0.003 0.011 -0.083 0.062 -0.038 0.054 
rs10803138  A G -0.072 0.013 0.009 0.013 -0.130 0.072 -0.147 0.063 
rs10860964  T C 0.063 0.011 0.009 0.012 -0.066 0.064 -0.021 0.056 
rs11027857  A G 0.064 0.011 0.015 0.011 -0.080 0.061 -0.051 0.054 
rs1106568  A G -0.069 0.013 -0.008 0.013 0.028 0.070 0.053 0.061 
rs111294930  A G 0.088 0.014 -0.005 0.012 -0.008 0.067 0.024 0.059 
rs11139497  A T 0.066 0.012 -0.002 0.012 0.079 0.067 0.073 0.058 
rs11191419  A T -0.102 0.012 -0.001 0.012 -0.074 0.065 -0.048 0.057 
rs11210892  A G -0.068 0.012 -0.019 0.012 0.040 0.066 0.031 0.058 
rs11682175  T C -0.073 0.011 0.005 0.011 0.027 0.062 0.009 0.054 
rs11683083  A G -0.078 0.014 0.016 0.014 -0.047 0.078 -0.066 0.068 
rs11693094  T C -0.074 0.011 0.023 0.011 -0.074 0.062 -0.055 0.054 
rs12129573  A C 0.069 0.011 0.014 0.012 -0.134 0.064 -0.142 0.056 
rs12148337  T C 0.057 0.011 0.004 0.011 -0.042 0.062 -0.048 0.054 
rs12325245  A T -0.086 0.016 0.002 0.017 -0.040 0.092 0.023 0.080 
rs12421382  T C -0.065 0.012 0.021 0.012 -0.079 0.064 -0.078 0.056 




rs12691307  A G 0.072 0.011 -0.020 0.011 0.108 0.061 0.042 0.054 
rs12704290  A G -0.106 0.017 0.026 0.017 0.025 0.095 -0.029 0.083 
rs12826178  T G -0.168 0.024 -0.025 0.022 -0.202 0.122 -0.168 0.107 
rs12903146  A G 0.067 0.011 -0.011 0.011 0.079 0.062 0.016 0.054 
rs13074054  A G 0.077 0.014 0.028 0.015 -0.058 0.080 -0.078 0.070 
rs13240464  T C 0.081 0.012 0.002 0.012 -0.020 0.065 -0.042 0.057 
rs1416544 rs1339227 A G -0.063 0.011 -0.003 0.012 0.055 0.063 0.002 0.055 
rs14403  T C -0.067 0.013 0.0003 0.013 0.060 0.073 -0.007 0.064 
rs1498232  T C 0.072 0.012 -0.020 0.012 0.047 0.066 0.038 0.058 
rs1501357  T C -0.069 0.014 0.008 0.015 -0.054 0.082 -0.009 0.072 
rs16867576  A G 0.096 0.017 -0.017 0.016 0.035 0.085 0.038 0.074 
rs1702294  T C -0.118 0.014 -0.007 0.014 -0.116 0.076 -0.051 0.067 
rs17149781  A G -0.086 0.017 -0.030 0.017 0.014 0.091 -0.026 0.080 
rs17194490  T G 0.097 0.015 -0.022 0.016 0.079 0.085 0.072 0.075 
rs2007044  A G -0.092 0.011 -0.012 0.012 0.068 0.063 0.016 0.056 
rs2053079  A G -0.072 0.013 0.007 0.013 -0.054 0.072 0.007 0.063 
rs211829  T C 0.054 0.011 0.006 0.012 0.051 0.064 -0.042 0.056 
rs215411  A T 0.069 0.012 0.005 0.012 -0.023 0.064 0.020 0.056 
rs2239063  A C 0.069 0.012 -0.014 0.013 0.145 0.068 0.096 0.060 
rs2514218  T C -0.072 0.012 -0.010 0.012 0.110 0.066 0.050 0.058 
rs2535627  T C 0.070 0.011 -0.003 0.011 -0.053 0.062 0.049 0.054 
rs2851447  C G -0.084 0.012 -0.022 0.013 -0.007 0.072 0.052 0.063 
rs2905426  T G -0.068 0.012 0.0001 0.012 -0.018 0.064 -0.017 0.056 
rs2909457  A G -0.060 0.011 -0.017 0.011 0.046 0.062 -0.0005 0.054 
rs2973161 rs2973155 A C -0.069 0.011 -0.022 0.012 0.100 0.064 0.097 0.056 
rs324017  A C -0.064 0.012 -0.010 0.013 -0.030 0.069 0.021 0.061 




rs35672725 rs7819570 T C 0.074 0.014 -0.022 0.016 0.103 0.086 0.089 0.075 
rs36068923  A G -0.084 0.013 -0.002 0.014 0.101 0.074 0.045 0.065 
rs3735025  T C 0.063 0.011 -0.009 0.012 -0.024 0.065 -0.006 0.057 
rs3768644  A G -0.094 0.018 0.013 0.019 -0.023 0.103 0.015 0.090 
rs3845840 rs11685299 A G -0.062 0.012 -0.020 0.012 0.107 0.065 0.082 0.057 
rs3849046  T C 0.062 0.011 0.015 0.011 -0.032 0.062 -0.077 0.054 
rs4128242  T C 0.067 0.011 0.003 0.011 -0.006 0.062 0.023 0.055 
rs4129585  A C 0.079 0.011 -0.001 0.011 0.013 0.062 0.012 0.054 
rs4330281  T C -0.058 0.011 0.006 0.011 0.049 0.062 -0.004 0.055 
rs4388249  T C 0.067 0.014 -0.018 0.015 0.010 0.081 0.017 0.071 
rs4391122  A G -0.078 0.011 -0.008 0.011 0.049 0.062 0.034 0.054 
rs4523957  T G 0.070 0.012 -0.005 0.012 -0.006 0.063 -0.050 0.055 
rs4648845  T C 0.067 0.012 -0.008 0.011 0.043 0.061 0.025 0.054 
rs4702  A G -0.081 0.012 -0.013 0.011 0.081 0.062 0.032 0.054 
rs4766428  T C 0.069 0.011 0.002 0.011 0.017 0.062 0.041 0.054 
rs55661361  A G -0.079 0.012 0.004 0.012 -0.119 0.065 -0.089 0.057 
rs55833108  T G 0.074 0.014 0.005 0.013 0.009 0.073 -0.005 0.064 
rs56205728  A G 0.066 0.013 -0.001 0.013 0.070 0.068 0.042 0.060 
rs59979824  A C -0.071 0.012 -0.002 0.012 -0.011 0.064 -0.008 0.056 
rs6002655  T C 0.069 0.011 0.007 0.011 0.059 0.062 0.058 0.054 
rs6065094  A G -0.075 0.012 0.00009 0.012 0.001 0.067 0.009 0.059 
rs6434928  A G -0.079 0.012 0.003 0.012 0.012 0.066 -0.014 0.057 
rs6461049  T C 0.080 0.011 -0.012 0.011 -0.017 0.062 0.041 0.055 
rs6466055  A C 0.069 0.011 -0.002 0.012 -0.011 0.066 -0.014 0.058 
rs6670165  T C 0.074 0.014 -0.009 0.015 0.075 0.082 0.011 0.071 
rs6704641  A G 0.075 0.015 0.013 0.016 -0.137 0.086 -0.102 0.076 




rs679087  A C -0.064 0.012 0.011 0.012 -0.131 0.063 -0.017 0.055 
rs6984242  A G -0.062 0.011 -0.006 0.012 -0.005 0.063 0.032 0.055 
rs715170  T C -0.067 0.012 -0.011 0.013 -0.079 0.069 -0.030 0.060 
rs7267348  T C -0.066 0.013 0.0004 0.013 -0.048 0.072 -0.017 0.063 
rs72934570  T C -0.145 0.021 0.006 0.020 0.098 0.108 -0.045 0.095 
rs73229090  A C -0.099 0.018 -0.012 0.018 0.119 0.096 0.083 0.084 
rs7405404  T C 0.077 0.013 0.013 0.014 0.089 0.076 0.091 0.067 
rs7432375  A G -0.071 0.011 -0.009 0.012 -0.020 0.063 0.059 0.055 
rs75059851  A G 0.091 0.014 0.014 0.013 -0.095 0.072 -0.092 0.063 
rs7523273  A G 0.060 0.012 -0.001 0.012 0.026 0.063 -0.032 0.055 
rs75968099  T C 0.080 0.011 0.003 0.012 0.023 0.065 0.017 0.057 
rs7730110  T C -0.059 0.011 -0.007 0.012 0.085 0.063 0.061 0.055 
rs77447799 rs75575209 T G 0.106 0.019 -0.002 0.020 -0.057 0.107 0.059 0.094 
rs77502336  C G 0.062 0.012 -0.001 0.012 -0.003 0.067 0.003 0.059 
rs7801375  A G -0.083 0.015 0.011 0.016 -0.073 0.085 -0.071 0.075 
rs7893279  T G 0.112 0.018 -0.008 0.018 -0.120 0.098 0.007 0.086 
rs79212538  T G 0.141 0.026 -0.003 0.024 -0.019 0.133 -0.118 0.116 
rs8042374  A G 0.090 0.013 -0.003 0.014 0.057 0.075 0.030 0.065 
rs8044995  A G 0.077 0.014 -0.004 0.015 -0.123 0.082 -0.058 0.072 
rs8082590  A G -0.066 0.012 -0.006 0.012 0.036 0.067 0.084 0.059 
rs8113357 rs56873913 T C 0.062 0.013 -0.004 0.013 -0.058 0.073 -0.009 0.064 
rs832187  T C -0.070 0.011 -0.0002 0.012 -0.082 0.065 -0.038 0.057 
rs9420  A G 0.058 0.011 0.019 0.012 -0.072 0.065 -0.072 0.057 
rs950169  T C -0.079 0.012 0.017 0.013 0.034 0.070 -0.033 0.061 
rs9607782  A T 0.089 0.013 0.001 0.013 0.069 0.071 0.052 0.062 
rs9636107  A G -0.080 0.011 -0.004 0.011 0.027 0.062 -0.015 0.054 




rs9922678  A G 0.068 0.012 0.005 0.012 -0.116 0.068 -0.093 0.059 




 Appendix 16 List of SNPs associated with schizophrenia (p<5×10-8) and associations with number of children, age at first birth and number of sexual 
partners for ALSPAC G0 analyses. 
      Schizophreniaa Parity at 85 monthsb Parity at 18 yearsc Age at first pregnancyd 
SNP Effect allele Other allele ln(OR) SE β SE β SE β SE 
rs10043984 T C 0.064 0.012 0.0003 0.021 0.025 0.033 0.114 0.075 
rs1023500 T C 0.076 0.014 -0.027 0.022 -0.002 0.036 -0.004 0.082 
rs10503253 A C 0.072 0.013 -0.004 0.023 0.010 0.036 0.030 0.081 
rs10520163 T C 0.058 0.011 0.051 0.018 0.056 0.029 -0.024 0.064 
rs10779702 A G 0.063 0.011 -0.017 0.019 0.001 0.030 0.049 0.068 
rs10791097 T G 0.077 0.011 -0.023 0.018 0.007 0.028 -0.046 0.064 
rs10803138 A G -0.072 0.013 0.025 0.020 0.036 0.032 -0.067 0.074 
rs10860964 T C 0.063 0.011 0.011 0.019 0.0005 0.029 -0.039 0.067 
rs11027857 A G 0.064 0.011 0.018 0.018 0.038 0.028 -0.106 0.064 
rs1106568 A G -0.069 0.013 -0.025 0.021 0.054 0.033 0.061 0.074 
rs111294930 A G 0.088 0.014 -0.004 0.024 -0.020 0.037 0.035 0.085 
rs11139497 A T 0.066 0.012 0.017 0.019 0.022 0.031 -0.084 0.070 
rs11191419 A T -0.102 0.012 -0.012 0.019 -0.001 0.031 0.122 0.070 
rs11210892 A G -0.068 0.012 -0.029 0.019 -0.063 0.030 0.074 0.068 
rs115329265 A G 0.196 0.016 0.030 0.023 0.038 0.038 -0.055 0.085 
rs11682175 T C -0.073 0.011 -0.015 0.018 -0.014 0.028 0.074 0.066 
rs11683083 A G -0.078 0.014 0.010 0.023 0.004 0.037 -0.056 0.084 
rs11685299 A C -0.066 0.012 0.006 0.019 0.003 0.030 -0.013 0.068 
rs11693094 T C -0.074 0.011 0.011 0.018 0.013 0.028 -0.076 0.065 
rs117074560 T C -0.157 0.028 -0.006 0.046 -0.057 0.075 -0.052 0.166 
rs12129573 A C 0.069 0.011 0.017 0.019 0.016 0.030 -0.094 0.067 




rs12325245 A T -0.086 0.016 -0.002 0.026 -0.014 0.043 -0.130 0.094 
rs12421382 T C -0.065 0.012 0.012 0.019 -0.022 0.030 0.089 0.069 
rs12522290 C G 0.082 0.015 -0.025 0.023 -0.034 0.037 -0.032 0.085 
rs12659129 T C 0.052 0.011 0.024 0.018 -0.010 0.028 0.043 0.065 
rs12691307 A G 0.072 0.011 -0.014 0.018 -0.015 0.029 0.203 0.066 
rs12704290 A G -0.106 0.017 -0.027 0.028 -0.059 0.044 0.127 0.102 
rs12887734 T G 0.088 0.012 0.017 0.020 -0.038 0.032 -0.079 0.073 
rs12903146 A G 0.067 0.011 0.022 0.018 0.052 0.029 -0.048 0.064 
rs13074054 A G 0.077 0.014 -0.033 0.022 -0.062 0.035 0.088 0.079 
rs13240464 T C 0.081 0.012 0.021 0.019 0.001 0.030 0.004 0.068 
rs1339227 T C -0.063 0.011 0.002 0.019 -0.013 0.030 -0.019 0.068 
rs140505938 T C -0.090 0.015 0.036 0.024 -0.035 0.038 -0.047 0.086 
rs14403 T C -0.067 0.013 -0.012 0.022 -0.013 0.034 -0.035 0.079 
rs1498232 T C 0.072 0.012 -0.013 0.020 0.005 0.031 0.005 0.071 
rs1501357 T C -0.069 0.014 0.001 0.023 0.022 0.037 -0.025 0.082 
rs16867576 A G 0.096 0.017 -0.033 0.026 -0.017 0.042 -0.098 0.096 
rs1702294 T C -0.118 0.014 0.011 0.023 0.067 0.037 0.004 0.084 
rs17149781 A G -0.086 0.017 -0.028 0.028 0.027 0.045 -0.152 0.102 
rs17194490 T G 0.097 0.015 -0.023 0.024 -0.014 0.038 0.070 0.088 
rs190065944 A G 0.077 0.014 -0.016 0.019 0.001 0.031 0.043 0.069 
rs2007044 A G -0.092 0.011 0.001 0.018 0.006 0.030 0.003 0.067 
rs2053079 A G -0.072 0.013 -0.008 0.021 0.067 0.034 0.135 0.076 
rs2068012 T C -0.070 0.013 -0.042 0.021 -0.043 0.032 0.096 0.076 
rs211829 T C 0.054 0.011 -0.015 0.019 0.003 0.029 0.065 0.067 
rs215411 A T 0.069 0.012 0.016 0.019 -0.002 0.030 -0.036 0.069 




rs2332700 C G 0.077 0.013 0.003 0.020 -0.017 0.032 0.053 0.074 
rs2514218 T C -0.072 0.012 -0.016 0.019 -0.003 0.030 0.104 0.069 
rs2535627 T C 0.070 0.011 -0.006 0.018 -0.025 0.028 -0.029 0.064 
rs2693698 A G -0.062 0.011 0.008 0.018 0.019 0.028 -0.042 0.064 
rs2851447 C G -0.084 0.012 0.046 0.021 0.026 0.033 -0.162 0.075 
rs2905426 T G -0.068 0.012 0.014 0.019 0.029 0.030 0.092 0.069 
rs2909457 A G -0.060 0.011 0.006 0.018 0.016 0.028 -0.059 0.064 
rs2973155 T C -0.067 0.011 0.014 0.018 0.026 0.029 0.027 0.067 
rs324017 A C -0.064 0.012 0.008 0.019 -0.007 0.032 0.032 0.071 
rs35518360 A T -0.145 0.020 -0.023 0.037 -0.051 0.058 -0.077 0.132 
rs36068923 A G -0.084 0.013 -0.008 0.022 -0.055 0.035 0.041 0.079 
rs3735025 T C 0.063 0.011 -0.001 0.019 -0.019 0.030 -0.072 0.067 
rs3768644 A G -0.094 0.018 0.023 0.028 0.098 0.045 0.005 0.102 
rs3849046 T C 0.062 0.011 -0.007 0.018 -0.017 0.028 0.025 0.064 
rs4128242 T C 0.067 0.011 0.029 0.018 0.031 0.029 -0.079 0.066 
rs4129585 A C 0.079 0.011 -0.009 0.018 -0.011 0.028 0.034 0.065 
rs4240748 C G -0.057 0.011 -0.028 0.018 -0.051 0.029 0.033 0.066 
rs4330281 T C -0.058 0.011 0.003 0.018 0.019 0.028 0.015 0.064 
rs4388249 T C 0.067 0.014 0.018 0.025 0.011 0.040 0.168 0.089 
rs4391122 A G -0.078 0.011 0.020 0.018 0.056 0.029 0.033 0.066 
rs4523957 T G 0.070 0.012 0.006 0.019 -0.023 0.030 -0.095 0.069 
rs4648845 T C 0.067 0.012 0.003 0.019 0.030 0.031 -0.095 0.070 
rs4702 A G -0.081 0.012 -0.018 0.018 -0.031 0.029 0.130 0.065 
rs4766428 T C 0.069 0.011 0.001 0.019 0.048 0.030 -0.072 0.070 
rs55661361 A G -0.079 0.012 0.001 0.019 -0.023 0.030 -0.140 0.069 




rs56205728 A G 0.066 0.013 0.026 0.022 -0.043 0.034 0.072 0.078 
rs56873913 T G 0.066 0.013 0.003 0.022 -0.032 0.035 -0.007 0.079 
rs59979824 A C -0.071 0.012 -0.023 0.020 -0.002 0.031 0.027 0.070 
rs6002655 T C 0.069 0.011 -0.022 0.019 0.016 0.029 0.064 0.067 
rs6065094 A G -0.075 0.012 -0.0004 0.019 -0.013 0.030 0.001 0.069 
rs6434928 A G -0.079 0.012 -0.012 0.019 -0.026 0.030 -0.103 0.069 
rs6461049 T C 0.080 0.011 -0.012 0.018 -0.005 0.029 0.120 0.065 
rs6466055 A C 0.069 0.011 0.009 0.019 0.030 0.030 0.005 0.067 
rs6670165 T C 0.074 0.014 0.024 0.023 0.019 0.036 -0.042 0.083 
rs6704641 A G 0.075 0.015 -0.024 0.024 -0.003 0.038 0.177 0.086 
rs6704768 A G -0.077 0.011 0.010 0.018 -0.015 0.028 0.054 0.065 
rs679087 A C -0.064 0.012 -0.018 0.019 -0.012 0.031 -0.061 0.070 
rs6984242 A G -0.062 0.011 0.021 0.018 0.008 0.029 -0.133 0.066 
rs715170 T C -0.067 0.012 -0.015 0.020 0.011 0.032 0.041 0.072 
rs7267348 T C -0.066 0.013 -0.002 0.021 -0.009 0.034 0.026 0.076 
rs72934570 T C -0.145 0.021 -0.031 0.032 -0.040 0.051 0.070 0.117 
rs73229090 A C -0.099 0.018 0.024 0.028 0.013 0.045 0.014 0.101 
rs7405404 T C 0.077 0.013 0.001 0.021 0.009 0.034 -0.112 0.076 
rs7432375 A G -0.071 0.011 0.010 0.018 0.023 0.030 0.034 0.066 
rs75059851 A G 0.091 0.014 -0.015 0.023 -0.034 0.036 0.198 0.083 
rs7523273 A G 0.060 0.012 0.0003 0.019 -0.041 0.030 0.019 0.069 
rs75575209 A T -0.112 0.019 0.030 0.032 0.019 0.050 0.030 0.115 
rs75968099 T C 0.080 0.011 -0.006 0.019 -0.018 0.029 0.065 0.068 
rs7730110 T C -0.059 0.011 0.029 0.019 -0.004 0.030 -0.043 0.069 
rs77502336 C G 0.062 0.012 -0.011 0.019 -0.018 0.030 0.144 0.070 




rs7819570 T G 0.076 0.014 0.032 0.025 -0.002 0.039 0.037 0.089 
rs78322266 T G 0.177 0.031 0.079 0.061 0.054 0.090 -0.032 0.217 
rs7893279 T G 0.112 0.018 -0.020 0.028 0.005 0.045 -0.027 0.100 
rs7907645 T G 0.144 0.022 -0.052 0.041 -0.030 0.063 -0.134 0.146 
rs79212538 T G 0.141 0.026 -0.016 0.045 0.062 0.071 -0.128 0.163 
rs8042374 A G 0.090 0.013 0.030 0.021 0.064 0.034 -0.027 0.076 
rs8044995 A G 0.077 0.014 0.018 0.024 0.009 0.037 -0.093 0.086 
rs8082590 A G -0.066 0.012 0.0001 0.019 -0.007 0.031 0.130 0.070 
rs832187 T C -0.070 0.011 0.001 0.019 0.006 0.030 0.040 0.068 
rs9420 A G 0.058 0.011 0.019 0.019 0.008 0.030 0.001 0.069 
rs950169 T C -0.079 0.012 -0.014 0.020 -0.031 0.032 0.073 0.073 
rs9607782 A T 0.089 0.013 0.006 0.021 -0.004 0.034 0.043 0.076 
rs9636107 A G -0.080 0.011 -0.029 0.018 -0.048 0.029 0.046 0.065 
rs9841616 A T -0.074 0.015 0.030 0.023 0.049 0.037 -0.069 0.084 
rs9922678 A G 0.068 0.012 -0.002 0.019 0.002 0.030 0.033 0.070 
a Schizophrenia genetic data from the PGC GWAS; b Parity at 85 months post index child data from ALSPAC G0; c Parity at 18 years post index child data 





Appendix 17 List of SNPs associated with schizophrenia (p<5×10-8) and associations with number of number of sexual partners and having had a child yet in 
ALSPAC G1 data. 
      Schizophreniaa 
No. of sexual 
partnersb 









ln(OR) SE β SE β SE ln(OR) SE 
rs10043984 T C 0.064 0.012 -0.132 0.337 0.123 0.317 0.107 0.115 
rs1023500 T C 0.076 0.014 -0.534 0.365 -0.509 0.345 0.143 0.131 
rs10503253 A C 0.072 0.013 0.194 0.368 0.081 0.348 -0.297 0.142 
rs10520163 T C 0.058 0.011 -0.209 0.292 0.145 0.275 0.229 0.101 
rs10779702 A G 0.063 0.011 0.183 0.302 0.180 0.286 -0.208 0.108 
rs10791097 T G 0.077 0.011 -0.123 0.290 0.035 0.274 0.025 0.100 
rs10803138 A G -0.072 0.013 -0.199 0.334 -0.026 0.316 -0.020 0.114 
rs10860964 T C 0.063 0.011 -0.098 0.307 -0.267 0.287 0.071 0.109 
rs11027857 A G 0.064 0.011 0.018 0.294 0.033 0.276 0.092 0.102 
rs1106568 A G -0.069 0.013 0.292 0.338 0.283 0.319 0.130 0.120 
rs111294930 A G 0.088 0.014 -0.264 0.403 -0.537 0.372 -0.050 0.136 
rs11139497 A T 0.066 0.012 -0.063 0.315 0.215 0.298 -0.072 0.111 
rs11191419 A T -0.102 0.012 -0.220 0.313 0.000 0.300 -0.029 0.109 
rs11210892 A G -0.068 0.012 -0.117 0.312 0.048 0.294 0.139 0.111 
rs115329265 A G 0.196 0.016 -0.233 0.379 -0.012 0.357 -0.111 0.127 
rs11682175 T C -0.074 0.011 -0.491 0.296 -0.336 0.279 -0.039 0.104 
rs11683083 A G -0.078 0.014 -0.369 0.380 -0.208 0.357 -0.209 0.127 
rs11685299 A C -0.066 0.012 -0.328 0.316 -0.243 0.297 -0.039 0.108 
rs11693094 T C -0.074 0.011 -0.045 0.293 -0.190 0.277 0.103 0.102 




rs12129573 A C 0.069 0.011 -0.141 0.305 -0.226 0.285 0.143 0.105 
rs12148337 T C 0.057 0.011 -0.081 0.294 -0.235 0.276 0.054 0.102 
rs12325245 A T -0.086 0.016 0.216 0.434 0.046 0.407 0.136 0.155 
rs12421382 T C -0.065 0.012 -0.014 0.322 0.154 0.304 -0.076 0.111 
rs12522290 C G 0.082 0.015 0.041 0.378 0.048 0.356 -0.008 0.133 
rs12659129 T C 0.052 0.011 -0.023 0.294 -0.220 0.276 0.160 0.102 
rs12691307 A G 0.072 0.011 -0.045 0.296 -0.043 0.281 -0.056 0.106 
rs12704290 A G -0.106 0.017 -0.755 0.451 -0.562 0.427 0.259 0.147 
rs12887734 T G 0.088 0.012 0.282 0.327 0.146 0.306 0.320 0.110 
rs12903146 A G 0.067 0.011 0.057 0.290 0.093 0.274 0.171 0.103 
rs13074054 A G 0.077 0.014 0.005 0.354 -0.064 0.336 0.046 0.123 
rs13240464 T C 0.081 0.012 -0.064 0.312 0.142 0.295 0.005 0.109 
rs1339227 T C -0.063 0.011 -0.410 0.305 -0.220 0.286 -0.107 0.108 
rs140505938 T C -0.090 0.015 -0.050 0.392 0.348 0.366 0.129 0.133 
rs14403 T C -0.067 0.013 0.175 0.355 0.356 0.332 0.032 0.124 
rs1498232 T C 0.072 0.012 -0.352 0.319 -0.556 0.301 0.123 0.110 
rs1501357 T C -0.069 0.014 0.500 0.382 0.515 0.359 -0.018 0.132 
rs16867576 A G 0.096 0.017 -0.212 0.430 -0.305 0.402 -0.119 0.145 
rs1702294 T C -0.118 0.014 0.098 0.379 0.100 0.361 0.029 0.130 
rs17149781 A G -0.086 0.017 0.396 0.474 0.268 0.448 0.108 0.172 
rs17194490 T G 0.097 0.015 -0.549 0.395 -0.799 0.375 0.276 0.133 
rs190065944 A G 0.077 0.014 0.358 0.309 0.464 0.293 -0.103 0.110 
rs2007044 A G -0.093 0.011 -0.084 0.304 -0.066 0.289 -0.190 0.102 
rs2053079 A G -0.072 0.013 0.456 0.343 0.268 0.322 -0.150 0.116 
rs2068012 T C -0.070 0.013 0.276 0.356 0.415 0.335 -0.069 0.121 
rs211829 T C 0.054 0.011 -0.580 0.299 -0.526 0.282 0.112 0.107 




rs2239063 A C 0.069 0.012 0.307 0.328 0.343 0.308 0.001 0.113 
rs2332700 C G 0.077 0.013 -0.177 0.338 -0.116 0.319 -0.014 0.118 
rs2514218 T C -0.072 0.012 -0.241 0.315 -0.231 0.296 -0.149 0.111 
rs2535627 T C 0.070 0.011 -0.260 0.295 -0.183 0.279 -0.096 0.103 
rs2693698 A G -0.062 0.011 0.086 0.290 -0.114 0.273 -0.084 0.102 
rs2851447 C G -0.084 0.012 0.373 0.340 0.475 0.320 -0.055 0.118 
rs2905426 T G -0.068 0.012 0.453 0.313 0.403 0.295 -0.245 0.107 
rs2909457 A G -0.060 0.011 -0.561 0.292 -0.547 0.275 -0.037 0.102 
rs2973155 T C -0.067 0.011 -0.146 0.299 -0.244 0.283 0.107 0.104 
rs324017 A C -0.064 0.012 0.068 0.328 -0.045 0.306 0.206 0.110 
rs35518360 A T -0.145 0.020 -0.165 0.578 0.097 0.555 -0.052 0.205 
rs36068923 A G -0.084 0.013 0.552 0.362 0.420 0.339 0.017 0.125 
rs3735025 T C 0.063 0.011 0.073 0.300 0.216 0.284 0.119 0.106 
rs3768644 A G -0.094 0.018 -0.616 0.472 -0.258 0.441 -0.219 0.175 
rs3849046 T C 0.062 0.011 0.253 0.296 0.303 0.277 0.122 0.104 
rs4128242 T C 0.067 0.011 -0.061 0.297 0.092 0.280 0.105 0.104 
rs4129585 A C 0.079 0.011 -0.345 0.294 -0.180 0.276 -0.072 0.102 
rs4240748 C G -0.057 0.011 -0.256 0.299 -0.340 0.282 0.030 0.103 
rs4330281 T C -0.058 0.011 0.234 0.290 0.204 0.274 -0.039 0.101 
rs4388249 T C 0.067 0.014 -0.539 0.401 -0.412 0.381 -0.037 0.141 
rs4391122 A G -0.078 0.011 -0.524 0.299 -0.345 0.285 0.011 0.107 
rs4523957 T G 0.070 0.012 -0.868 0.316 -0.622 0.298 0.126 0.111 
rs4648845 T C 0.067 0.012 0.723 0.309 0.712 0.288 -0.071 0.114 
rs4702 A G -0.081 0.012 -0.290 0.297 -0.292 0.279 -0.056 0.104 
rs4766428 T C 0.069 0.011 0.727 0.314 0.440 0.300 0.026 0.111 
rs55661361 A G -0.079 0.012 0.159 0.313 0.205 0.293 0.007 0.110 




rs56205728 A G 0.066 0.013 0.948 0.376 0.728 0.354 0.050 0.126 
rs56873913 T G 0.066 0.013 -0.075 0.351 0.157 0.330 -0.011 0.122 
rs59979824 A C -0.071 0.012 0.227 0.323 0.255 0.302 -0.063 0.112 
rs6002655 T C 0.069 0.011 0.080 0.314 0.177 0.296 -0.023 0.109 
rs6065094 A G -0.075 0.012 0.665 0.305 0.575 0.290 0.180 0.105 
rs6434928 A G -0.079 0.012 0.100 0.311 -0.021 0.295 0.078 0.111 
rs6461049 T C 0.080 0.011 0.026 0.304 0.028 0.286 -0.085 0.106 
rs6466055 A C 0.069 0.011 0.328 0.305 0.476 0.288 0.228 0.106 
rs6670165 T C 0.074 0.014 0.837 0.365 0.632 0.349 -0.086 0.132 
rs6704641 A G 0.075 0.015 -0.693 0.393 -0.560 0.372 -0.039 0.135 
rs6704768 A G -0.077 0.011 -0.125 0.295 -0.225 0.276 0.096 0.103 
rs679087 A C -0.064 0.012 0.159 0.311 0.079 0.296 -0.105 0.110 
rs6984242 A G -0.062 0.011 0.134 0.297 0.026 0.280 0.035 0.104 
rs715170 T C -0.067 0.012 -0.293 0.329 -0.321 0.310 -0.072 0.119 
rs7267348 T C -0.066 0.013 -0.330 0.338 0.110 0.316 0.047 0.116 
rs72934570 T C -0.145 0.021 -0.194 0.521 -0.515 0.496 -0.123 0.185 
rs73229090 A C -0.100 0.018 -0.352 0.454 -0.426 0.426 -0.151 0.162 
rs7405404 T C 0.077 0.013 0.774 0.349 0.559 0.329 0.013 0.121 
rs7432375 A G -0.071 0.011 -0.042 0.299 -0.109 0.281 -0.191 0.109 
rs75059851 A G 0.091 0.014 -0.618 0.376 -0.397 0.354 0.061 0.135 
rs7523273 A G 0.060 0.012 -0.095 0.307 -0.290 0.291 -0.086 0.105 
rs75575209 A T -0.112 0.019 -0.706 0.519 -0.584 0.487 -0.452 0.161 
rs75968099 T C 0.080 0.011 -0.044 0.309 0.154 0.291 0.032 0.106 
rs7730110 T C -0.059 0.011 -0.519 0.310 -0.349 0.293 -0.286 0.105 
rs77502336 C G 0.062 0.012 -0.036 0.319 -0.226 0.301 -0.139 0.111 
rs7801375 A G -0.083 0.015 0.733 0.395 0.384 0.376 0.211 0.132 




rs78322266 T G 0.177 0.031 -0.790 0.921 -0.927 0.870 -0.127 0.342 
rs7893279 T G 0.112 0.018 0.370 0.448 0.665 0.424 -0.114 0.149 
rs7907645 T G 0.144 0.022 0.400 0.637 -0.332 0.609 0.095 0.235 
rs79212538 T G 0.141 0.026 0.124 0.788 -0.140 0.729 0.126 0.251 
rs8042374 A G 0.090 0.013 0.335 0.342 0.399 0.320 -0.147 0.116 
rs8044995 A G 0.077 0.014 0.187 0.387 -0.045 0.365 -0.304 0.148 
rs8082590 A G -0.066 0.012 -0.803 0.318 -0.670 0.298 -0.166 0.109 
rs832187 T C -0.070 0.011 -0.439 0.303 -0.200 0.287 0.090 0.106 
rs9420 A G 0.058 0.011 0.237 0.310 0.340 0.292 -0.076 0.111 
rs950169 T C -0.079 0.012 -0.259 0.335 -0.261 0.312 0.113 0.114 
rs9607782 A T 0.089 0.013 0.476 0.340 0.577 0.322 0.169 0.117 
rs9636107 A G -0.080 0.011 0.043 0.291 0.091 0.276 -0.056 0.103 
rs9841616 A T -0.074 0.015 -0.126 0.394 -0.041 0.371 0.142 0.134 
rs9922678 A G 0.068 0.012 -0.435 0.324 -0.088 0.306 -0.190 0.117 
a Schizophrenia genetic data from the PGC GWAS; b Number of sexual partners data from ALSPAC G1; c Number of sexual partners with 21-year data from 





Appendix 18 Estimates for associations between genetic scores with varying p-value thresholds and whether participants had ever smoked. 
 
UK Biobank 
(N = 335 957) 
ALSPAC G0 
(N = 7188) 
MoBa 
(N = 9360) 
ALSPAC G1 
(N = 2760) 
Genetic score for 
schizophrenia liability 
OR (95% CI), p 
Plink score     
p<5×10-8 1.002 (1.001, 1.003), 0.002 1.004 (0.958, 1.051), 0.87 1.011 (0.971, 1.053), 0.60 1.076 (0.995, 1.164), 0.07 
PRSice score     
p<1×10-5 - 1.061 (1.013, 1.111), 0.01 1.025 (0.984, 1.068), 0.24 - 
p<0.0005 - 1.069 (1.021, 1.120), 0.005 1.048 (1.006, 1.092), 0.03 - 
p<0.005 - 1.086 (1.037, 1.137), 0.001 1.059 (1.015, 1.104), 0.01 - 
p<0.05 - 1.107 (1.056, 1.159), <0.001 1.084 (1.039, 1.131), <0.001 - 
p<0.1 - 1.106 (1.056, 1.159), <0.001 1.100 (1.053, 1.15), <0.001 - 
p<0.5 - 1.113 (1.062, 1.166), <0.001 1.097 (1.05, 1.146), <0.001 - 





 Appendix 19 Genetic correlations of genetic liability for schizophrenia and number of 
children, age at first birth and number of sexual partners using LD score regression with 
outcome summary statistics also adjusted for genotype array (UK Biobank analyses). 
  No. of childrena Age at first birthb Number of sexual partnersc 
  rg SE p rg SE p rg SE p 
Genetic liability for 
schizophreniad 0.002 0.01 0.84 -0.007 0.01 0.44 0.007 0.01 0.43 
a Number of children data from UK Biobank (N = 333,628); b Age at first birth data from 
UK Biobank (N = 123 310); c Number of sexual partners data from UK Biobank (N = 






Appendix 20 Funnel plot for Cochran's Q values for genetic liability for schizophrenia in 






Appendix 21 Estimates of the causal effect of genetic liability for schizophrenia on 
outcomes using IVW, MBE and weighted median MR methods with cases of 
schizophrenia removed (UK Biobank analyses). 
 No. of childrenb Age at first birthc Number of sexual partnersd 
Method (101 
SNPsa) 
β (95% CI), p 
IVW 0.003 (-0.003, 0.009), 0.33 -0.004 (-0.043, 0.035), 0.83 0.166 (0.118, 0.213), <0.001 
Weighted 
Median 
0.006 (-0.004, 0.016), 0.23 0.027 (-0.036, 0.090), 0.41 0.179 (0.099, 0.258), <0.001 
MBE 0.021 (-0.011, 0.053), 0.21 0.063 (-0.169, 0.295), 0.60 0.261 (-0.024. 0.546), 0.08 
a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 
controls); b Number of children data from UK Biobank (N = 318 735 - 335 562). c Age at 
first birth data from UK Biobank (N = 117 822 - 124 069). d Number of sexual partners 





 Appendix 22 Estimates of the causal effect of genetic liability for schizophrenia on outcomes using IVW, MBE and weighted median MR methods with 
outcome summary statistics also adjusted for genotype array (UK Biobank analyses). 
 No. of childrenb Age at first birthc Number of sexual partnersd Childlessnesse 




β (95% CI), p OR (95% CI), p 
IVW 0.003 (-0.003, 0.009), 0.39 -0.004 (-0.043, 0.035), 0.84 0.165 (0.117, 0.212), <0.001 0.998 (0.985, 1.012), 0.79 1.057 (1.038, 1.077), <0.001 
Weighted 
Median 
0.006 (-0.003, 0.015), 0.22 0.018 (-0.047, 0.083), 0.59 0.171 (0.091, 0.250), <0.001 0.996 (0.975, 1.017), 0.68 1.035 (1.003, 1.068), 0.04 
MBE 0.020 (-0.011, 0.052), 0.21 0.050 (-0.175, 0.275), 0.66 0.385 (-0.034. 0.805), 0.08 0.993 (0.924, 1.068), 0.85 1.011 (0.884, 1.155), 0.88 
a Schizophrenia genetic data from the PGC GWAS (N= 35 123 cases and 109 657 controls); b Number of children data from UK Biobank (N = 318 921 – 335 
758). c Age at first birth data from UK Biobank (N = 117 844 – 124 093). d Number of sexual partners data from UK Biobank (N = 261 931- 275 700); e 





Appendix 23 Genetic score for schizophrenia liability (in deciles) and mean number of 






Appendix 24 Number of children and mean genetic score for schizophrenia liability in 



















































Appendix 25 Associations of the score for genetic liability for schizophrenia and outcomes removing cumulative deciles of the score, with cases of 
schizophrenia removed in UK Biobank data. 
  Number of children Age at first birth Number of sexual partners 
Schizophrenia 
genetic score 
β (95% CI), p 
Highest 10% 
removed 
0.0005 (-0.0002, 0.0013), 0.18 
N = 302 011 
-0.004 (-0.008, 0.001), 0.15 
N = 111 599 
0.011 (0.005, 0.017), <0.001 
N = 248 143 
Highest 20% 
removed 
0.0002 (-0.0007, 0.0011), 0.69 
N = 268 439 
-0.005 (-0.010, 0.001), 0.15 
N = 99 106 
0.012 (0.005, 0.019), <0.001 
N = 220 745 
Highest 30% 
removed 
0.0005 (-0.0006, 0.0016), 0.37 
N = 234 886 
-0.008 (-0.014, -0.001), 0.03 
N = 86 593 
0.017 (0.008, 0.025), <0.001 
N = 193 259 
Highest 40% 
removed 
0.0006 (-0.0006, 0.0019), 0.32 
N = 208 339  
-0.009 (-0.016, -0.001), 0.02 
N = 76 821 
0.015 (0.006, 0.025), <0.001 
N = 171 511 
Highest 50% 
removed 
0.0008 (-0.0006, 0.0023), 0.29 
N = 167 780 
-0.008 (-0.018, 0.001). 0.08 
N = 61 811 
0.012 (0.001, 0.024), 0.03 






Appendix 26 Curve for prediction for fitness from a linear regression of a genetic score 
for schizophrenia liability on number of children and a squared genetic score for 






Appendix 27 Curve for prediction for fitness from a linear regression of a genetic score 
for schizophrenia liability on number of children and a squared genetic score for 





Appendix 28 Curve for prediction for fitness from a linear regression of a genetic score 
for schizophrenia liability on number of children and a squared genetic score for 






Appendix 29 Funnel plot for Cochran's Q values for genetic liability for schizophrenia in 






Appendix 30 Curve for prediction for fitness from a linear regression of a genetic score 
for schizophrenia liability on parity and a squared genetic score for schizophrenia 






Appendix 31 Funnel plot for Cochran's Q values for genetic liability for schizophrenia in 







Appendix 32 Curve for prediction for fitness from a linear regression of a genetic score 
for schizophrenia liability on parity at 85 months post index child and a squared genetic 






Appendix 33 Curve for prediction for fitness from a linear regression of a genetic score 
for schizophrenia liability on parity at 18 years post index child and a squared genetic 






Appendix 34 Funnel plot for Cochran's Q values for genetic liability for schizophrenia in 







Appendix 35 Genetic score for schizophrenia liability (in deciles) and mean number of 





Appendix 36 Whether individuals had the highest number of sexual partners and mean 






Appendix 37 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners and a squared genetic score for 






Appendix 38 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners and a squared genetic score for 






Appendix 39 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners and a squared genetic score for 





Appendix 40 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners and a squared genetic score for 






Appendix 41 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners and a squared genetic score for 






Appendix 42 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners and a squared genetic score for 






Appendix 43 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners (plus 21-year data) and a squared 






Appendix 44 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners (plus 21-year data) and a squared 






Appendix 45 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on number of sexual partners (plus 21-year data) and a squared 






Appendix 46 Genetic score for schizophrenia liability (in deciles) and mean age at first 





Appendix 47 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on age at first birth and a squared genetic score for schizophrenia 






Appendix 48 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on age at first pregnancy and a squared genetic score for 






Appendix 49 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on age at first birth and a squared genetic score for schizophrenia 







Appendix 50 Curve for prediction from a linear regression of a genetic score for 
schizophrenia liability on age at first pregnancy and a squared genetic score for 






Appendix 51 Analyses using publicly available GWAS outcome data. 
Genetic liability for schizophrenia 
I used MR analyses of summary level results from GWAS to assess causal associations 
between genetic liability for schizophrenia and number of children. Here, I used SNPs 
associated with schizophrenia (p<5×10-8) from the PGC GWAS (Schizophrenia Working 
Group of the Psychiatric Genomics Consortium, 2014) and extracted the SNPs, or 
available proxy SNPs for them, from the SSGAC meta-analysis GWAS for number ever 
born (i.e., number of children) in combined sexes (N= 279 161 to 343 033) (Barban et al., 
2016). This analysis used GWAS estimates that were not restricted to the European 
sample for schizophrenia. Seventy-four SNPs were not available in the number of 
children data. Of these, I found proxies for 48 unavailable SNPs, using a LD r2 of 0.8 or 
above, through SNiPA or proxies used previously (Arnold et al., 2015; Gage et al., 2017). 
Where palindromic SNPs were used, the MAF was checked to ensure there were no 
issues with strand mismatches. There were no palindromic SNPs with MAF around 0.5. 
The final 102 SNPs and effect sizes for the schizophrenia risk and number of children 
analysis are listed in Appendix 52. These associations for SNP-number of children were 
recorded, taking the standardized beta coefficients and the corresponding SEs. The SEs 
for number of children were based on MAF and phenotypic variance (Barban et al., 
2016). Data were harmonized to ensure that effect of SNP on the exposure and the SNP 
on the outcome corresponded to the same allele. SNP-exposure and SNP-outcome data 
were combined using an IVW, MBE and weighted median regression to give causal 
estimates.  
Results 
There was some evidence that higher genetic liability for schizophrenia increased number 
of children (mean difference: 0.008 SD increase in number of children per doubling in the 
natural log OR of schizophrenia liability, 95% CI: 0.001 to 0.015) using an IVW 
approach. The Cochran’s Q for this analysis was 160.36 (p<0.001). Weighted median 
estimates were consistent with the main findings. An MBE approach showed no effect of 
risk of schizophrenia on number of children, although again estimates were in the 
direction of a reproductive advantage (see Appendix 53). It must be noted that the I2GX 
statistic for an unweighted MR-Egger regression in schizophrenia risk and number of 
children analysis was 0.2 and MR-Egger regression could not be conducted (Bowden, 
Fabiola Del Greco, et al., 2016). The mean F statistic for MR-Egger regression of 




Appendix 52 List of SNPs associated with schizophrenia (p<5×10−8) and proxies where 
used for GWAS summary data outcome analysis. 
SNP 
Original SNP if 
proxy used 




β SE β SE 
rs1009080 rs1498232 0.99 -0.069 0.012 0.006 0.004 
rs1023500   0.074 0.014 0.000 0.004 
rs10503253   0.071 0.013 -0.006 0.004 
rs10504857 rs7819570 1.00 -0.075 0.014 0.003 0.005 
rs10520163   0.061 0.011 0.000 0.003 
rs10779702 chr1_8424984_D 0.97 0.064 0.011 0.002 0.004 
rs10791097   0.074 0.011 0.007 0.003 
rs10803138   -0.071 0.013 0.002 0.004 
rs10860964   0.059 0.011 -0.001 0.004 
rs10900851 rs10043984 0.99 -0.067 0.012 0.002 0.004 
rs10933068 rs11685299 1.00 -0.062 0.011 -0.007 0.004 
rs11027857   0.063 0.011 0.007 0.003 
rs1106568   -0.069 0.012 -0.010 0.004 
rs11139497   0.068 0.012 -0.008 0.004 
rs11210892   -0.070 0.011 -0.006 0.004 
rs1160682 rs12129573 1.00 -0.069 0.011 -0.005 0.004 
rs11632947 rs12903146 0.99 0.065 0.011 0.004 0.003 
rs11682175   -0.074 0.011 0.000 0.003 
rs11683083 chr2_146436222_I 1.00 -0.079 0.014 0.004 0.005 
rs12063329 rs140505938 1.00 0.088 0.015 -0.004 0.005 
rs12148337   0.057 0.011 0.000 0.003 
rs12325245   -0.087 0.015 -0.001 0.005 
rs12421382   -0.059 0.011 0.000 0.004 
rs12522290   0.082 0.015 0.009 0.005 
rs12619354 rs59979824 0.87 0.056 0.011 -0.001 0.004 
rs12654855 rs79212538 0.95 -0.112 0.024 -0.020 0.008 
rs12659129 chr5_140143664_I 1.00 0.052 0.011 0.003 0.003 
rs12716972 rs12691307 0.98 0.062 0.011 -0.002 0.003 
rs13074054 chr3_180594593_I 0.99 0.081 0.013 0.004 0.004 
rs13107325 rs35518360 0.85 0.152 0.022 0.004 0.007 
rs1339227   -0.060 0.011 -0.001 0.004 
rs1501357   -0.077 0.013 -0.001 0.005 
rs16867576   0.096 0.017 -0.009 0.005 
rs17049247 rs75575209 0.97 -0.103 0.019 0.009 0.006 




rs17194490   0.097 0.015 -0.006 0.005 
rs17273111 rs4330281 1.00 0.057 0.011 -0.004 0.003 
rs17594526 rs78322266 1.00 0.169 0.031 0.013 0.010 
rs17602354 rs72934570 0.92 0.141 0.021 -0.001 0.006 
rs1782810 rs1702294 0.99 0.115 0.014 0.008 0.004 
rs2007044   -0.092 0.011 0.004 0.004 
rs2053079   -0.073 0.012 -0.003 0.004 
rs2057070 rs9607782 0.81 -0.066 0.012 0.002 0.004 
rs2068012   -0.069 0.013 0.005 0.004 
rs211829   0.055 0.011 0.003 0.004 
rs215411   0.065 0.011 -0.009 0.004 
rs2239063   0.069 0.012 0.006 0.004 
rs2514218   -0.072 0.012 -0.001 0.004 
rs2535627   0.070 0.011 0.007 0.003 
rs2693698   -0.063 0.011 -0.004 0.004 
rs2796275 rs7523273 0.98 0.054 0.012 -0.002 0.004 
rs2851447   -0.091 0.012 0.001 0.004 
rs2965180 rs2905426 0.97 0.061 0.011 0.000 0.004 
rs2973161 rs2973155 0.97 -0.065 0.011 -0.008 0.004 
rs324015 rs324017 0.81 -0.064 0.012 0.001 0.004 
rs3802924 rs75059851 0.95 0.089 0.013 0.006 0.004 
rs3849046   0.063 0.011 0.000 0.003 
rs4128242 chr18_52749216_D 1.00 0.070 0.011 -0.001 0.004 
rs4129585   0.078 0.011 -0.005 0.003 
rs4240748   -0.059 0.011 0.002 0.004 
rs436124 rs679087 1.00 0.059 0.011 -0.002 0.004 
rs4388249   0.072 0.014 -0.009 0.005 
rs4391122   -0.079 0.011 -0.002 0.003 
rs4518583 rs3735025 1.00 0.061 0.011 -0.005 0.004 
rs4523957   0.068 0.011 -0.004 0.004 
rs4648845   0.069 0.012 0.009 0.004 
rs4702   -0.078 0.011 -0.002 0.004 
rs6065094   -0.074 0.011 -0.002 0.004 
rs6461049 chr7_2025096_I 0.93 0.078 0.011 0.003 0.004 
rs6466056 rs6466055 1.00 0.066 0.011 0.003 0.004 
rs6670165   0.071 0.014 0.004 0.004 
rs6704641   0.076 0.014 0.005 0.005 
rs6704768   -0.074 0.011 -0.001 0.004 
rs7085104 rs11191419 0.99 0.094 0.011 0.003 0.004 




rs715170   -0.066 0.012 0.002 0.004 
rs7267348   -0.064 0.012 0.006 0.004 
rs7432375   -0.071 0.011 -0.001 0.004 
rs7499750 rs7405404 1.00 0.078 0.013 -0.005 0.004 
rs7730110 rs11740474 0.81 -0.057 0.011 -0.003 0.004 
rs7801375   -0.083 0.015 -0.001 0.005 
rs7815859 rs36068923 1.00 0.084 0.013 -0.001 0.004 
rs7893279   0.113 0.017 -0.005 0.005 
rs7927176 rs77502336 0.96 -0.064 0.011 0.000 0.004 
rs8042374   0.087 0.012 -0.004 0.004 
rs8044995   0.078 0.014 -0.005 0.005 
rs832187   -0.061 0.011 -0.003 0.004 
rs867743 rs6984242 1.00 -0.064 0.011 -0.003 0.004 
rs884808 rs14403 0.86 -0.052 0.013 0.002 0.004 
rs9420   0.061 0.011 -0.004 0.004 
rs950169   -0.079 0.012 -0.009 0.004 
rs9636107   -0.076 0.011 -0.010 0.003 
rs982256 rs13240464 0.98 0.077 0.011 0.000 0.004 
rs9841616   -0.081 0.014 -0.009 0.005 
rs9876421 rs75968099 0.93 0.078 0.011 -0.013 0.004 
rs9922678   0.067 0.012 0.004 0.004 
rs6579959 rs111294930 0.96 -0.064 0.012 0.000 0.004 
rs4664442 rs2909457 0.98 0.058 0.011 0.000 0.003 
rs2296569 rs55833108 0.83 -0.068 0.014 0.001 0.004 
rs10412446 rs56873913 0.97 0.056 0.013 0.001 0.004 
rs787983 rs6434928 0.98 -0.072 0.011 -0.012 0.004 






Appendix 53 Estimates of the causal effect of genetic liability for schizophrenia on 
number of children using IVW, MBE and weighted median MR methods in combined 
sexes. 
Method β 95% CI p 
Number of children: 102 SNPs    
IVW 0.008 0.001, 0.015 0.03 
Weighted median 0.008 -0.003, 0.020 0.14 
MBE 0.008 -0.036, 0.051 0.99 
 
